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Abstract
Breast cancer is one of the most common types of cancer worldwide, and standard-of-care
for early-stage disease typically involves a lumpectomy or breast-conserving surgery
(BCS). BCS involves the local resection of cancerous tissue, while sparring as much
healthy tissue as possible. State-of-the-art methods for intraoperatively evaluating BCS
margins are limited. Approximately 20% of BCS cases result in a tissue resection with
cancer at or near the resection surface (i.e., a positive margin). A two-fold increase in
ipsilateral breast cancer recurrence is associated with the presence of one or more positive
margins. Consequently, positive margins often necessitate costly re-excision procedures to
achieve a curative outcome. X-ray micro-computed tomography (micro-CT) is emerging
as a powerful ex vivo specimen imaging technology, as it provides robust three-dimensional
sensing of tumor morphology rapidly. However, X-ray attenuation lacks contrast between
soft tissues that are important for surgical decision making during BCS. Optical structured
light imaging, including spatial frequency domain imaging and active line scan imaging,
can act as adjuvant tools to complement micro-CT, providing wide field-of-view, noncontact sensing of relevant breast tissue subtypes on resection margins that cannot be
differentiated by micro-CT alone. This thesis is dedicated to multimodal imaging of BCS
tissues to ultimately improve intraoperative BCS margin assessment, reducing the number
of positive margins after initial surgeries and thereby reducing the need for costly followup procedures. Volumetric sensing of micro-CT is combined with surface-weighted, subdiffuse optical reflectance derived from high spatial frequency structured light imaging.
Sub-diffuse reflectance plays the key role of providing enhanced contrast to a suite of
normal, abnormal benign, and malignant breast tissue subtypes. This finding is
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corroborated through clinical studies imaging BCS specimen slices post-operatively and is
further investigated through an observational clinical trial focused on combined,
intraoperative micro-CT and optical imaging of whole, freshly resected BCS tumors. The
central thesis of this work is that combining volumetric X-ray imaging and sub-diffuse
optical scanning provides a synergistic, multimodal imaging solution to margin
assessment, one that can be readily implemented or retrofitted in X-ray specimen imaging
systems and that could meaningfully improve surgical guidance during initial BCS
procedures.
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Chapter 1 Introduction
1.1 How to read this thesis
This thesis is based on the findings of six peer-reviewed, technical publications (Chapter 2
through Chapter 7) and one clinical manuscript currently in preparation (Chapter 8). Each
chapter is tied to a specific paper or manuscript. All figures and tables presented in this
thesis were included in these peer-reviewed publications, unless explicitly stated otherwise.
The studies presented in Chapter 4 through Chapter 6 used the same breast cancer tissue
image dataset; therefore, content related to the imaging protocol and imaging system is the
same in these chapters. For a high-level overview, including key results and final remarks
from each chapter, refer to Chapter 9. Finally, note that an effort was made to define all
abbreviations, acronyms, and variables at first use in each chapter. Please refer to the List
of Abbreviations, Acronyms, and Variables section at the beginning of this thesis as
needed.

1.2 Problem statement
In 2021, breast cancer became the most common cancer globally (excluding nonmelanoma
skin cancer), accounting for 12% of all new annual cancer diagnoses worldwide [1]. Breast
cancer is currently the second-leading cause of cancer death among women in the United
States [2]. A lumpectomy or breast-conserving surgery (BCS) involves local excision of
breast cancer with a surrounding margin of healthy tissue. The goal of BCS is to completely
resect the cancer while sparing healthy tissue and preserving the shape and appearance of
the breast. For early-stage cancers, BCS achieves equivalent disease-free survival as
mastectomy [3,4]. Thus, BCS in combination with radiation therapy is the most common
treatment for in situ (i.e., stage 0) and early-stage (i.e., stage I and II) breast cancers [5] and
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is used to treat some advanced stage cancers following successful neoadjuvant therapy [6].
Several studies document the association of positive margins with ipsilateral breast
tumor recurrence [7–13]. A 2014 consensus report by the Society of Surgical Oncology
(SSO) and American Society for Radiation Oncology (ASTRO), based on a meta-analysis
of 33 studies and nearly 30,000 patients, concluded that a positive margin (i.e., cancer cells
on the outer surface of a resection) is associated with a two-fold increase in risk of
ipsilateral breast cancer recurrence [14]. Thus, the success of BCS hinges on the ability of
the surgical team to assess resection margins thoroughly and rapidly during the initial
procedure.
The surface of a BCS resection is comprised of six anatomical margins: cranial,
caudal, medial, lateral, anterior (a.k.a. superficial), and posterior (a.k.a. deep). Current
state-of-the-art methods for intraoperative margin assessment in BCS include visual
inspection and palpation of the resected tissue, meticulous recording of resection
anatomical orientation using surgical ink and/or sutures, two-dimensional (2D) specimen
radiography (i.e., projection X-ray imaging), radiosensitive wire or surgical clip
localization, and at some medical centers, routine circumferential cavity shaving and/or
intraoperative pathological processing (i.e., frozen section pathology and/or touch prep
cytology) [15]. Wire or surgical clip localization is used to identify the approximate center
of nonpalpable cancers but offers little information about the extent of disease. Although
intraoperative pathological processing provides high diagnostic accuracy (sensitivities of
73-91%) [16–19], these methods are resource-intensive and suffer from slow turnaround
times (~30 minutes per case) [16,18], limiting their widespread adoption. Routine
circumferential cavity shaving has been shown to reduce re-excision rates substantially
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(rates of 8-10% with vs. 21-24% without routine cavity shaving) [20–22]; however, the
technique necessitates the removal of increased volumes of tissue, raising cosmetic
concerns [18] and significantly increasing procedural costs [21]. X-ray-based specimen
radiography is a mainstay for intraoperative margin assessment. The tissue is imaged
immediately after resection, and within minutes, a radiologist interprets the radiograph and
notifies the surgeon of suspicious peripheral margins revealed in the 2D image. A
suspicious margin may warrant the removal of additional tissue from the surgical cavity (a
so-called “targeted cavity shave”). Importantly, overlapping features and the margins
normal to the imaging axis (typically the superficial and deep margins) are occluded in the
projection and cannot be assessed thoroughly. This limitation may contribute to the fact
that specimen radiography suffers from relatively low sensitivity for assessing margin
status (pooled sensitivity of 53% from nine studies [18]). Furthermore, the predictive value
of standard radiography is low for ductal carcinoma in situ (DCIS), pre-invasive cancer
that is frequently nonpalpable, discontinuous, and responsible for one of the largest shares
of positive margins [23]. The specimen subsequently undergoes post-operative
pathological processing to determine final margin status, including bread-loaf slicing,
fixation and staining with hematoxylin and eosin, and microscopic evaluation of margins.
An overview of standard-of-care margin assessment is shown in Figure 1.1.
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Figure 1.1 Overview of standard-of-care margin assessment and histopathological processing of a breastconserving surgery resection. Steps progress from (a) through (e). OR = operating room.

This standard histopathological process takes several hours to days to complete. If residual
tumor is identified on the margin via post-operative, standard-of-care pathological
processing, a re-excision procedure is typically required.
SSO-ASTRO consensus guidelines published in 2014 defined a positive margin as
“tumor on ink” for invasive cancers [14]. Additional consensus guidelines published in
2016 defined a positive margin as <2 mm for resections containing only pre-invasive DCIS
(though the “tumor on ink” rule applies if the resection has both invasive and pre-invasive
components) [24]. Prior to these guidelines, several studies reported BCS re-excision rates
>20% (22-60%) [25–31]. The SSO-ASTRO guidelines led to a statistically significant
reduction in re-excision rates in recent years [23,32], but the clinical problem is not solved.
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First, the overall re-excision rate due to positive margins remains relatively high: 17.2%
based on a recent analysis of Medicare claims, which found that a total of 185,227 initial
BCS cases resulted in 31,949 re-excisions between 2014 and 2017 [31]; and 18.8% based
on a very recent study at one integrated healthcare consortium, which tracked 9,054 total
BCS procedures between 2016 and 2020 [33]. Second, a recent metanalysis of 30 peerreviewed clinical studies between 2014 and 2019 found a wide range of overall re-excision
rates (1-23%) [32]. Third, significant inter-surgeon variability exists in initial BCS
performance: based on 3,954 initial BCS cases documented in the American Society of
Breast Surgeons Mastery registry in 2017, an eightfold difference between surgeons in the
10th and 90th percentile performance groups was observed (3% vs. 25%, n = 71 surgeons)
[23]. Several studies report the negative cosmetic [34,35] and financial impacts [36–42]
that BCS re-excision procedures pose to patients and healthcare system. A need exists for
improving intraoperative margin assessment, such that positive margin rates, and thus reexcision procedures, become less frequent.

1.3 Proposed alternative solutions
Identification of cancer at the margin is a spatial detection problem, filtered visually by
pathology technicians and pathologists performing labor-intensive searches of tissue
sections. Proposed techniques to improve intraoperative BCS margin assessment strive to
emulate the performance of histopathological analysis but in a timeframe relevant for
surgical guidance (ideally, ≤10 minutes per the guidance of Surgical Oncology at
Dartmouth Health). Many alternative methods and technologies have been investigated for
BCS margin assessment. Proposed solutions include radiofrequency spectroscopy [43],
bioimpedance spectroscopy [44], specimen magnetic resonance imaging [45,46],
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ultrasound [47], specimen micro-computed tomography (micro-CT) [48,49], and a host of
optical imaging methods. Optical methods span a wide range of implementations,
formfactors, and mechanisms of contrast, including diffuse spectroscopy [50], Raman
spectroscopy [51], Cerenkov luminescence [52], optical coherence tomography [53], and
fluorescent probes [54–56].
Each technique presents pros and cons, and the interested reader is directed to
several recent reviews of these methods [57–61]. A limitation that plagues several proposed
techniques is a relatively small field of view and/or slow acquisition speed, such that
analyzing the entire margin of an irregularly shaped BCS resection would be too timeconsuming or logistically complex for intraoperative use. Fluorescence imaging typically
requires the introduction of exogenous agents and often suffers from nonspecific uptake in
background tissues. Finally, several individual modalities are yet to demonstrate useful
contrast between healthy, abnormal benign, and malignant tissues, the sensing of these
tissue subtypes being key to accurate margin diagnosis.

1.4 Approach
This thesis focuses on the combination of two imaging modalities for improved BCS
margin assessment: volumetric specimen imaging (VSI) via X-ray micro-CT and wide
field-of-view optical structured light imaging. Chapter 2 introduces micro-CT as an
emerging specimen scanning technology with substantial momentum toward clinical
translation. Chapter 3 reviews measurement parameters of light and how these parameters
can be leveraged to extract useful information from biological tissues. Chapter 4 introduces
optical spatial frequency domain imaging (SDFI) for differentiating breast cancer tissue
subtypes. Chapter 5 reports quantitative comparisons between micro-CT and spatial
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frequency domain imaging (SFDI) data of breast tumor tissues and highlights the
limitations of X-ray contrast alone for sensing intra-tumoral structures and fibrous tissue
boundaries. Chapter 6 introduces combined micro-CT and optical radiomic analysis,
demonstrating improved malignancy detection using multimodal feature sets. Chapter 7
details an alternative form of optical structured light imaging using an active line scan with
key advantages over SFDI for analyzing surface tissues (e.g., BCS margin assessment).
Chapter 8 summarizes results from a recent observational clinical trial through which
whole BCS resections were imaged intraoperatively using micro-CT with optical SFDI
functioning as an adjuvant tool. Overarching conclusions are provided in Chapter 9.
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Chapter 2 X-ray imaging for breast-conserving surgery margin
assessment
This chapter is based on the following peer-reviewed article:
Streeter SS, Hunt B, Paulsen KD, Pogue BW. Emerging and future use of intra-surgical
volumetric X-ray imaging and adjuvant tools for decision support in breast-conserving
surgery. Current Opinion in Biomedical Engineering. 2022 Jun 1;22:100382. DOI:
10.1016/j.cobme.2022.100382.
This chapter introduces micro-computed tomography (micro-CT) as an emerging ex vivo
specimen imaging technology and reviews several recent studies evaluating its
performance for breast-conserving surgery (BCS) margin assessment.

2.1 Importance and scope
This chapter focuses on advancements in intraoperative X-ray imaging for margin guidance
during BCS over the last five years. Emphasis is placed on X-ray imaging technologies for
the following reasons: X-ray imaging is ubiquitous in clinical diagnostic imaging;
radiologists are already experts at interpreting images derived from X-ray attenuation;
intraoperative specimen radiography is one of the most common techniques for BCS
margin assessment today [62]; and finally, recent pre-clinical and clinical studies focused
on X-ray VSI show promise for improving intraoperative BCS margin assessment [49,63–
73]. Figure 2.1 summarizes conventional BCS margin assessment using specimen
radiography, which clearly resolves only the four peripheral anatomical margins in the
image plane, and emerging X-ray VSI, which enables rapid scanning of all six anatomical
margins of a BCS resection.
The structure of this chapter is as follows: section 2.2 highlights key studies that
evaluated the efficacy of VSI using X-rays for BCS margin assessment; in Section 2.3,
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phase-contrast X-ray imaging (Section 2.3.1) and a range of adjuvant tools (Section 2.3.2)
– particularly optical sensing – are discussed for overcoming the limited soft tissue contrast
provided by current X-ray specimen imaging systems; in Section 2.4, deep learning (DL)
approaches in X-ray VSI for decision support and radiological interpretation guidance are
discussed; and Section 2.5 presents concluding remarks and future directions for X-ray VSI
for margin assessment in BCS.

Figure 2.1 Overview of conventional and emerging methods of intraoperative X-ray imaging during breastconserving surgery for margin guidance.

2.2 State-of-the-art for margin assessment via volumetric X-ray imaging
Intraoperative specimen radiography and radiological interpretation are already
commonplace in standard-of-care BCS. Thus, adopting VSI in the clinic appears feasible
without major changes in surgical workflow. Several recent studies have demonstrated the
benefits of VSI over conventional specimen radiography for BCS margin assessment and
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tested the feasibility of translating VSI into the clinic. In this chapter, intraoperative
imaging refers to the combined process of image acquisition, reconstruction, and
interpretation, and in general, these steps should take 10-20 minutes to be considered
clinically feasible. Some studies focused on micro-CT, which involves the acquisition of
X-ray projection images over a full 360° around the target and filtered back projection to
reconstruct the scan volume at high spatial resolution. Other studies used tomosynthesis,
which involves acquisition of X-ray projection images over a narrow range of angles,
typically less than 60°, followed by volume reconstruction into axial planes. The benefit of
tomosynthesis over micro-CT is primarily increased acquisition and/or reconstruction
speed at the expense of lower reconstruction quality; the drawback is significant blurring
between planes of reconstruction. The following paragraphs highlight results from a subset
of clinical studies over the last five years focused on VSI for BCS margin assessment.
Salient findings from these studies are summarized in Table 2.1.
In 2016, Tang et al. demonstrated that micro-CT scans of 50 BCS resections
provided more accurate measurements of primary tumor diameter relative to specimen
radiography when compared to gold standard pathologic tumor diameter (Pearson’s
correlation coefficient of 0.82 vs. 0.40) [49]. In 2018, McClatchy et al. correlated readings
of 32 whole BCS resection micro-CT scans by a breast radiologist to final histopathology,
finding that micro-CT matched final pathological diagnosis of margins in 64% of cases and
provided a negative predictive value of 89% (positive margin definition: tumor on the
specimen edge) [65]. The study also demonstrated full three-dimensional (3D) scanning of
whole resections in a clinically relevant timeframe (less than four minutes total for image
acquisition and reconstruction). Another study in 2018 by Qiu et al. assessed the feasibility
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of micro-CT for intraoperative BCS margin assessment by scanning 30 consecutive whole
resections and having two investigators interpret the volumetric scans together in 15
minutes or less [66]. The accuracy, sensitivity, and specificity of the micro-CT-based
readings were 86%, 56%, and 100%, respectively (positive margin definition: invasive
tumor on the specimen edge; ductal carcinoma in situ (DCIS) within 2 mm of specimen
edge). In 2019, Janssen et al. reported results from a multi-phase study in which four
observers retrospectively analyzed two sets of 30 whole resection micro-CT scans and then
prospectively analyzed a final set of 40 whole resection scans [67]. The prospective study
resulted in an overall accuracy of 70% classifying margins when compared to final
pathology (positive margin definition: tumor on the specimen edge). However, the authors
found only fair interobserver agreement (Cohen’s kappa of 0.31 and 0.23 in the first and
second retrospective studies, respectively). Park et al. published a 2019 study focused on
the ability of tomosynthesis to detect positive margins in 99 whole BCS resections relative
to standard-of-care intraoperative “extensive processing” that utilized SR [68]. The study
concluded that tomosynthesis performed similarly to labor-intensive standard-of-care
processing, yielding sensitivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV) of 74%, 91% 22%, and 99%, respectively (positive margin
definition: tumor on the specimen edge).
Studies through 2019 offered valuable insight into the feasibility and the potential
value of using X-ray VSI for BCS margin assessment. However, relatively small sample
sizes limited the generalizability of findings. In 2020, DiCorpo et al. published a study in
which 173 whole BCS resections were imaged with micro-CT for intraoperative margin
assessment, achieving overall positive margin accuracy of 93% (positive margin definition:
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tumor on the specimen edge) [70]. The study concluded that micro-CT could detect
malignancy on small regions of the margin likely to be missed by pathological sectioning.
In 2021, Kulkarni et al. published a two-center study in which 200 BCS resections were
imaged, and three radiologists interpreted SR, tomosynthesis, and micro-CT VSI of each
specimen [73]. The three radiologists reported area under the curve (AUC) values of 0.91,
0.90, and 0.94 using VSI, showing relative improvement over the AUC values using
specimen radiography by 54%, 13%, and 40% and tomosynthesis by 32% and 11%
(positive margin definition: invasive tumor on the specimen edge; DCIS within 2 mm of
specimen edge).
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Figure 2.2 Recent studies focused on micro-CT volumetric specimen imaging for BCS margin guidance. (i)
Kulkarni et al. demonstrated that positive margins missed by multi-view projection radiography could be
identified by micro-CT scanning [73]. (ii) Janssen et al. developed a custom specimen container for localizing
suspected margins prior to pathological processing – adapted from Ref. [67]. (iii) McClatchy et al.
demonstrated that X-ray attenuation lacks contrast between non-malignant fibroglandular tissue and
malignancy [65]. (iv) DiCorpo et al. illustrated proof-of-principle tumor segmentation based on X-ray
attenuation thresholding [70], although robust segmentation for complex specimens containing substantial
tumor and fibroglandular tissue components was not demonstrated.

X-ray VSI provides improved sensing of BCS resection margins relative to
standard-of-care margin assessment tools (Table 2.1 and Figure 2.2i). Gold standard, postoperative histopathological margin analysis involves gross dissection (“bread loafing” or

13

slicing the specimen into millimeters thick sections), and then microscopic evaluation is
selectively performed on thin (~5 μm) slices of tissue sections. Thus, gold standard
histopathology inherently involves substantial under sampling of the margin. For this
reason, it is possible that high-resolution X-ray VSI may detect residual disease on the
margin that is not detected by gross dissection or histopathological analysis [65,70]. At
least one innovative method has been developed to facilitate exact VSI correlation to
pathology (Figure 2.2ii), and such solutions should be prioritized in future BCS margin
assessment studies to meaningfully gauge efficacy. X-ray VSI provides superior
correlation with pathology with respect to largest tumor dimension [49], lesion delineation
[63], and tumor-free margin distances [72] compared to specimen radiography. Notably,
X-ray VSI suffers from low PPV, typically ranging from 20-30% [65,67,68,73]. This trend
– the result of a high number of false positive readings (Figure 2.2iii) – is discussed in
more detail in Section 2.3.1. X-ray VSI acquisition and reconstruction can be achieved in
less than 15 minutes [49,65,66,70,73], demonstrating that the technology is appropriate for
intraoperative use. While fewer studies report the time required for scan interpretation,
evidence suggests that a trained observer can interpret a volumetric scan of a BCS resection
in five minutes or less [66,73]. Nevertheless, developing volumetric analysis tools to guide
tumor segmentation (e.g., Figure 2.2iv) and suspicious margin identification has garnered
significant interest in medical imaging in recent years and will likely empower clinicians
with improved BCS margin assessment in years to come (see Section 2.4). It is noteworthy
that most VSI studies in the last five years were observational in nature – not in any way
connected to patient care or clinical decision making. However, two studies involved
intraoperative interpretation of VSI scans to guide resection [69,71]. More interventional,
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prospective studies are required to fully capture the benefits of X-ray VSI relative to
standard-of-care techniques for BCS margin assessment.
Finally, the detection of pre-invasive DCIS at or near the margin poses a unique
challenge. The Society of Surgical Oncology and American Society for Radiation
Oncology consensus guidelines published in 2016 state that for specimens containing only
DCIS, tumor within 2 mm of the margin should be considered positive, while specimens
containing both pre-invasive and invasive components, the standard “tumor on ink” (i.e.,
tumor on the margin) rule defines a positive margin [24]. Most DCIS lesions are diagnosed
by X-ray mammography through the identification of specific types and structures of
microcalcification deposits [74]. It is possible that high-resolution X-ray VSI could
leverage microcalcification signatures to differentiate DCIS and benign lesions, although
to the authors’ knowledge, this has not yet been demonstrated.
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Table 2.1 Summary of recent volumetric X-ray specimen imaging studies for intraoperative margin assessment during BCS. Unless otherwise specified, all
measurements/results focused on final margin status on the specimen level and were assessed relative to final margin status determined by post-operative
pathological analysis. Bold numbers in the “Result(s)” column correspond to the bolded modality in the “Measurements” column.
Reference
Tang et al.
2016 [49]
Urano et al.
2016 [63]

Specimen
Count
50
65

Study Type

Measurement(s)

Result(s)

Positive Margin Basis
for Comparison to
Pathology

Observational;
single-center

Micro-CT vs. SR; largest tumor dimension

Pearson’s correlation coefficient of 0.82 vs. 0.40

Positive margins not
assessed

Observational;
single-center

Tomosynthesis vs. SR; extent of invasive
lesion detected by 1 blinded radiologist

Clear whole lesion delineation in 45% vs. 6% of
specimen images

Positive margins not
assessed

Amer et al.
2017 [64]

102

Observational;
single-center

Overall accuracy of 69% vs. 40%

McClatchy
et al. 2018
[65]

Tomosynthesis vs. SR independently analyzed
by 2 blinded radiologists; direction closest to
margin and margin width

<1 mm for invasive
cancers; 5 mm for
DCIS

32

Observational;
single-center

Micro-CT read by 1 blinded radiologist

Accuracy (64%), sensitivity (50%), specificity
(67%), NPV (89%), PPV (20%)

Tumor on margin

30

Observational;
single-center

Micro-CT read jointly by 2 blinded
radiologists

Accuracy (86%), sensitivity (56%), specificity
(100%), NPV (83%), PPV (100%)

Tumor on margin for
invasive cancers; <2
mm for DCIS

100

Observational;
single-center

Micro-CT independently read by 4 blinded
observers in 2 phases (P1-P2), read by 1
blinded observer in phase 3 (P3)b

99

Observational;
single-center

Tomosynthesis read by 1 blinded radiologist
vs. “SEP” including SR

89

Interventional;
single-center

Tomosynthesis independently read by 2
blinded radiologists with access to SR

173

Observational;
single-center

Micro-CT read by more than one reader

191

Interventional;
two centers

Qiu et al.
2018 [66]
Janssen et
al. 2019
[67]
Park et al.
2019 [68]
Garlaschi et
al. 2019
[69]
DiCorpo et
al. 2020
[70]
Partain et
al. 2020
[71]
Romanucci
et al. 2021
[72]

Tomosynthesis (191 specimens, site 1) vs. SR
(466 specimens, sites 1-2) read intraoperatively
by surgeons to guide targeted cavity shaves
Tomosynthesis vs. SR independently read by
2 blinded radiologists; tumor-free resection
margin distances

(P1: 63%; P2: 72%; P3: 70%),
(P1: 38%; P2: 40%; P3: 38%),
(P1: 70%; P2: 78%; P3: 78%),
(P1: 22%; P2: 26%; P3: 30%),
(P1: 0.31; P2: 0.23)
(74% vs. 84%),
(91% vs. 78%),
(99% vs. 99%),
(21.5% vs. 11%)

Accuracy
sensitivity
specificity
PPV
κ
Sensitivity
specificity
NPV
PPV

(A)cquisition,
(R)econstruction,
(I)nterpretation Time
A
7 min
R
7 min
I
Not reported
None reported
None reported
A
R
I
A
R
I

1 min
2 min
Not reported
7 min
1.5 min
5 min

Imaging Systema
Bruker SkyScan
1173
Siemens
MAMMOMAT
Inspiration
Siemens
MAMMOMAT
Inspiration
PerkinElmer IVIS
SpectrumCT
Bruker SKYSCAN
1275

Tumor on margin

A
8-10 min
R
4-7 min
A+R+I 20 min

Bruker SKYSCAN
1275B

Tumor on margin

A
R
I

Kubtec Medical
Imaging Mozart

ROC curve AUC of 0.82 vs. 0.65

<1 mm

None reported

Kubtec Medical
Imaging Mozart

Accuracy of 93% detecting cases with positive
margins

Tumor on margin

A+R
I

Bruker SkyScan
1173, 1275, and
Nikon XTH225

Final positive margin rate of 4% vs 9%

Tumor on margin

None reported

1 min
Not reported
Not reported

8-10 min
“Many hours”

Kubtec Medical
Imaging Mozart

Pearson’s correlation coefficient of 0.92 vs. 0.79 in
Positive margins not
Hologic Selenia
cranial-caudal view and 0.92 vs. 0.72 in medialNone reported
assessed
Dimensions
lateral view
Sensitivity (91-94% vs. 38-53% vs. 34-49%),
Kulkarni et
Micro-CT vs. tomosynthesis vs. SR
Tumor on margin for
Observational;
A+R 5-7 min
Clarix Imaging Corp.
Specificity (81-85% vs. 71-88% vs. 78-88%),
al. 2021
200
independently read by 3 blinded radiologists at
invasive cancers; <2
two centers
I
1-2 min
“Prototype system”
PPV
(25-30% vs. 11-17% vs. 10-17%),
c
[73]
2 sites (S1-S2)
mm for DCIS
NPV
(99%
vs. 96%
vs. 95-96%)
SR = specimen radiography; IDCa = invasive ductal carcinoma; ILCa = invasive lobular carcinoma; NPV = negative predictive value; PPV = positive predictive value; ROC = receiver operating characteristic; AUC = area under
the curve; SEP = standard extensive processing, unique to Ref. [68]; κ = Cohen’s kappa for interobserver agreement. a Companies and locations: Bruker, Kontich, Belgium; Siemens, Munich, Germany; PerkinElmer, Hopkinton,
MA, USA; Kubtec Medical Imaging, Stratford, CT, USA; Nikon, Tokyo, Japan; Hologic, Bedford, MA, USA; Clarix Imaging Corp., Chicago, IL, USA. b Results are given as averages from the 4 blinded observers. c Results
reported on an individual margin level (i.e., six margins per specimen were individually tallied).
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Observational;
single-center

16

2.3 The problem of limited soft tissue contrast
2.3.1 Phase-contrast computed tomography
It is well known that X-ray imaging suffers from poor contrast between soft tissues of
similar density. In the context of imaging BCS resections, this limitation impacts the ability
to differentiate solid tumor and non-malignant fibroglandular tissues [49,65,66,70,75]. If
scans are interpreted conservatively, this limitation results in a high number of false
positives, leading to unnecessary removal of additional tissue from the surgical cavity and
prolonged procedural times. At least one potential solution exists for overcoming this
limitation of current X-ray VSI systems. Massimi et al. recently published an inceptive
study using X-ray phase-contrast CT for detecting involved margins in breast specimens
[76]. They demonstrated superior sensitivity and comparable specificity to conventional
specimen radiography for detecting disease at the margin, and importantly, provided an
example of heterogeneity within a solid tumor mass that correlated strongly with
microscopic histological analysis (Figure 2.3i). While the study provides a valuable
example of technological advances in micro-CT specimen scanning, additional analysis
using X-ray phase-contrast CT with exact correlations to histology are required to
demonstrate sensitivity between healthy breast parenchyma and malignant tissues.
Additionally, technological advances are still required to expedite scan times such that
phase-contrast CT of macroscopic volumes can be performed in a timeframe relevant for
surgical guidance (as opposed to the “hours” currently required to achieve high-resolution
scans) [77].

2.3.2 Adjuvant tools
Several alternative technologies have been investigated for BCS margin assessment in
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recent years (e.g., Figure 2.3ii). Optical methods in particular span a wide range of
implementations, formfactors, and mechanisms of contrast, including diffuse spectroscopy
[50], Raman spectroscopy [51], Cerenkov luminescence [52], optical coherence
tomography [53], and fluorescent probes [54–56]. These methods have demonstrated
potential for the identification of malignancy and even specific tissue subtypes on the
margin. Multimodal optical imaging has also recently been proposed for margin
assessment. For example, tissue auto-fluorescence combined with Raman spectroscopy
demonstrated >99% sensitivity to the challenging pre-invasive tissue subtype DCIS [78].
Nevertheless, each proposed technique presents pros and cons. While one or more
individual margin assessment technologies may successfully translate into the clinic, it is
possible that multiple solutions working in consort will provide optimal performance.
These novel methods may function as adjuvant tools for BCS margin assessment alongside
X-ray VSI in the future, providing the much-needed sensitivity to differentiate nonmalignant and malignant fibrous tissues on the margin, while benefitting from the robust
3D morphological sensing of X-ray VSI.

18

Figure 2.3 Recent advances in intraoperative margin assessment technologies. (i) X-ray phase-contrast CT
provides increased contrast to soft tissue in breast specimens – adapted from Ref. [76]. (ii) Examples of
emerging techniques that could function as adjuvant tools alongside X-ray volumetric specimen imaging:
intraoperative pathology – adapted from Ref. [19]; Cerenkov luminescence – adapted from Ref. [52]; Raman
spectroscopy – adapted from Ref. [51]; bioimpedance spectroscopy – adapted from Ref. [44]; radiofrequency
spectroscopy – adapted from Ref. [43]; Lumicell (LUM015) fluorescence – adapted from Ref. [54]; optical
spectroscopy – adapted from Ref. [50]; and 5-aminolevulinic acid hydrochloride (5-ALA HCl) fluorescence
– adapted from Ref. [56].

2.4 Intraoperative analysis by deep learning approaches
One of the key problems in using advanced imaging tools during a surgical procedure is
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that the volume and complexity of information generated can be too much for reasonable
decision making by the surgeon or consulting radiologist and pathologist. Multi-scale
datasets that have combinations of macroscopic, radiologic, and microscopic information
present the problem of how to distill this information for fast decision making. In the past
five years, DL approaches have garnered significant attention in the application of digital
mammography [79,80], and there is a rapidly growing body of work with conventional CT
datasets which can, in principle, also be applicable to the micro-CT domain. This section
highlights recent DL studies that can improve X-ray VSI in three important areas: 1) highquality image reconstruction; 2) automated segmentation of tumor margins (Figure 2.4iii); and 3) multi-modal fusion of imaging data with adjuvant tools and clinical records
(Figure 2.4iii-iv). As this review is application focused, many of the technical aspects of
DL are not covered in detail, but the interested reader is referred to additional topical
reviews for DL in medical imaging applications [81–83].
Radial sampling with volumetric reconstruction is fundamental to all CT methods
and involves practical trade-offs in image quality, radiation dose, and acquisition speed. In
the context of ex vivo specimen imaging, radiation dose to the specimen is immaterial;
however, acquisition time remains an important constraint. Multiple studies have
demonstrated that DL models can be trained to approximate high-quality reconstructions
(sampled at 0.5° or 1° intervals) using very sparse imaging data (8-12 times fewer
projections) as input [84,85]. These sparse sampling schemes could significantly reduce
acquisition time and provide meaningful time/cost savings in surgical settings. Importantly,
there is ongoing work to investigate whether or not DL methods are fundamentally solving
the sparse-view CT inverse problem (similar to compressive sensing techniques) as well as
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to make datasets to evaluate these methods publicly available [86]. Beyond sparse
reconstruction, DL has also been utilized for noise reduction and metal artifact removal
[87,88], which could potentially improve the overall quality of the volumetric data in
preparation for subsequent margin analysis.
For volumetric imaging to be utilized for decision support, careful review of the
full specimen volume is necessary to delineate normal, abnormal benign, and suspected
malignant tissues extending from the primary tumor volume toward the margin. In recent
years, DL methods for automated segmentation of 3D medical image datasets have
advanced substantially [89]. Multiple studies have now demonstrated promising results
using DL in resected specimen margin delineation [90–92]. Figure 2.4i shows examples
of both two-dimensional (2D) and 3D segmentation networks which take specimen images
as input and output the tumor segmentation. Figure 2.4ii demonstrates how these
segmentation networks can extend to multi-class labeling schemes as well as provide
heatmap visualizations of high-risk areas. An important limitation of these studies,
however, is sample size (min-max samples: 7-24 tissue specimens; 20-21 mice). Larger
scale datasets and assessments of automated segmentation of tumor volumes using microCT are greatly needed. Recent developments in DL (such as self-supervised learning and
attention mechanisms) can help address many of the limitations of small and imperfectly
labeled datasets common in biomedical image segmentation [89]. These approaches should
be highly beneficial for future development of micro-CT segmentation models.
Lastly, the integration of additional data sources from adjuvant tools and/or preoperative biopsy histology represent an emerging opportunity to provide more robust risk
stratification and probability estimates throughout the micro-CT volume. In the case of
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adjuvant tools, ideally this could be achieved by spatially correlating additional
measurements with the surface mesh of the micro-CT volume. DL methods which leverage
multi-modal image volumes can outperform single modality networks on medical image
segmentation [93]. Additionally, because DL is agnostic to input data structures, clinical
data (e.g., pre-operative cancer diagnoses, tumor genomics) can also be used as input to
separate branches of a multi-modal classification network with a separate feature encoder
for each data source (Figure 2.4iii). Huang et al. demonstrated the utility of a multi-modal
DL approach for detection of pulmonary emboli in CT scans (Figure 2.4iv). Their work
provides a proof-of-principle for future studies that integrate both clinical and imaging data
in a unified probabilistic model.

Figure 2.4 Potential for automated analysis of breast specimen images using deep learning. (i) Diagram of
deep learning-based segmentation models for 2D and 3D margin analysis – adapted from Ref. [91]. (ii) Deep
learning-based tumor segmentation in lung specimens with visual overlay of model predictions by Moriya et
al. [90]. (iii) Diagram of deep learning-based data fusion of clinical records and adjuvant tools to improve
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segmentation and overall risk stratification. (iv) Example of multimodal data fusion between medical CT
imaging and electronic medical record (EMR) data by Huang et al. [94].

Streamlining of micro-CT acquisition and analysis will be crucial for broad
adoption in a surgical setting. DL methods are becoming increasingly capable in several
foundational medical imaging tasks and can add value to multiple aspects of X-ray VSI.
Because application of DL within VSI is still relatively new, an urgent need exists for open
datasets that serve as benchmarks to foster further research and development of DL in VSI.

2.5 Conclusions
Volumetric X-ray scanning of BCS specimens shows strong potential for improving breastconserving surgery margin assessment, although X-ray imaging alone lacks contrast
between fibrous breast tissues, suggesting value in multimodal solutions using adjuvant
tools. Computational decision support in medical imaging in general is rapidly advancing
but is still needed in BCS margin assessment. Collaboration between surgeons,
radiologists, pathologists, and engineers is needed to validate proposed techniques with
exact correlation to gold standard pathological results. Emphasis should be placed on
making image data and decision support model output interpretable and intuitive for use
by clinicians (e.g., model output is mapped to actual tissue surfaces). Finally, a need exists
for larger, multi-center, prospective studies to fully capture the benefits of X-ray VSI and
to determine if these technologies can be translated into standard BCS clinical practice.
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Chapter 3 Optical imaging and sub-sampling diffuse photon
populations
This chapter draws from the following peer-reviewed article:
Streeter SS, Jacques SL, Pogue BW. Perspective on diffuse light in tissue: subsampling
photon populations. Journal of Biomedical Optics. 2021 Jul 1;26(7):1–8. DOI:
10.1117/1.JBO.26.7.070601.
This chapter provides a broad overview of biomedical optics by introducing different
measurement parameters of light and how various optical modalities leverage one or more
of these parameters to achieve different types of contrast. The optical imaging investigated
in this thesis is wide field-of-view structured light imaging – in particular, spatial frequency
domain imaging (SFDI, introduced in Chapter 4) and active line scan imaging (introduced
in Chapter 7). This chapter provides valuable context for these approaches in relation to
other optical imaging modalities.

3.1 Introduction
Biological tissue is a form of turbid medium that causes light to scatter repeatedly, resulting
in a diffuse optical signal that can be measured as reflectance from or transmittance through
the tissue. The process of light becoming diffuse is the progression from an organized state
to a fully disorganized state, through a series of elastic scattering events that spread photon
distributions with respect to several physical properties. Each individual scattering event is
physically based, with a stochastic probability density function (i.e., the scattering phase
function) that describes the range of possible outcomes. The transition to diffusion is driven
by a multi-event sequence of these individual steps, whereby the full range of initial states
becomes increasingly distributed to partially and then fully randomized. The state of the
system, e.g., in time and space, can be modeled with basic principles of the underlying
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physics. When each event is taken individually, the probability of a scatter event is
binomial in nature (i.e., scatter versus no scatter), although the physical outcome of the
event is distributed across a wide probability of outcome states (i.e., the angle of scattering
as dictated by the scattering phase function). The expansion of this process to multiple
events provides a Poisson distribution of each state. After many scattering events, the state
of the system can be approximated by a Gaussian distribution following the Central Limit
Theorem, and in many cases, by simple exponential behavior [95]. Modeling the spread of
the state coordinates as ordinate parameters can provide an analytical methodology to
interpret the data or design measurements.
Early characterization of light diffusion in biological tissue came with the empirical
observation of a spatial spread over several centimeters that appears diffuse. Analytical
modeling of the underlying physics suggested that it could be treated as a random walk,
typical of early radiation transport models [96]. The extension of random walk theory to
many events leads to a diffusive appearance both empirically in experiment and
analytically in theory [97]. The extension of this concept of multiple scattering leading to
a population distribution that is Poisson or Gaussian in shape can be applied to many
measurement parameters of light, including spatial, temporal, and angular distributions,
wavelength dispersion, electromagnetic polarization, and phase coherence. These six
parameters are illustrated in Figure 3.1. In this perspective article, the theory of how one
can predict the transition of light from an initially organized state to an increasingly
randomized state is explored generally, with potential application to each of these
individual parameters.
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Figure 3.1 Measurement parameters of light that are affected by the process of diffusion.

Modeling of macroscopic light diffusion in tissue is well developed, and the
modeling of individual sub-populations of light has been developed in specific applications
with insightful analytic modeling [95]. Individual photon interactions occur on a
microscopic scale and include both absorption and scattering events. Scattering specifically
must be present for light diffusion to occur and is dependent on index of refraction
fluctuations in the tissue that are 10s of nm to 10s of μm in scale [98]. The linkage between
these individual microscopic events and the macroscopic distribution of light provides key
insight that can be used to measure biophysically relevant features of the tissue. Modelbased interpretation of measurements resolved with respect to one or more parameters of
light (Figure 3.1) can be used to quantify tissue features, such as absorption and scattering
coefficients or chromophore concentrations. Model-based interpretations can also inform
the design of instrumentation to provide maximal sensitivity to signals with the highest
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dynamic range to the underlying biophysics of the tissue, such as scatter angle, coherence
loss, or polarization change.
Light transport in tissue adheres to three regimes: initial non-scattering or nondiffuse transport, sub-diffuse transport, and fully diffuse transport. While diffuse light in
tissue is the bedrock of biomedical optics, challenges inherent to diffuse light transport
limit its use in some applications. Specifically, as a turbid medium, tissue diffusely scatters
light, resulting in a blurred or low-pass filtered optical signal. This filtering effect
transcends the different measurement parameters of light in Figure 3.1. While diffuse light
contains a wealth of information about the interrogated tissue, this information is limited
by reduced resolution in time, space, angular trajectory, etc. Thus, methods of subsampling populations of photons can improve measurement resolution. Figure 3.2
illustrates the six parameters of light in the context of common measurement schemes to
perform photon population sub-sampling. In Section 3.2, Monte Carlo simulations
illustrate the diffusive behavior of light in a scattering medium, and a general analytical
expression is given for describing diffusion of an individual parameter of light. Section 3.3
provides a general framework for categorizing the different ways in which sub-diffuse or
fully diffuse photon populations can be sampled.
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Figure 3.2 Measuring the six parameters of light, where ti is time, xi is spatial position, θi is angular trajectory,
ODλ is wavelength-dependent optical density, DOP stands for degree of polarization, and ΔΦ is the difference
in phase between light waves.

Central to this article is the distinction between the diffusive behavior of light in
tissue and distributed parameters of light in tissue. “Diffusion” implies a process of
migration in some parameter space (e.g., space, time, or angle). “Diffuse” light might refer
to multiply scattered light that has achieved some distribution of parameters, but this is
often considered a static state rather than a dynamic, continuous process. Distributed
parameters in and of themselves lack the active progression from an organized, well
characterized state to a randomized state. For example, light reflected from a rough metal
surface may be characterized by a distribution of photon angular trajectories, and thus, the
reflectance is diffuse in appearance. However, the metal is not a diffuse medium. A turbid
medium, one that allows the penetration of light and contains a suspension of particles that
act as scattering sites (i.e., index of refraction fluctuations), is required for light diffusion
to occur. The key distinction is between the process of diffusion of light and the distributed
parameters of light; light diffusion is a sufficient but not necessary condition leading to
distributed parameters of light.
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3.2 Light propagation in tissue is a diffusive process
Figure 3.3 shows the spread of a narrow beam penetrating into a light-scattering tissue,
simulated using the Monte Carlo Multi-Layered (MCML) codebase [99]. Each pane in the
figure shows the light fluence field for a different simulated, homogeneous tissue. The
primary beam enters each tissue and is attenuated due to scattering. The scattered photons
spread in the tissue yielding a superficial zone of strong fluence. Within this zone, the
photons are not “diffuse” but still oriented in response to the initial trajectory of the
launched beam; thus, they are “sub-diffuse” photons. Distant from this zone the light
attenuates as a function of distance from a central point at z = 1/(μs(1-g)), a depth equal to
the transport mean free path, which is 0.1 cm in this example (here, μs is the scattering
coefficient, and g is a scattering anisotropy parameter). In this outer zone, the photon
trajectories are randomized, and photons are effectively diffusing downwards along
concentration gradients [95], so the photons can be called “diffuse.”
In the figure, the parameters μa and μs(1-g) are held constant at 1 cm-1 and 10 cm-1,
respectively, while four pairs of g and μs are tested: 0.50, 20 cm-1; 0.80, 50 cm-1; 0.90, 100
cm-1; and 0.95, 200 cm-1. (Note: the product of μs(1-g) is also known as the “reduced
scattering coefficient” and is often referred to as μs’.) Holding μa and μs(1-g) constant
results in the diffuse pattern distant from the source being equivalent in all cases. However,
as g increases, μs also increases. Therefore, photons undergo more scattering events before
reaching the depth 1/(μs(1-g)), allowing multiple scattering to broaden the beam. The
photons in this “sub-diffuse” region near the source are not yet “diffuse” since they are
predominantly still moving forward, down into the tissue rather than diffusing along photon
concentration gradients. However, their trajectories are spreading in trajectory-angle space
by a diffusive process.
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For low g (see g = 0.50), the μs is also low, which allows some of the on-axis
primary beam to penetrate unscattered into the tissue (red line along z at x = 0). However,
as g increases, μs also increases, and the primary beam is more quickly scattered into a
diffusive process. For g = 0.8, 0.9, and 0.95, the shapes of the zone of strong fluence
become increasingly similar as g increases. Importantly, a variety of parameters may
characterize this “sub-diffuse” zone such as spatial variation of escaping flux, angles of
escaping flux, time course of escaping flux, photon pathlength (and coherence) in escaping
of flux, and polarization of escaping flux.
Notably, Monte Carlo simulations are not the only method of illustrating diffuse
light transport in tissue. One can simply illuminate human skin and observe diffusely
scattered reflectance. Limitations associated with Monte Carlo simulation of light transport
are tied to the underlying assumptions in each simulation. In Figure 3.3, a key assumption
is that of a homogeneous medium, which is rarely if ever true in biological tissue.
Nevertheless, the simulations in Figure 3.3 demonstrate the impact of tuning optical
scattering properties and the transitions between non-diffuse, sub-diffuse, and fully diffuse
transport, concepts central to this perspective article.
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Figure 3.3 The spread of light within a tissue in response to a very narrow collimated beam, where μs(1-g)
is held constant while the scattering anisotropy parameter, g, and scattering coefficient, μs, are varied. g was
varied as 0.5, 0.8, 0.9, and 0.95, while μs varied as 20, 50, 100, and 200 cm-1, such that μs(1-g) remained a
constant 10 cm-1. The absorption coefficient was held constant at μa = 1 cm-1; the tissue was semi-infinite;
and the surface boundary was refractive index-matched. The dashed line indicates an isoline at a constant
fluence (φ) of 10 cm-2, beyond which photon diffusion down concentration gradients acts as though the source
were at x, z = 0.0, 0.1 (i.e., the small, white circle at a depth of one transport mean free path). Colormap
fluence field values were scaled logarithmically for improved visualization of the range.

Diffusion describes the process of an initial amount of a parameter (U0) spreading
in a parameter space x,
𝐶𝐶(𝑥𝑥, 𝑡𝑡) = 𝑈𝑈0

𝑥𝑥2

−
𝑒𝑒 4𝐷𝐷𝑥𝑥 𝑡𝑡

�4𝜋𝜋𝐷𝐷𝑥𝑥 𝑡𝑡

,

(1)

where C(x,t) is the one-dimensional “concentration” of the parameter (amount/unit), i.e.,
amount at value x per incremental dx at time t, and Dx is the diffusivity of the parameter in
the x space (units2/s) (note that the spatially resolved diffusion may have time-dependence
or be steady-state [95]). The integral
∞

∫0 𝐶𝐶(𝑥𝑥, 𝑡𝑡)𝑑𝑑𝑑𝑑 = 1
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(2)

is true for all times. The generic term “units2/s” is used because diffusivity could relate to
a spread in some parameter, such as angular trajectory (radians2/s) or pathlength
(pathlength2/s). Sometimes, a loss process such as absorption is also present, for which an
additional term, exp(-μact), multiplies Equation 1, where c is the speed of light in the
medium. The key lesson emphasized here is that a diffusive process can describe the
transition of a photon from an initial state to a truly “diffuse” state, and this process applies
to various measurement parameters of light.
Collected photons will usually involve a distribution of pathlengths through the
tissue, which consequently spread the attenuation of collected light. The absorption spectra
of a chromophore in the tissue will be distorted by this spread of attenuation, and therefore,
reflectance with respect to wavelength is also subject to distortion by a diffusive process.

3.3 Source-, detector-, and tissue population-encoding schemes
The ways in which sub-populations of light can be sampled from tissue can be described
in several ways, but a useful way to categorize them is active source-encoding, detectorencoding, and population-encoding (i.e., external tagging) of the signals. Each of these
encoding schemes is described in the following subsections.

3.3.1 Source-encoding methods
The term source-encoding here indicates that the imaging technique leverages a
specifically designed source to isolate a desired optical signal. Widespread advances in
photonics technology have created a cornucopia of ways in which light can be encoded by
a unique source. The use of custom light sources can be chosen to selectively enhance or
focus any of the six parameters described in the first section. The most obvious are factors
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such as wavelength choices, but this can be further augmented by methods such as
wavelength-encoding coupled to time [100] or space [101] or angle of incidence [102].
Careful design of methods to match the source-encoding with detector-decoding can allow
for intelligent design of diffuse or sub-diffuse spectroscopy, while avoiding some of the
less desirable aspects of diffusion. Polarization-encoding of the source is a technique that
persists only through one or two scattering events but can be extremely effective when
coupled to sequential subtraction methods to remove diffuse light from an image [103]. In
comparison, coherence source-encoding is a technique widely used in both optical
coherence tomography (OCT) and diffuse correlation spectroscopy (DCS), whereby the
key to success has been the innovation of using long coherence length light sources that
match the length scale of need. In the case of OCT, the coherence length defines the axial
spatial resolution in Fourier domain methods over short path lengths in tissue (d ~ 1 mm)
[104]. Whereas in DCS, the coherence length of the speckle pattern, dictated by underlying
hemodynamics, determines the lifetime of decorrelation events that can be quantified over
long path lengths in tissue (d ~ 1 cm) [105]. Encoding angular trajectory by the source is
commonly done in microscopy and in fiber optic delivery, where numerical aperture is
tailored, but this is typically restricted to sub-diffuse light sampling. It is possible that
broader field angular source-encoding could have value with lens arrays or other delivery
technologies. Spatial encoding of the source is commonly done in diffuse light sampling
of tissue, such that the modeling can be simplified, and boundary matching or calibration
of the model can be avoided through multi-distance methods [106]. This is also an active
area of development in optical methods such as Raman, fluorescence, and pulse oximetry.
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3.3.2 Detector-encoding methods
The term detector-encoding here indicates that the imaging technique leverages a
specifically designed detection scheme to isolate a desired optical signal. The range of
detectors and detection techniques is almost as broad as sources, and many methods of
diffuse light sampling use custom approaches to this, most of which are coupled to a
source-encoding method as well. Temporal, wavelength, polarization, and coherence
gating methods are all widely employed for various applications, and again, wavelength is
widely used for spectroscopic sampling of fluorescence, Raman, blood, or other
chromophores. Several unique approaches to coherence gating exist, including Fourier
transform methods in OCT [107] and direct coherence gating methods in phase conjugation
that extend the range of sampling to cm rather than mm [108]. Detector spatial gating is
perhaps the most widely deployed in confocal imaging where the simple definition of a
pinhole or a light sheet can be used to define the volume sampled in the imaging. The
extension of this to diffuse light has been illustrated to some degree by active illumination
coupled to active detection, such as SFDI methods, where the spatial Fourier distribution
of light can be used to depth section tissue layers [109,110]. Widefield coherence gating or
polarization gating have not achieved the same level of success as SFDI at widefield
sampling of tissue, although there could be innovations to be gained here. Wavelength
encoding of detection can provide some sectioning capabilities as well, in examples such
as hyperspectral imaging [111] or ultra-violet fluorescence methods [112].

3.3.3 Population-encoding methods within tissue
The term population-encoding here indicates imaging methods that leverage the tagging of
specific optical signals within the tissue of interest. These are perhaps the most
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scientifically compelling approaches that have captured the imagination of many
researchers. Techniques such as acousto-optic tagging can be used to identify a tissue
volume which is then interrogated by optical spectroscopy or transmission, and thereby
provide higher resolution of the volumes sampled. Even below the range of ultrasound, it
is feasible to identify volumes within tissue by mechanical means, as in elastography OCT
[113], or by vibrational excitation means, such as the Grüneisen coefficient [114] or
Brillouin spectroscopy [115]. Coupling these tagging methods further to source- or
detection-encoding of the features of sub-diffuse or diffuse light may still provide unique
opportunities for functional imaging of tissue. Related to this are methods where generation
of light from within the medium can be used to tag regions, as has been shown by
fluorescence, upconversion, or radioluminescence methods. In these methods, light is
encoded by position of origin inside the medium. Again, there are likely ways to encode
these unique spatial sources by other electromagnetic features of the light signal, such as
polarization-encoding of fluorescence from within tissue, that yields information about the
origins of the molecules producing it [116]. Finding ways to encode space, time, angle,
wavelength, polarization, or phase into uniquely tagged locations of light within tissue
remains a scientific frontier to be developed.
Figure 3.4 categorizes various optical measurement techniques by the source-,
detector-, and/or population-encoding scheme employed. Only optical signal encodings are
considered for methods that rely on non-optical excitation or detection (i.e., opto-acoustic,
acousto-optic, radioluminescence). Many general techniques listed can be combined with
other forms of encoding to selectively isolate sub-populations of photons. Importantly, all
techniques in Figure 3.4 employ one or more measurement parameters of light previously
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discussed (Figure 3.2 and Figure 3.3). Figure 3.4 also reinforces the point that sourceand detector-encoding techniques are widely used today, but fewer established techniques
leverage population-encoding to sub-sample diffusely scattered photons in tissue. This
general framework for thinking about ways of encoding parameters of light into
measurement techniques may inspire new ways of uniquely tagging optical signals within
tissue.

Figure 3.4 Venn diagram of a representative set of techniques of study in populations of photons, categorized
by optical source-, detector-, and/or population-encoding scheme. OCT = optical coherence tomography.
DCS = diffuse correlation spectroscopy.

3.4 Conclusions
Different sub-populations of photons in physical parameter space undergo diffusion as light
is delivered into tissue. The mathematics of diffusion are useful for analyzing most of these
parameters and generally follow Gaussian-distributed behavior. In some cases, a simple
exponential expression effectively approximates the optical phenomenon of interest, and
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the decay parameters that govern the population changes can themselves provide insight
into the light-tissue interaction. The predictable, diffusive nature of light transport in tissue
provides ample opportunities for experimental and theoretical analysis, spanning space,
time, angular trajectory, wavelength dispersion, electromagnetic polarization, and phase
coherence, with a wide range of measurement or encoding techniques to sub-sample these
distributions.
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Chapter 4 Optical scatter textural analysis of breast cancer tissues
This chapter is derived from the following peer-reviewed publication:
Streeter SS, Maloney BW, McClatchy DM, Jermyn M, Pogue BW, Rizzo EJ, Wells WA,
Paulsen KD. Structured light imaging for breast-conserving surgery, part II: texture
analysis and classification. J Biomed Opt. 2019 Sep;24(9):096003. PMCID: PMC6744928.
DOI: 10.1117/1.JBO.24.9.096003.
Note that Figure 4.2 and Figure 4.3 are included in this chapter for clarity but were not
included in the peer-reviewed paper. The key concept of this chapter is that high spatial
frequency optical reflectance imagery contains textural information that can be leveraged
for breast cancer tissue classification.

4.1 Introduction
Spatial frequency domain imaging (SFDI) is a wide field-of-view, noncontact optical
modality that involves illuminating tissue samples with one-dimensional (1D) sinusoidal
patterns at different spatial frequencies (fx) and optical wavelengths (λ) and imaging the
reflected light. Using a diffuse or sub-diffuse light transport model, SFDI data can
distinguish optical absorption and scattering properties of biological tissue [117,118]. A
strength of SFDI is that it can be readily implemented with standard imaging and display
hardware and that it requires no mechanical scanning to achieve wide-field sensing.
Perhaps most promisingly in the context of surface tissue characterization (e.g., breastconserving surgery (BCS) margin assessment), the illumination pattern fx and λ can be
honed to decrease sensitivity to absorption and increase sensitivity to scatter. This is
accomplished by using high spatial frequencies [119] and relatively short optical
wavelengths [120]. This pattern-wavelength combination reduces photon density wave
penetration depth (i.e., depth sensitivity), avoids volumetric averaging over tortuous
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photon pathlengths, and thereby natively enhances reflectance spatial resolution. At
sufficiently high spatial frequencies, SFDI illumination penetrates to depths less than the
length scale of diffuse photon propagation. Photons are intrinsically confined to surface
tissue and are most sensitive to large, single backscattering events with the angle and
intensity of reflectance dependent on cellular ultrastructures [121]. In this regime, the
imaging approach was originally termed “scatteroscopy” (due to high relative sensitivity
to optical scatter versus optical absorption) [119] and was later referred to as sub-diffuse
SFDI (sd-SFDI) [110]. More recently, the approach has also been described generally as
“high spatial frequency structured light imaging” [122,123] or as wide-field “optical scatter
imaging” [75].
Previous studies investigated diffuse and sub-diffuse SFDI for BCS specimen
margin assessment using optical properties [110,124,125]. The work presented in this
chapter represents part two of a two-part study that analyzed the largest SFDI dataset of
fresh BCS tissue specimens published as of 2019 with the most extensive categorization of
benign and malignant tissue subtypes. The complete dataset was introduced in part one of
the study [123], which focused on optical scatter and color property quantification. Optical
scatter and color properties demonstrated potential for distinguishing breast tumor tissues
subtypes, but these properties are inherently pixel-based, lacking spatial context between
groups of neighboring pixels. Furthermore, optical property quantification necessitates
significant computation, requiring either nonlinear least squares fitting of data to an
appropriate light transport model or the generation of an empirical look-up table using a
Monte Carlo model [117,126]. The process can be slow [110], and model-based inversion
fitting can introduce additional errors [117].
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Texture analysis refers to the appearance, structure, and arrangement of features
within an image, and thus inherently relies on the spatial relationship of multiple pixels in
an image. Here, the SFDI dataset introduced in part one was reprocessed using texture
analysis and a machine learning framework for tissue subtype classification. The primary
objectives of this work were two-fold. First, an sd-SFDI imaging and analysis protocol was
introduced for BCS tissue surface characterization that uses one sub-diffuse spatial
frequency (fx = 1.37 mm-1), one optical wavelength (λ = 490 nm), and reflectance texture
instead of tissue optical and/or color properties. Reflectance texture benefits from increased
computational efficiency, as property quantification does not involve inverse model fitting.
Importantly, the protocol avoids light transport model assumptions for metric quantitation
(e.g., tissue homogeneity). Second, the statistical significance of a limited set of statistical,
structural, and transform-based texture metrics was evaluated by hypothesis testing, and
the relative importance of these metrics was evaluated using a supervised a classification
model.

4.2 Materials and methods
The image data for this clinical study were collected according to the protocol outlined in
Section 4.2.1. Imaging system details are given in Section 4.2.2. An overview of the optical
imaging mechanism of contrast is given in Section 4.2.3. Figure 4.1 illustrates the
processing workflow for this work: region of interest (ROI) sampling, texture metric
quantitation and statistical analysis, and classification. These steps are discussed in detail
in Sections 4.2.4-4.2.9. All computational aspects of this study were implemented in
MATLAB (v2018a, Mathworks, Inc., Natick, MA).
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Figure 4.1 The processing workflow for this chapter: (a) Color, diffuse (fx = 0.00 mm-1) a.k.a. naked eye
image reconstructed using the approach detailed in Ref. [122]; (b) monochromatic (λ = 490 nm), sub-diffuse
reflectance (fx = 1.37 mm-1) image of the same specimen; (c) specimen with invasive lobular carcinoma lesion
ROI (red) and sampled sub-images (blue); and (d) sub-image texture analysis and classification steps.

4.2.1 Imaging protocol
Imaging was performed at Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon,
New Hampshire. The clinical study was approved by the Institutional Review Board at
Dartmouth College and DHMC for the protection of human subjects, and all procedures
followed the approved protocol. Procurement of tissue specimens involved patients
undergoing consented and elective breast surgeries at DHMC.
Specimen imaging occurred post-operatively during standard pathological
processing and did not hinder clinical workflow. A resected tumor was “bread-loafed” or
sliced serially into ~5 mm sections along a single axis perpendicular to the long axis of the
lump (Figure 4.2a-b). One slice from the lump was selected by a pathology specialist and
imaged with random anatomical orientation (Figure 4.2c). Image data were therefore
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assumed to be free of rotational bias. After standard-of-care histological processing and
staining with hematoxylin and eosin, a board-certified breast pathologist (Wendy Wells,
MD) determined microscopic ROIs (Figure 4.2d) that were manually co-registered to wide
field-of-view SFDI data (Figure 4.2e). For an imaged slice, SFDI ROIs were
conservatively outlined within the histopathologic ROIs. ROIs did not necessarily
encompass the entirety of each specimen. Many lesions were relatively small compared to
the total surface area of the specimens. ROI selection was intentionally conservative to
ensure that the regions were completely contained within the lesions. For the texture
analysis in this chapter, the enrolled tissue ROIs were sampled using a sliding-box
algorithm. The sampling process extracted a subset of the original image data for texture
analysis.

Figure 4.2 Overview of pathological processing, histological mosaicking, and co-registration to wide-field
optical images. (a) A freshly resected BCS specimen on a radiography grid. (b) “Bread loaf” slicing of the
specimen. (c) Gross pathology image with (d) corresponding histology mosaic with tissue regions labeled.
(e) Conservatively drawn wide-field regions of interest on optical images. Illustration in (b) adapted from
Ref. [127]. Note that this figure is not published in a peer-reviewed journal but was included in a successful
National Institutes of Health F31 proposal and provides a condensed overview of the pathological processing
and imaging protocol used in the study reported in this chapter.

4.2.2 Imaging system
A previously developed and characterized multimodal imaging system that combines SFDI
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and micro-computed tomography imaged all BCS tissue specimens in this study [122]. The
system was a customized version of an In Vivo Imaging System SpectrumCT (PerkinElmer,
Hopkington, MA) with retrofitted optical imaging hardware necessary for SFDI. The
highest spatial resolution demonstrated by the SFDI subsystem was 3.78 cycles/mm and
involved using the highest spatial frequency (fx = 1.37 mm-1) and lowest optical wavelength
at which data were collected (λ = 490 nm). This spatial frequency was the highest
achievable experimentally, given the SFDI subsystem geometry and the limitations of the
digital micromirror device (DMD) used. Each specimen was placed between two laser-cut,
optically clear acrylic plates and secured using elastic bands. Fixing the specimen in the
holder provided a flat tissue surface for imaging. The projector, stage, and camera created
an off-axis projection scheme. The flat imaging surface and off-axis projection reduced the
occurrence of specular reflections. Crossed polarizers were not used to avoid undesired
rejection of sub-diffusely scattered photons, which undergo a phase shift close to 180°.
Image acquisition followed the standard SFDI procedure of imaging at three phase offsets
(i.e., Ф1 = 0°, Ф2 = 120°, Ф3 = 240°) for a given fx and λ pair [109]. Sd-SFDI data were
demodulated using the standard procedure, normalized to calibrated reflectance using a
99% reflectance Spectralon standard (Labsphere Inc., North Sutton, NH), and median
filtered using a 3 x 3-pixel kernel prior to further processing.

4.2.3 Mechanism of contrast for sub-diffuse optical reflectance
Krishnaswamy et al. introduced wide field-of-view, optical, sub-diffuse reflectance
imaging and demonstrated that the contrast is dominated by optical scatter [119].
McClatchy et al. then published a key study characterizing the mechanism of contrast in
sd-SFDI in the context of breast tissue imaging [110]. A brief overview of this contrast
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mechanism is provided in this section, and the key aspects are summarized in Figure 4.3.

Figure 4.3 Optical scattering regimes due to common biological tissue components. (a) The length scale of
characteristic components found in three common breast cancer tissue types and associated types of optical
scattering (adapted from Ref.[110]). (b) Length scales of common cellular components relative to the length
scales of optical wavelengths of light (vertical yellow bar) (adapted from Ref. [128]). Note that this figure is
not published in a peer-reviewed journal but was included in a successful National Institutes of Health F31
proposal and provides a useful illustration of different optical scatter regimes in biological tissue.

The composition and structure of biological tissues are characterized by refractive index
fluctuations on the order of 10s of nm to 10s of μm. The angular probability of scattering
is governed by the relative length scale of the wavelength of light and these refractive index
fluctuations [129]. Structures on the same length scale or larger than the wavelength of
light cause Mie-type scattering, which is forward scatter dominant. Meanwhile, structures
that are smaller than the wavelength of light give rise to Rayleigh-type scattering, which is
more isotropic in nature with relatively more backscattering. Reflectance-based sd-SFDI
thus detects lower intensity signals from forward-dominant Mie-type scatterers and higher
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intensity signals from Rayleigh-type scatterers. By this mechanism, the density,
composition, and spatial arrangement of biological structures in surface tissue (<1 mm in
depth [110]) lead to different sub-diffuse reflectance textures.

4.2.4 Region of interest sampling
Texture analysis was performed on 32 x 32-pixel (i.e., ~4 mm x ~4 mm) sub-image samples
extracted from each specimen ROI. The size was chosen such that macroscale tissue
features were captured in each sub-image. Square sub-image sampling enabled direct
comparisons of localized tissue textures found in different tissue subtypes. A custom
MATLAB script implemented a sliding-box algorithm for sub-image sampling (Figure
4.1c-d). Tissue diagnoses found in fewer than n = 3 specimens and ROIs too small to
contain a single sample were excluded. Samples with large specular reflections were
identified and censured via a custom MATLAB script based on the median absolute
deviation of pixel intensities in each sample. A total of 42 specimens containing 56 ROIs
(37 benign, 19 malignant) met these criteria. The primary cause for data exclusion was the
requirement of a ~4 mm x ~4 mm sample of confirmed and homogenous tissue. Several
lesion ROIs in the dataset were too small or irregular in shape to contain a square sample
of this size. The 56 eligible ROIs provided a total of 163 sub-images (100 benign, 63
malignant) for texture analysis. Table 4.1 summarizes the 163 samples with respect to
tissue subtype, specimen count (which in this study was equivalent to ROI count), and
sample count. Benign tissue subtypes considered for texture analysis were adipose tissue,
connective tissue, and fibrocystic disease (FCD). Fibroadenoma was not included in the
analysis; this type of benign lesion, although present in sufficient numbers for inclusion
(four ROIs, 24 samples), was assumed to be of nominal clinical importance, because it is
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typically known prior to surgery and rarely warrants a re-excision procedure [130].
Malignant subtypes considered for texture analysis were intermediate- and high grade
invasive ductal carcinoma (IDCa) and invasive lobular carcinoma (ILCa) (i.e., only
invasive cancers).

Table 4.1 Summary of 32 x 32-pixel (~4 mm x ~4 mm) SFDI reflectance samples.
Tissue Subtype
Adipose
Connective
Fibrocystic Disease
Invasive Ductal Carcinoma, Intermediate Grade
Invasive Ductal Carcinoma, High Grade
Invasive Lobular Carcinoma

Total

Specimen
(ROI) Count
26
6
5
5
8
6
56

Sample
Count
56
20
24
14
29
20
163

4.2.5 Texture analysis
Texture analysis of spectroscopic images is known to provide unique information about
scattering ultrastructures in human breast tissues [130]. Here, texture is considered as an
analysis tool for sd-SFDI data. A variety of texture representations were explored in this
study, all of which can be broadly categorized as statistical, structural, or transform-based
in nature. These three representations of texture have been used to analyze radiological
images of biological tissues, including mammography [131]. Statistical metrics included
gray level co-occurrence matrix (GLCM) contrast, correlation, and homogeneity [130].
Structural or image primitive metrics included fractal dimension, lacunarity, and Euler
number [130,132–134]. Transform-based metrics were derived from Fourier transform
power spectral density (PSD) curve linear fit parameters [135]. Details associated with
GLCM pixel statistics, structural image primitives, and Fourier transform PSD curve
parameters are given in Sections 4.2.6, 4.2.7, and 4.2.8, respectively.
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Table 4.2 Summary of texture metrics quantified for each sample.
Texture Analysis Method
Pixel Statistics
Image Primitives
Power spectral Density Curve Parameterization
Total

Metric
Count
3
3
5
11

Texture analysis generated a total of 11 features associated with each sample. Table
4.2 summarizes these features. All features were quantified rapidly for each sample (<1 s).
Figure 4.4 provides an overview of the three representations of texture investigated in this
work and gives qualitative/visual comparisons between tissue subtypes undergoing each
type of texture analysis.

Figure 4.4 Overview of the three texture analysis approaches in this study: GLCM pixel statistics, structural
image primitives, and Fourier transform PSD curve parameters. Flow of processing started with sampled
reflectance samples, which were converted to binary images via Bernsen thresholding, to GLCM scaled
images, and to the frequency domain for metric quantification. Dashed arrows signify additional processing
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steps. FCD = fibrocystic disease. Int = intermediate. IDCa = invasive ductal carcinoma. ILCa = invasive
lobular carcinoma.

A Mann-Whitney U-test was used to test the null hypothesis that two samples come
from the same population. This statistical test was used, because it is nonparametric and
thus avoids the assumption of normally distributed metrics. U-test p-values quantified the
statistical significance of pixel statistics, image primitives, and PSD curve parameters
between three benign and three malignant tissue subtypes. A p-value of <0.05 was
considered statistically significant.

4.2.6 Gray level co-occurrence matrix pixel statistics
The GLCM representation of texture features assesses the spatial dependence of pairs of
pixel intensities within an image. Pixel statistics of contrast, correlation, and homogeneity
were calculated for each sample based on eight-level grayscale scaled intensity images (8
x 8-element GLCMs). Contrast quantifies the local variation in an image, correlation
measures its gray-tone linear dependencies, and homogeneity assesses the prevalence of
gray-tone transitions [136]. Each GLCM invoked a one-pixel displacement distance and
vector directionality symmetric about 0°, 45°, 90°, and 135°. Reported values were
averaged over the four angles. Each GLCM was generated using the MATLAB
graycomatrix function, and statistics were quantified via the MATLAB graycoprops
function (MATLAB Image Processing Toolbox v10.2).

4.2.7 Image primitives
The arrangement of repeating patterns or features in an image, referred to as image
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primitives, were also used to characterize texture. Samples were converted to binary
images using a Bernsen local thresholding algorithm implemented in MATLAB [137].
Bernsen thresholding is based on local contrast within a moving window (a 13 x 13-pixel
window in this case). Local contrast thresholding was found to effectively isolate
reflectance structures sometimes lost by global thresholding. Euler number, fractal
dimension, and lacunarity were quantified from each binarized image sample. Euler
number codifies the difference between the number of connected components or objects in
an image and the number of holes in those objects. Euler number was computed using the
function bweuler (MATLAB Image Processing Toolbox v10.2). The Hausdorff boxcounting fractal dimension, which is a measure of self-similarity and roughness in an
image, was computed using the MATLAB function hausDim [138]. Lacunarity is a
measure of inhomogeneity or transitional and rotational invariance of features in an image
and was computed by the MATLAB function lacunarity_glbox [139].

4.2.8 Power spectral density curve parameters
A PSD curve depicts the relative amplitude of spatial frequencies within an image. The
PSD curve of each sample was calculated via a two-dimensional (2D) discrete Fourier
transform followed by radial averaging of the amplitude of the shifted image data. Radial
averaging decomposed the 2D image into a 1D profile, which was then converted to power
and normalized by its maximum value (i.e., the zeroth frequency component).
Parameterization involved visual identification of two distinct spatial frequency ranges that
consistently exhibited different slopes in the PSD curves. These two spatial frequency
ranges formed low spatial frequency (LSF) and high spatial frequency (HSF) PSD
contributions. Linear fits were applied to these two spatial frequency ranges, yielding slope
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and intercept parameters for each contribution. The spatial frequency at which the two
linear fits intersected provided a fifth parameter.
The LSF and HSF ranges for linear fit parameterization were set to 0-1 mm-1 and
1-2 mm-1, respectively. These ranges were selected after inspection of an ensemble of PSD
curves for all samples (Figure 4.5a). In Figure 4.5b, the five linear fit parameters derived
from each PSD curve are illustrated. To demonstrate the potential value of PSD curve
parameterization, the PSD curves for all adipose tissue and ILCa samples tallied in Table
4.1 are plotted together in Figure 4.5b. Adipose tissue and ILCa samples contain
significantly different spatial frequency content indicated by different HSF linear fit slopes
and intercepts. In contrast, FCD and ILCa PSD curves shows similar linear fits (Figure
4.5c). The comparison in Figure 4.5b-c reinforces the concept that different
representations of texture may be effective at distinguishing different types of tissue.

Figure 4.5 Normalized power spectral density (PSD) curves for (a) all fx = 1.37 mm-1, λ = 490 nm samples
tallied in Table 4.1, (b) for only adipose and invasive lobular carcinoma (ILC) samples with linear fits applied
to each diagnosis separately, and (c) only fibrocystic disease (FCD) and ILCa samples with linear fits applied
to each diagnosis separately. Vertical, dashed, black and blue lines delimit the low spatial frequency and high
spatial frequency linear fit ranges, respectively. The derivation of the five PSD linear fit parameters is
illustrated in (b) in green.

4.2.9 Classification analysis
Previous studies combined SFDI with classification analysis. Laughney et al. were the first
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to leverage SFDI for breast cancer pathology discrimination [124]. They used SFDIderived optical properties and a nearest-neighbor learning algorithm to discriminate
normal, fibroadenoma, pre-invasive ductal carcinoma in situ (DCIS), invasive cancer, and
treated invasive cancer tissues with 82% accuracy. McClatchy et al. used SFDI-derived
optical properties to predict stromal, epithelial, and adipose fractions in surgically resected
breast tissues with a threshold-based tissue classification model. They demonstrated pixellevel classification accuracy of 75% and specimen-level accuracy of 84% [125]. Beyond
breast tissue characterization, recent work by Rowland et al. used SFDI reflectance data at
multiple spatial frequencies to predict burn severity in a porcine model using a cubic
support vector machine (SVM) classifier [140]. They demonstrated 92.5% accuracy
classifying burn severity at 24 hr after injury.
In the present work, sd-SFDI reflectance texture metrics were provided as input to
a machine learning framework for tissue subtype classification. Binary classifications were
performed between three benign and three malignant breast tissue diagnoses. Texture
feature vectors (11 total features detailed in Table 4.2) associated with one benign tissue
subtype and one malignant tissue subtype were classified using a linear SVM classifier
(MATLAB function fitcsvm with default settings, Image Processing Toolbox v10.2) with
correlation-based feature selection. Classification performance was evaluated using
random five-fold cross-validation (CV). Five-fold CV was chosen such that each train/test
set contained >30 samples and was representative of the broader dataset [141]. Feature
selection used two-sample t-tests (MATLAB function ttest2, Statistics and Machine
Learning Toolbox v11.3) across all 11 textural metrics and a grid-search for determining
the optimal number of features to include in classification. The grid-search involved using
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a range of features (e.g., one feature, two features, etc.) in the classification model, and the
optimal number of features corresponded to the highest classification accuracy achieved.
Feature selection identified the most relevant parameters, thereby reducing the
dimensionality of the classification problem and mitigating overfitting to noise in the data
[142]. Binary classification was performed on randomly matched sample sizes, which
injected variability into classification results. Each classification scenario was repeated n
= 100 times to quantify this variability in classification outcomes.
Receiver operating characteristic (ROC) curves were generated for every benignmalignant tissue subtype classification. Area under the ROC curve (AUC), sensitivity,
specificity, and accuracy were quantified for every classification iteration. To integrate
results over all iterations, average ROC curves were generated using a vertical averaging
technique [143], and performance metrics were derived from the average ROC curves.

4.3 Results
4.3.1 Sub-diffuse reflectance signatures of breast tissue subtypes
Representative calibrated reflectance samples from six breast tissue subtypes are shown in
Figure 4.6. In the figure, the bordering around each three-by-three block of samples is
color-coded by tissue subtype. The solid border denotes diffuse, planar illumination
reflectance (fx = 0.00 mm-1, λ = 490 nm) derived from the SFDI data. The dashed border
denotes sub-diffuse reflectance (fx = 1.37 mm-1, λ = 490 nm) derived from the SFDI data.
The same tissue samples are displayed in the diffuse and sub-diffuse reflectance panes. The
comparison demonstrates that sub-diffuse reflectance is sensitive to small-scale surface
tissue features that are occult to typical, planar illumination imaging. Furthermore, the
figure shows how sd-SFDI scatter might function as a useful surface tissue contrast
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mechanism. Section 4.3.1 relates the various sub-diffuse reflectance textures observed in
Figure 4.6 to underlying tissue subtype compositions. Importantly, Figure 4.6 highlights
the fact that when tissues appear different visually, texture-based feature extraction
algorithms are likely to discriminate them quantitatively (e.g., Figure 4.5b).

Figure 4.6 Representative calibrated reflectance samples of healthy and benign tissue subtypes (left column)
and malignant tissue subtypes (right column). Panes are color-coded by tissue subtype. Solid boarders denote
planar, diffuse illumination (fx = 0.00 mm-1, λ = 490 nm) reflectance, and dashed boarders denote sub-diffuse
illumination (fx = 1.37 mm-1, λ = 490 nm) reflectance. Diffuse and sub-diffuse samples are displayed as pairs
(e.g., top-left diffuse sample is spatially co-registered with top-left sub-diffuse sample for each subtype, etc.).
Scalebar applies to all sub-image samples. FCD = fibrocystic disease. Int = intermediate. IDCa = invasive
ductal carcinoma. ILCa = invasive lobular carcinoma.

4.3.2 Texture metric statistical significance
Mann-Whitney U-test p-values were computed between all benign and malignant breast
tissue diagnoses using the 11 statistical, structural, and transform-based texture metrics.
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Metrics across all three representations of texture demonstrated statistically significant
differences between the three benign and three malignant tissue subtypes. The authors note
that p-values were quantified using texture metrics derived from all sub-images due to the
limited number of samples of each tissue subtype. Consequently, p-values are not robust
against inter-patient bias. This limitation could be overcome in future studies with larger
sample sizes.

4.3.3 Gray level co-occurrence matrix pixel statistics
GLCM pixel statistics are summarized in Figure 4.7. Sub-diffuse reflectance of adipose
tissue exhibits low contrast, low correlation, and high homogeneity relative to all malignant
diagnoses, shown in Figure 4.7a, Figure 4.7b, and Figure 4.7c, respectively. These results
are expected given that adipose tissue is predominately forward scattering with relatively
low intensity, unstructured reflectance. Figure 4.7d indicates that adipose tissue can be
separated from all three malignant diagnoses with statistical significance using GLCM
metrics. Sub-diffuse reflectance from connective tissue and FCD exhibit high contrast, high
correlation, and low homogeneity relative to all malignant diagnoses. The combination of
weakly backscattering collagen fibers and strongly backscattering collagen fibrils in
connective tissue and the fibrotic nature of FCD might explain these statistics. Notably, the
three GLCM statistics separate FCD from the malignant diagnoses, including ILCa. The
capability of GLCM metrics to statistically separate these two diagnoses is notable; part
one of this study reported that optical scatter and color properties alone were unable to
statistically separate these two diagnoses [123].
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Figure 4.7 Boxplots of GLCM (a) contrast, (b) correlation, and (c) homogeneity statistics for fx = 1.37 mm, λ = 490 nm samples tallied in Table 4.1. Statistical discrimination between the three benign and three
malignant tissue subtypes using GLCM (Con)trast, (Cor)relation, and (Hom)ogeneity was determined using
a Mann-Whitney U-Test. P-value heat maps are shown for (d) adipose, (e) connective, and (f) FCD versus
intermediate grade invasive ductal carcinoma (IDC), high grade IDC, and invasive lobular carcinoma (ILC).
Red dots in (a)-(c) depict outliers.
1

4.3.4 Image primitives
Image primitive metrics are summarized in Figure 4.8. The Bernsen local thresholding
rendered many of the low intensity, low contrast adipose tissue samples featureless. This
explains the low fractal dimension, unit lacunarity, and zero Euler number for this tissue
subtype in Figure 4.8a, Figure 4.8b, and Figure 4.8c, respectively. High grade IDCa
samples follow a similar trend but to a lesser extent. The highly structured reflectance
signatures characteristic of connective tissue and FCD result in relatively high lacunarity,
shown in Figure 4.8b. These results are expected given the rotational variance of these
samples. Intermediate grade IDCa and ILCa exhibit pockmarked textures (Figure 4.6) that
result in elevated Euler numbers, as indicated in Figure 4.8c. Figure 4.8f shows that fractal
dimension and lacunarity also statistically separate the rare combination of FCD and ILCa.
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Figure 4.8 Boxplots of structural image primitive metrics of (a) fractal dimension, (b) lacunarity, and (c)
Euler number for fx = 1.37 mm-1, λ = 490 nm samples tallied in Table 4.1. Statistical discrimination between
these metrics is shown via Mann-Whitney U-Test p-value heat maps for (d) adipose, (e) connective, and (f)
FCD versus intermediate grade invasive ductal carcinoma (IDC), high grade IDC, and invasive lobular
carcinoma (ILC). Red dots in (a)-(c) depict outliers.

4.3.5 Power spectral density curve parameters
Figure 4.9 contains the PSD curve parameters derived from the sub-diffuse reflectance
samples. In Figure 4.9a, FCD samples present with relatively steep LSF slope, indicative
of less LSF range content overall. In Figure 4.9h, LSF slope and intercept are both
statistically distinct between FCD and the three malignant tissues. HSF slope and intercept
separate both adipose tissue and connective tissue samples from the malignant tissue
samples. Adipose tissue presents with a steeper HSF slope, because adipose tissue
reflectance contains relatively less HSF range content. Connective tissue samples exhibit
a more gradual HSF slope relative to the malignant tissues, because connective tissue
reflectance contains additional HSF features relative to the malignant tissues.
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Figure 4.9 Boxplots of normalized PSD curve linear fit parameters for fx = 1.37 mm-1, λ = 490 nm samples
tallied in Table 4.1. Parameters include low spatial frequency range (a) slope and (b) intercept, high spatial
frequency (c) slope and (d) intercept, and (e) the spatial frequency at which the two fits intersect. Statistical
discrimination between these metrics is shown in Mann-Whitney U-Test p-value heat maps for (f) adipose,
(g) connective, and (h) FCD versus intermediate grade invasive ductal carcinoma (IDC), high grade IDC,
and invasive lobular carcinoma (ILC). Red dots in (a)-(c) depict outliers.

4.3.6 Classification analysis
The ROC curves in Figure 4.10 reflect optimal classification performance based on a
feature selection grid-search. Table 4.3 summarizes optimal classification performance in
the form of AUC, sensitivity, specificity, and accuracy with 95% confidence intervals.
Adipose tissue versus intermediate grade IDCa and ILCa can be classified with relatively
high accuracy compared to adipose tissue versus high grade IDCa. Connective tissue can
be classified against high grade IDCa with relatively high accuracy compared to connective
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tissue versus ILCa. FCD can be classified relatively well against high grade IDCa, while
the model is less effective at classifying FCD versus ILCa. Accuracy confidence intervals
were wide for some tissue subtypes given the tissue subtype sample sizes.

Figure 4.10 Classification performance using sub-diffuse reflectance (fx = 1.37 mm-1, λ = 490 nm) and
evaluated by receiver operator characteristic curve analysis for (a) adipose, (b) connective, and (c) FCD
versus the three malignant tissue subtypes. Classification used a linear SVM classifier, correlation-based
feature selection with grid-searching, five-fold CV, sample size matching, and averaging over n = 100
iterations. At most, 11 texture features were included in each classification. IDC = invasive ductal carcinoma.
Int = intermediate grade. High = high grade. ILC = invasive lobular carcinoma.

Table 4.3 Summary of classification performance using sub-diffuse reflectance, a linear SVM classifier,
correlation-based feature selection with grid-searching for the optimal feature set, and a total of 11 possible
texture features. Accuracy 95% confidence intervals are given in parentheses. IDCa = invasive ductal
carcinoma. Int = intermediate grade. High = high grade. ILCa = invasive lobular carcinoma.
Adipose versus
IDCa IDCa
Int
High
ILCa

Connective versus
IDCa
IDCa
Int
High
ILCa

FCD versus
IDCa
IDCa
Int
High
ILCa

AUC

0.97

0.77

0.98

0.79

0.93

0.58

0.91

0.93

0.67

Sensitivity

0.99

0.74

0.99

0.72

0.89

0.59

0.89

0.92

0.61

Specificity

0.86

0.67

0.90

0.71

0.95

0.50

0.79

0.92

0.65

Accuracy

0.92
(0.880.96)

0.70
(0.580.82)

0.95
(0.901.00)

0.72
(0.540.90)

0.92
(0.890.95)

0.55
(0.410.69)

0.84
(0.750.93)

0.92
(0.900.94)

0.63
(0.470.79)

The texture features used in optimal classifications are reported in Figure 4.11 in heat map
form. The most frequently used metrics in benign-malignant classification pairs are boxed
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in gray, and the percent of the n = 100 classification CV folds that employed the given
metric is displayed. Figure 4.11a indicates that the most valuable metric for classifying
adipose tissue versus intermediate grade IDCa or ILCa is GLCM correlation, while
classifying adipose versus high grade IDCa involved a more distributed selection of
metrics. In Figure 4.11b, a range of metrics were used to classify connective tissue versus
intermediate grade IDCa and ILCa. GLCM correlation was always found in the optimal
classification of connective tissue versus high grade IDCa. In Figure 4.11c, GLCM
contrast and correlation were the most important features for classifying FCD against the
malignant tissue subtypes. Figure 4.12 reports the optimal number of features used in every
benign-malignant classification. Values are averaged over all n = 100 iterations and
rounded to the nearest integer. No classification scenario used more than eight texture
features on average. The benign-malignant pair that used the most features for optimal
classification was connective tissue versus ILC, which demonstrated the poorest
classification performance overall.

Figure 4.11 Feature selection for classification of samples using only sub-diffuse reflectance texture metrics
(fx = 1.37 mm-1, λ = 490 nm). The percent of n = 100 classification iterations that used specific texture metrics
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is shown in heat map form for (a) adipose, (b) connective, and (c) FCD versus the three malignant tissue
subtypes. Boxed percentages identify how frequently the most important metric(s) was/were used in each
benign-malignant classification scenario. IDC = invasive ductal carcinoma. Int = intermediate grade. High =
high grade. ILC = invasive lobular carcinoma. Listed features are: GLCM (Con)trast, (Cor)relation, and
(Hom)ogeneity; (Frac)tal (Dim)ension; (Lac)unarity; power spectral density (L)ow Frequency (Slope),
(L)ow Frequency (Int)ercept, (H)igh Frequency (Slope), (H)igh Frequency (Int)ercept, and (Fit Inter)section.

Figure 4.12 Optimal number of features (averaged over n = 100 classification iterations and rounded to the
nearest integer) determined by correlation-based feature selection and grid-searching for sample
classification using sub-diffuse (fx = 1.37 mm-1, λ = 490 nm) reflectance texture metrics. IDC = invasive
ductal carcinoma. Int = intermediate grade. High = high grade. ILC = invasive lobular carcinoma.

4.4 Discussion
4.4.1 The value of studying tissue subtypes
BCS margin assessment technology studies often adopt broad tissue categories, such as
normal versus malignant [57]. This categorization lumps together healthy adipose and
fibroglandular tissues with benign lesions, such as FCD and fibroadenoma, although these
tissue subtypes contain different cellular and subcellular structures. Malignant tissue
subtypes, including IDCa of low, intermediate, and high grade and ILCa, are all
characterized by different densities of subcellular components (e.g., nuclei and
mitochondria) and different types and organizations of cells. Nevertheless, these malignant
tissue subtypes are also commonly lumped together into a single malignant tissue category.
Studies that rely on broad tissue categorization complicate the tissue classification task and
jeopardize clinical potential. The problem of intraoperative BCS margin assessment could
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be simplified by ensuring sensitivity to key benign and malignant breast tissue subtypes.
Biopsies are typically performed prior to BCS procedures. Using such a priori tissue
information could improve tissue margin diagnostic accuracy by reducing the number of
possible malignant tissue subtypes [123].
The sub-diffuse scattering behavior of various breast tissue subtypes can be inferred
from Figure 4.6. Adipose tissue is composed primarily of adipocytes, which contain
forward-scattering vacuoles with length scales >25 μm. Adipose tissue is thus
characterized by a relatively low intensity, homogenous sub-diffuse reflectance signal (topleft, dashed, yellow pane of Figure 4.6). Fibroglandular tissue contains collagen fibers
(length scale >1 μm), which are weakly backscattering, and collagen fibrils (length scale
of 10s of nm), which act as strong Rayleigh scatterers. Together, these structures create
relatively high intensity, structured sub-diffuse reflectance, seen in the second row, dashed
pink pane in Figure 4.6. FCD, a common type of benign lesion, can be characterized by
fibrosis of surrounding stroma (i.e., proliferation of connective tissue), resulting in
Rayleigh scattering structures on the order of millimeters [144]. These structures are visible
in the cyan colored panes on the left side of Figure 4.6. As a final example, high grade
IDCa is characterized by an elevated density of nuclei (~5 μm in diameter), which are
relatively large, forward scattering cellular components. This may explain why high grade
IDCa yields a relatively low intensity, homogeneous sub-diffuse reflectance, like adipose
tissue. Comparing adipose tissue and high grade IDCa demonstrates that using sd-SFDI
reflectance texture analysis alone may not be effective for surface tissue diagnostics,
because different tissue subtypes may contain biologically distinct Mie- or Rayleigh-type
scatterers that give rise to similar sub-diffuse reflectance. In the case of adipose tissue and

61

high grade IDCa, for example, sd-SFDI texture in combination with diffuse SFDI
reflectance could potentially overcome this limitation.
In summary, Figure 4.6 highlights the heterogeneity in reflected signals from
common breast tissues and shows that sub-diffuse reflectance enhances contrast to smallscale surface tissue texture relative to diffuse, planar illumination imaging. Figure 4.6 also
qualitatively reinforces the concept that broad categorization of breast tissues (e.g., normal
versus malignant) is an oversimplification of tissue categorization, because all malignant
tissue subtypes do not necessarily share the same set of meso-/macroscale reflectance
features.

4.4.2 Study limitations
The classification model used a linear SVM for binary classification, but tissue diagnostics
are inherently a multiclass classification problem. The current model could be clinically
relevant given the tissue subtype-limiting benefits of preoperative biopsy. Nevertheless,
potential clinical value would be increased if it were a multiclass classification model. An
important limitation of the classification model in this work was that random five-fold CV
was implemented due to sample size limitations. With increased tissue sample sizes, leaveone-out CV, which partitions the data by patient, specimen, or ROI, should be
implemented. Often, partitioning is done on the patient-level and is referred to as leaveone-patient-out CV (LOPOCV). LOPOCV avoids confounding scenarios when unique
features contained within a single patient’s data are spread across multiple folds, thus
appearing in both the training and testing datasets and potentially leading to inter-patient
model bias [141]. Classification results reveal that reflectance texture analysis has both
strengths and weaknesses. Sub-diffuse reflectance is directly related to microscopic
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structures in tissue but does not necessarily provide unique signals associated with all tissue
subtypes diagnosed on the histopathological level. Adipose tissue and high grade IDCa
cannot be accurately resolved using sub-diffuse reflectance alone using the model
presented here. The same applies for differentiating between connective tissue or FCD
from ILCa. Combining tissue texture features with other tissue properties may overcome
these limitations. For instance, quantitative color properties can readily separate adipose
tissue and high grade IDCa [123]. Future studies could focus on the collection of a larger
hold-out dataset, such that the classification model is trained and tested on a subset of the
data and a second subset is reserved purely for assessing classification performance.

4.4.3 Future work
The potential benefits of sub-diffuse reflectance texture quantification over optical
property quantification include a simplified data collection protocol, computational
efficiency, and avoiding light transport model assumptions, which may lead to additional
errors. Still, it is known that optical properties offer invaluable characterization of a wide
range of biological tissues. Future work could compare surface tissue classification
performance using sd-SFDI reflectance textures and optical properties. Additional studies
are required to validate these classification results on larger sample sizes, to test the
inclusion of other tissue properties in the classification model, and to improve the
generalization and applicability of this approach.

4.5 Conclusions
Intraoperative optical imaging may help clinicians to reduce the positive margin rate in
BCS by rapidly providing enhanced contrast to surface tissue features over a wide field of
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view. Sd-SFDI shows promise for this application. In this chapter, an sd-SFDI imaging and
analysis protocol for BCS tissue surface characterization was introduced that uses one subdiffuse spatial frequency of illumination at a single blue optical wavelength and reflectance
texture. The protocol leverages wide field-of-view optical scatter imaging, which is
sensitive to only surface layer tissue features and benefits from relatively fast acquisition
and processing times relative to optical property quantification. The protocol avoids light
transport model assumptions for metric quantitation, as it analyzes intrinsic reflectance
textures in the imaged tissue. Finally, different combinations of pixel statistics, image
primitives, and PSD curve parameters provided statistical significance between three
benign and three malignant breast tissue subtypes, and classification results provide one
method of determining the relative importance of these metrics for characterizing resected
BCS tissues. A broadened set of reflectance textural features in combination with other
image features may offer clinically valuable diagnostics for intraoperative BCS margin
guidance.
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Chapter 5 Optical scatter versus micro-computed tomography contrast
This chapter draws from the following peer-reviewed publication:
Streeter SS, Maloney BW, Zuurbier RA, Wells WA, Barth RJ, Paulsen KD, Pogue BW.
Optical scatter imaging of resected breast tumor structures matches the patterns of microcomputed tomography. Phys Med Biol. England; 2021 Jun 1;66(11). PMID: 34061046.
DOI: 10.1088/1361-6560/ac01f1.
Note that Figure 5.1 through Figure 5.5 and a limited amount of background content
presented in this chapter were drawn from the supplemental materials associated with this
publication. The key finding from this work is that X-ray-based micro-computed
tomography (micro-CT) contrast and optical scatter (i.e., sub-diffuse reflectance) contrast
are similar on a macroscale but differ on meso- and microscales. On smaller spatial scales,
optical scatter reveals useful intra-tumoral and fibrous tissue boundary features that are not
detected by micro-CT.

5.1 Introduction
Recent studies have explored the value of volumetric micro-CT [49,65,70] and
tomosynthesis [68,71] for improving intraoperative breast-conserving surgery (BCS)
margin assessment. These technologies overcome the dimensional limitation inherent to
projection imaging and provide rapid sensing of the three-dimensional (3D) morphology
of specimens. Nonetheless, X-ray imaging alone lacks contrast between normal, abnormal
benign, and malignant fibrous tissues that may be important for assessing breast tumor
margins [145]. Coupling volumetric X-ray imaging with other imaging modalities sensitive
to fibrous tissue subtypes may be one attractive solution for margin assessment [57,65,70].
Several imaging techniques have been proposed for improving BCS margin
assessment, including compact magnetic resonance imaging [146], diffuse reflectance
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spectroscopy [147], Raman spectroscopy [148], fluorescence microscopy [149], and
photoacoustic microscopy [150]. A typical BCS resection will have a surface area that is
10s of cm2 (roughly 45 cm2 on average based on a recent study [70]). The relatively small
field of view of these imaging techniques (i.e., 100s μm2 – 1 cm2) limit their potential to
thoroughly analyze the surface of a BCS resection in a clinically relevant timeframe.
Intraoperative pathological techniques, including frozen section pathology, touch smear,
and imprint cytology, are used in some medical centers for BCS margin assessment, but
these methods are known to be time- and resource-intensive [151].
In this study, BCS specimens were imaged using micro-CT and wide field-of-view
(>100 cm2) optical scatter imaging (a.k.a. sub-diffuse spatial frequency domain imaging or
sd-SFDI). SFDI involves illuminating the tissue with one-dimensional (1D) sinusoidal
patterns of light and imaging the reflected light intensity. When the sinusoidal patterns are
finer than the length scale of diffuse photon transport, the measured reflectance is
dominated by sub-diffusely scattered photons, and the observed contrast is dominated by
optical scatter; this is sd-SFDI [119]. This form of optical scatter imaging provides rapid,
non-contact, and wide-field scanning of the top layer of tissue with increased sensitivity to
tumor-associated, collagen-rich matrix structures (<1 mm depth sensitivity) [110] and does
not require any exogenous contrast agents. Diffuse white light (DWL) imaging, which is
similar to the surgeon’s view of the tissue in the operating room (OR), and optical scatter
imaging were compared directly to micro-CT for visualizing BCS specimens exhibiting 13
distinct tissue subtypes confirmed by histopathological analysis. The goal of the study was
to investigate the potential synergy between micro-CT and optical scatter imaging for
analyzing BCS tissues.
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5.2 Methods
5.2.1 Imaging protocol
The imaging protocol reported here is identical to that reported in Chapter 4 (Section 4.2.1)
except that in this chapter micro-CT scanning was also involved. Multimodal micro-CT
and optical scatter imaging of BCS specimens was performed at Dartmouth-Hitchcock
Medical Center (DHMC) in Lebanon, New Hampshire. The observational study was
approved by the Institutional Review Board at Dartmouth for protection of human subjects,
and all procedures followed the approved protocol. Procurement of tissue specimens
involved patients undergoing consented and elective breast surgeries at DHMC. Specimen
imaging occurred postoperatively during standard pathological processing using a
validated multimodal imaging system [122] and did not impact clinical workflow or
subsequent tissue processing and diagnostic reporting. Each resected BCS tumor was
“bread-loafed” or serially sliced into ∼5-mm thick sections perpendicular to its long axis
according to standard-of-care practices at DHMC. One representative slice from each
tumor was selected by an experienced Pathologists’ Assistant, positioned firmly between
optically clear acrylic plates, and imaged ex vivo in the multimodal system, which was
stationed in the specimen grossing laboratory. Each imaged specimen was de-identified
and referenced only by a unique specimen accessioning number. The top surface of each
imaged slice underwent standard-of-care specimen processing, sectioning, staining with
hematoxylin and eosin, and microscopic analysis by a board-certified breast pathologist
(Wendy Wells, MD). Representative histologic glass slides corresponding to the imaged
tissue underwent whole slide, high-resolution digital imaging to confirm tissue subtype
regions of interest (ROIs). These microscopic ROIs were co-registered to the wide field67

of-view micro-CT and optical imagery. Figure 5.1 illustrates the process of histological
mosaicking and ROI co-registration to optical and micro-CT imagery.

Figure 5.1 Demonstration of optical and micro-CT slice images co-registered with histopathology. ILCa =
invasive lobular carcinoma; Ca = carcinoma; LCIS = lobular carcinoma in situ. λ = optical wavelength. fx =
spatial frequency of illumination. kVp = kilovoltage peak.

5.2.2 Imaging system
Note that the imaging system and optical acquisition settings reported here are identical to
those reported in Chapter 4 (Section 4.2.2). Micro-CT scans were performed using an In
Vivo Imaging System (IVIS) SpectrumCT system (PerkinElmer, Hopkington, MA)
housing a cone-beam CT in a “pancake” geometry and with settings reported in a previous
BCS specimen study [65]. X-ray settings were 50 kVp and 1 mA with a 440-μm aluminum
filter. The X-ray source-detector distance was fixed with a 50-μm focal spot size. A scan
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involved 360° rotation of the specimen with a 100-ms exposure every 0.5° (720 total
projections). A scan volume of 12 x 12 x 3 cm3 was reconstructed with 150-μm3 voxels
(~4 min acquisition and reconstruction). The X-ray detector (3072 x 864 pixels) was binned
by a factor of four (1024 x 216 pixels) to increase the signal-to-noise ratio and reduce total
scan time. The optical imaging system consisted of the native SpectrumCT charged
coupled device camera (Andor iKon, Andor Technologies Ltd., Belfast, UK) and a digital
light projector or digital micromirror device (DMD) (CEL5500 Fiber, Digital Light
Innovations Inc., Austin, TX) retrofitted into the light-tight, fully shielded SpectrumCT
imaging cabinet. Optical imaging involved acquisitions at seven wavelengths (λ = 490 –
800 nm, 15-nm bandwidth) and seven structured illumination frequencies (fx = 0.00 – 1.37
mm-1) produced by the DMD (~8 min acquisition and saving). The optical imaging field
of view was ~13 cm x ~13 cm with a pixel size in the imaging plane of ~126 μm x ~126
μm. Each imaged specimen was positioned firmly between acrylic plates and was not
moved or altered between micro-CT and optical image acquisition, allowing for spatial coregistration between the two modalities.

5.2.3 Image data and pre-processing
A total of 70 BCS tumor specimens were imaged using the study protocol. Previous studies
analyzed only the optical image data from these 70 specimens, demonstrating statistical
differentiation between healthy, abnormal benign, and malignant tissue subtypes using
either optical property quantification [123] or reflectance textural information [152].
Recently, the top tissue slice from each volumetric micro-CT scan (i.e., the tissue surface
imaged optically) was extracted, rescaled, and spatially co-registered with the optical data
of the same specimen using rigid transformations. The present study is the first quantitative
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analysis of the micro-CT data in the form of image similarity and quality relative to the coregistered optical images.
All optical images were converted to calibrated reflectance maps using a previously
described normalization routine [122] and were then median filtered using a 3 x 3-pixel
kernel. All micro-CT slice images were extracted from volumetric scans calibrated to 50
kVp linear attenuation coefficient values (in units of cm-1). No additional image preprocessing (e.g., histogram stretching) was performed on any image data prior to
quantitative image analysis.
True color, DWL images of each specimen were reconstructed from planar
illumination (fx = 0.00 mm-1) imagery at five wavelengths in the visible spectrum (λ = 490,
550, 650, 700 nm) using 1931 International Commission on Illumination color space
tristimulus values [153] and a previously described process [122]. These true color
reconstructions represented how each tissue specimen would appear to the naked eye (e.g.,
to the surgeon in the OR). Optical scatter color reconstructions were created by the same
method, except using only the highest spatial frequency illumination data (fx = 1.37 mm-1).
Optical scatter color reconstructions were not used in the image analysis in this study but
were included for qualitative inspection. For the image analysis, true color DWL images
were converted to grayscale intensity (i.e., luminance), and optical scatter images were
derived from the shortest optical wavelength (λ = 490 nm) and highest spatial frequency
pattern (fx = 1.37 mm-1). This created three grayscale (i.e., single channel) image types to
be quantitatively compared: DWL luminance, monochromatic 490 nm optical scatter, and
micro-CT.
Of 70 imaged specimens, five were excluded due to inconsistent micro-CT scan
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settings, six were excluded due to ambiguous histology co-registrations, one was excluded
due to neo-adjuvant chemotherapy treatment, and one was excluded due to a small crosssectional area (<2 cm2). Thus, 57 specimens were further analyzed. Table 5.1 summarizes
the 57 imaged specimens by primary tissue subtype diagnosis. Each specimen contained
one or more tissue subtypes confirmed by microscopic histopathological analysis. Some
specimens contained multiple benign and/or malignant subtypes with normal adipose tissue
and/or connective tissue components.
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Table 5.1 Summary of imaged breast-conserving surgery specimens by primary tissue subtype. Inv =
invasive.
Primary Diagnosis

Specimen Count

Healthy and benign
Healthy connective tissue*

3

Fibrocystic disease

1

Fibroadenoma

3

Myofibroblastic

1

Phyllodes

1
Subtotal:

9

Pre-invasive and invasive ductal carcinoma
Ductal carcinoma in situ

3

Inv. tubular carcinoma

2

Inv. ductal carcinoma low grade

9

Inv. ductal carcinoma intermediate grade

14

Inv. ductal carcinoma high grade

8

Inv. mucinous carcinoma

2
Subtotal:

38

Invasive lobular carcinoma/Other
Inv. lobular carcinoma

9

Inv. metaplastic

1
Subtotal:

10

Total:

57

Imaged surfaces of these specimens did not contain abnormal benign
and/or malignant lesion(s) based on histological analysis.
*

5.2.4 Image analysis
Figure 5.2 provides an overview of the image similarity analysis performed in this study.
The true color, DWL image for each specimen was converted to a grayscale luminance
image, which was compared to the grayscale micro-CT slice image as a baseline
measurement. The grayscale optical scatter image was then compared to the micro-CT slice
to demonstrate the increased similarity of optical scatter to micro-CT relative to typical
DWL visualization of tissue.
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Figure 5.2 Similarity image analysis was performed on two pairs of grayscale image types: Diffuse white
light (DWL) luminance versus micro-CT and optical scatter versus micro-CT.

Three forms of image analysis were performed in this study. First, mutual
information (MI) and the Sørensen–Dice (Dice) coefficient quantified wide-field similarity
between micro-CT and optical images of all n = 57 specimens. MI was used as a pixellevel joint intensity distribution similarity metric, as it is insensitive to spatial relationships
between pixels [154] (Figure 5.3). The Dice coefficient based on an isodata binary
thresholding algorithm [155] compared high-contrast, two-dimensional structures in the
optical and micro-CT images (Figure 5.4). DWL luminance versus micro-CT provided a
baseline similarity measurement (i.e., an approximation of how the naked eye view relates
to the radiological view of the tissue), and optical scatter versus micro-CT similarity was
compared to this baseline.
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Figure 5.3 Mutual information was quantified using four-bit intensity scaled images (top row) and based on
the joint histogram between each image type pair (bottom row). Bivariate histogram bin counts are
normalized to the maximum optical scatter/micro-CT bin count value to emphasize the increased image
similarity in the optical scatter/micro-CT image pair. This figure illustrates mutual information quantification
using the same specimen as Figure 5.2.

Figure 5.4 The Sørensen–Dice coefficient for each image pair was determined between binary images
derived using an isodata binary thresholding algorithm. This figure illustrates Sørensen–Dice coefficient
quantification using the same specimen as Figure 5.2.

The second form of analysis involved the quantification of the coefficient of
variation (CVar) for all n = 57 wide-field specimen images (Figure 5.5). CVar was defined
as the ratio of the standard deviation of tissue pixel values divided by the mean value of
tissue pixel values. CVar provided a standardized measure of dispersion about the mean
image pixel intensity and quantified the relative amount of feature content in each image
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(i.e., the image quality). An image with high CVar was interpreted as having relatively
more feature content, and vice versa.

Figure 5.5 The coefficient of variation captured the dispersion of pixel intensities about the mean in each
grayscale image type. The coefficient of variation was defined as the standard deviation of pixel values (σ,
blue horizontal lines in histograms) divided by the mean pixel value (μ, red vertical lines in histograms). This
illustration uses the same specimen as Figure 5.2. Note that in this figure, coefficient of variation is
abbreviated as “CV” instead of “CVar.”

The third form of analysis focused on targeted (i.e., 1.5 cm x 1.5 cm or 2 cm x 2
cm) regions in the micro-CT and optical imagery. CVar was quantified within malignant
tumor-bearing sections and sections containing malignant tissue boundaries with adjacent
healthy/benign fibrous tissue to quantify intra-tumoral and tumor boundary feature content,
respectively. The tumor boundary contrast ratio (TBCR) was defined as the ratio of
intensities between a malignant tissue region and adjacent healthy/benign fibrous tissue
region (each being a 2 mm diameter circular sample of intensity). The TBCR was defined
with the brighter and darker regions set to the numerator and denominator, respectively
75

(thus, TBCR ≥ 1 by definition; the numerator and denominator were set irrespective of
malignancy). The TBCR quantified the malignant versus healthy/benign tissue boundary
contrast achieved by each image type. TBCR was used instead of a conventional contrastto-noise ratio (CNR, defined as the difference in intensity between the malignant and nonmalignant regions divided by the standard deviation of the background), because sensitivity
to tumor and fibrous tissue heterogeneity would be penalized by the quantification of CNR.
For comparing results from all n = 57 specimens, differences in MI, Dice
coefficient, and CVar were evaluated statistically using nonparametric Mann-Whitney U
tests. A p-value of <0.05 was considered statistically significant. All image and statistical
analyses were performed using MATLAB (v2020a, Mathworks, Inc., Natick, MA).

5.3 Results
Wide field-of-view images from representative invasive ductal carcinoma (IDCa) and
invasive lobular carcinoma (ILCa) specimens are shown in Figure 5.6 and Figure 5.7,
respectively. In these figures, true color DWL images appear in the leftmost column,
followed by DWL luminance, optical scatter color reconstructions, monochromatic 490 nm
optical scatter images, and spatially co-registered micro-CT slices in the remaining four
columns.
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Figure 5.6 Wide field-of-view images of representative invasive ductal carcinoma specimens (yellow arrows
= adipose tissue; pink arrow = connective tissue; red arrows = malignant tissue). 1-cm scale bars are shown
in the first column. In the optical images, surgical ink (yellow, orange, red) is visible along some specimen
margins. Linear attenuation coefficient values correspond to 50 kVp. DWL = diffuse white light.

77

Figure 5.7 Wide field-of-view images of representative invasive lobular carcinoma specimens (yellow
arrows = adipose tissue; pink arrows = connective tissue; red arrows = malignant tissue). 1-cm scale bars are
shown in the first column. In the optical images, surgical ink (orange, red, blue) is visible along some
specimen margins. Linear attenuation coefficient values correspond to 50 kVp. DWL = diffuse white light.

Wide field-of-view micro-CT and optical image similarity analysis is summarized
in Figure 5.8a-d. In Figure 5.8a, optical scatter and DWL luminance exhibited similar MI
to micro-CT for healthy/benign tissue specimens (p-value = 0.11). Optical scatter exhibited
greater MI with micro-CT than DWL luminance for IDCa specimens (p-value < 0.001) and
greater MI with micro-CT than DWL luminance for ILCa specimens (p-value = 0.009). In
Figure 5.8c, optical scatter and DWL luminance exhibited similar Dice coefficients with
micro-CT for healthy/benign tissue specimens (p-value = 0.37). Optical scatter exhibited
greater Dice coefficients with micro-CT than DWL luminance for IDCa specimens (pvalue < 0.001) and similar Dice coefficients with micro-CT for ILCa specimens (p-value
= 0.08). When specimens were analyzed as a single group, optical scatter images exhibited
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greater similarity with co-registered micro-CT slices in 89% (51/57) of specimens using
MI (Figure 5.8b; mean ± one standard deviation of 0.48 ± 0.21 vs. 0.24 ± 0.12; p-value <
0.001) and in 81% (46/57) of specimens using the Dice coefficient (Figure 5.8d; mean ±
one standard deviation of 0.48 ± 0.21 vs. 0.33 ± 0.18; p-value < 0.001).
CVar values quantified from the wide field-of-view images effectively separated
the three image types with statistical significance (Figure 5.8e-f). In 100% (57/57) of
specimens, optical scatter yielded the highest CVar values, indicating that this image type
generated the greatest relative dispersion about the mean tissue pixel intensity compared
to co-registered DWL luminance and micro-CT images.
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Figure 5.8 Image similarity metrics quantified between micro-CT and either diffuse white light luminance
or optical scatter images (a-d), and image quality coefficient of variation quantified for each image type (ef). The legend in (a) applies to all subplots in A-D. The legend in E also applies to F. DWL Lum. = Diffuse
White Light Luminance; Scatter = 490 nm Optical Scatter; CT = Micro-CT; Ca = carcinoma; Other =
metaplastic tumor.

Figure 5.9 shows close-ups of BCS specimen tumor-bearing sections with various
intra-tumoral fibrous structures. In the leftmost column, wide field-of-view, true color
DWL specimen images show red ROIs that delineate malignant tissue confirmed by
histopathology. Square regions shown in this column (white border, 1.5 cm x 1.5 cm) are
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magnified in the next three columns of each row to visually highlight differences between
the optical and micro-CT images. Figure 5.10 presents tumor-bearing sections that contain
malignant tissue boundaries with adjacent healthy/benign fibrous tissue. In the leftmost
column, wide field-of-view, true color DWL specimen images show color-coded tissue
subtype ROIs, and square regions (white border, 2 cm x 2 cm) containing malignant tissue
boundaries are magnified in the next three columns of each row, again to highlight
differences in the images.

Figure 5.9 Representative tumor slices demonstrating intra-tumoral fibrous structures. Regions of interest
(white squares, 1.5 cm x 1.5 cm, column 1) magnify the malignant primary tumor (red lines) in the following
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four columns. Ring artifacts are seen in the micro-CT images in the top two rows, and a microcalcification
is seen in the micro-CT of the last specimen (yellow arrow). 1-cm scale bars are shown for each row. Linear
attenuation coefficient values correspond to 50 kVp. DWL = Diffuse White Light; IDCa, IG = invasive ductal
carcinoma, intermediate grade; ILCa = invasive lobular carcinoma.

Figure 5.10 Representative tumor slices exhibiting malignant tissue boundaries (red lines/arrows) with
adjacent non-malignant fibrous tissue (pink lines/arrows = healthy connective tissue; cyan line/arrow =
fibrocystic disease). Regions of interest (white squares, 2 cm x 2 cm, column 1) magnify malignant tissue
boundaries in the following four columns. A beam hardening artifact from a surgical clip is seen in the top
row micro-CT (yellow arrow), and a ring artifact is present in the bottom micro-CT. 1-cm scale bars are
shown for each row. Linear attenuation coefficient values correspond to 50 kVp. DWL = Diffuse White
Light; Ca = carcinoma; IDCa, LG = invasive ductal carcinoma, low grade; IDCa, IG = invasive ductal
carcinoma, intermediate grade; IDCa, HG = invasive ductal carcinoma, high grade.

Figure 5.11a summarizes image quality analysis performed on the 1.5 cm by 1.5
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cm ROIs containing intra-tumoral structures shown in Figure 5.9. For these n = 4
representative specimens, optical scatter exhibited the highest CVar in every case (0.200.30 versus 0.04-0.09 for DWL luminance, 0.03-0.08 micro-CT). Figure 5.11b
summarizes image quality analysis performed on 2.0 cm by 2.0 cm ROIs containing
malignant boundaries with adjacent healthy or benign fibrous tissue shown in Figure 5.10.
For these n = 4 representative specimens, optical scatter again exhibited the highest CVar
in every case (0.43 – 0.67 versus 0.13 – 0.31 for DWL luminance, 0.11-0.25 micro-CT),
suggesting greater sensitivity to malignant tissue boundaries with adjacent fibrous tissue.
Figure 5.11c reports TBCR values quantified from 2 mm diameter samples on either side
of the tumor boundaries shown in Figure 5.10 (solid colored dots in column 1). TBCR
values for the n = 4 representative specimens were 1.5 – 3.7 for optical scatter, while the
same samples yielded TBCR values of 1.0 – 1.1 for both DWL luminance and micro-CT.

Figure 5.11 Intra-tumoral structure coefficient of variation values from (a) 1.5 cm x 1.5 cm tumor-bearing
ROIs shown in Figure 5.9 and (b) 2 cm x 2 cm tumor boundary ROIs shown in Figure 5.10. (c) TBCR values
quantified in 2 mm diameter samples on either side of the tissue boundary (solid colored dots in Figure 5.10
column 1). DWL Lum. = Diffuse White Light Luminance; Scatter = 490 nm Optical Scatter; Ca = Carcinoma;
IDCa, LG = invasive ductal carcinoma, low grade; IDCa, IG = invasive ductal carcinoma, intermediate grade;
IDCa, HG = invasive ductal carcinoma, high grade; ILCa = invasive lobular carcinoma.

5.4 Discussion
The purpose of this study was to directly compare micro-CT and optical scatter images of
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surgical breast specimens. In general, monochromatic 490 nm optical scatter and microCT exhibited similar contrast between epithelial and stromal features relative to
backgrounds of low intensity adipose tissue. Figure 5.6 and Figure 5.7 show this visually,
and image analysis results in Figure 5.8a-d corroborate this finding quantitatively using
MI and Dice coefficient. Optical scatter and micro-CT had greater MI (p-value < 0.001)
and greater Dice coefficient (p-value < 0.001) versus DWL luminance and micro-CT
overall.
The fact that optical scatter relates to the radiological view of the tissue, despite
having a distinct mechanism of contrast, is notable. X-ray contrast is based on attenuation
resulting from both scattering and absorption events and is governed by the Beer-Lambert
𝑙𝑙

Law, 𝑁𝑁𝑜𝑜𝑜𝑜𝑜𝑜 (𝛦𝛦) = 𝑁𝑁𝑖𝑖𝑛𝑛 (𝛦𝛦)𝑒𝑒 − ∫0 𝜇𝜇(𝑥𝑥,𝑍𝑍,𝐴𝐴,𝜌𝜌,𝛦𝛦)𝑑𝑑𝑑𝑑 , where Nin and Nout are the incident and exiting

X-rays on either side of a tissue sample, respectively, E is the X-ray photon energy, and μ

is the linear attenuation coefficient, which may depend on spatial position (x) in a tissue
sample of certain thickness (l), and on the atomic number (Z), atomic mass (A), and density
(ρ) of the tissue. X-ray contrast arises from differences in tissue μ, mainly from changes in
tissue density (e.g., ρAdipose ≈ 0.94 g/cm3 versus ρOtherSoftTissue ≈ 1 g/cm3 in BCS specimens)
and from high atomic number material (e.g., Zcalcium = 20 in BCS specimen
microcalcifications) [156]. Tissue density (i.e., electron density) differences primarily
impact X-ray attenuation due to Compton scattering, which has the following
𝑍𝑍

proportionality: 𝜇𝜇𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 ∝ 𝜌𝜌 𝐴𝐴. Atomic number differences, meanwhile, primarly impact

X-ray attenuation due to the photoelectric effect, which has the following proportionality:
𝑍𝑍 3

𝜇𝜇𝑃𝑃ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 ∝ 𝐸𝐸3 [156]. X-ray imaging is less effective at detecting microscopic

differences between healthy, abnormal benign, and malignant fibrous tissues, because
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these tissues have similar radiodensity (i.e., similar tissue density and effective atomic
number) over the range of diagnostic X-ray energies (roughly 10 – 150 keV).
Optical scatter contrast is fundamentally tied to the lengthscale of index of
refraction fluctuations in tissue relative the wavelength of indicent light. Index of refraction
fluctuations that are larger than the indicent optical photon wavelength result in forwarddominant Mie scattering, while fluctuations that are smaller result in Rayleigh scattering
with relatively more backscattering [110]. Collagen fibrils (10s of nm in diameter) and
striations (<100 nm in diameter) are key Rayleigh scattering components in breast tissue
for optical wavelengths of light and thus contribute positive scatter contrast. In the context
of breast cancer, optical scatter contrast depends on the proportion of connective tissue
matrix versus epithelial tissue, with increased sensitivity to tumor-associated, collagen-rich
matrix, as observed in the optical scatter images presented in this study (e.g., connective
tissues in Figure 5.10 specimens, which also contain intermediate and high grade IDCa).
Meanwhile, adipose tissue vacuoles (>25 μm in diameter) and tightly packed sheets of
epithelium characteristic of high grade IDCa with high nuclear density (nuclei diameters
being ~5 μm) result in Mie-type scattering with relatively less backscattering and thus
lower reflectance (e.g., adipose tissue in Figure 5.6 and Figure 5.7; malignant tissue in the
high grade IDCa specimen in Figure 5.10).
MI and Dice coefficient values reported in this study also indicate micro-CT and
optical scatter imaging have differences in image feature content. Results in Figure 5.8e-f
reinforce this point, showing significantly higher CVar values for optical scatter images
(p-value < 0.001) relative to both DWL luminance and micro-CT. These relatively high
CVar values were in part due to the enhanced contrast that optical scatter has to intra-
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tumoral fibrous structures and tumor boundary features. Subsets of specimens containing
either clear cross sections of malignant tissue (Figure 5.9) or boundaries between
malignant and non-malignant fibrous tissue (Figure 5.10) underscore the potential value
of optical scatter imaging in the context of imaging BCS specimen margins. CVar values
from within tumor-bearing ROIs and malignant tissue boundary ROIs were greatest for
optical scatter relative to DWL luminance and micro-CT (Figure 5.11a-b). When
malignant tissue is adjacent to healthy and/or benign fibrous tissue, TBCR values were
highest for optical scatter relative to DWL luminance and micro-CT as well (Figure 5.11c).
This result suggests that optical scatter may be able to leverage the known association
between the growth and alignment of collagen structures and breast cancer for improving
margin assessment [157,158]. Importantly, optical scatter contrast to malignant tissue is
not necessarily positive (i.e., brighter) relative to surrounding tissues (e.g., all specimens
shown in Figure 5.10). Nonetheless, abrupt changes in optical scatter intensity and/or
texture that correspond to malignancy boundaries or tumor-associated collagen structures
may be of value for diagnostic interpretation of BCS specimen margins and for performing
targeted shave biopsies to remove residual tumor during initial BCS procedures.
The image data in this study exemplify the highly heterogenous nature of breast
cancer, both in terms of macroscale morphology and microscopic histological diagnosis,
but sample sizes were too small to derive robust statistical differences based on individual
tissue subtypes. Another study limitation is the fact that only BCS specimen slices were
imaged, rather than the margins of intact BCS resections. Nevertheless, representative
specimen slices offered the greatest diversity of healthy, abnormal benign, and malignant
tissues to demonstrate differences in micro-CT and optical contrast. Ring artifacts were
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present in a subset of the micro-CT images due to failed detector pixels in the IVIS
SpectrumCT system. Projection pattern artifacts in some optical images were also visible,
appearing as fine scale, 1D fluctuations in intensity. Specular reflection artifacts were also
present in some optical images, appearing as localized spikes in intensity. Micro-CT
scanning benefits from being relatively insensitive to tissue thickness over length scales
relevant to BCS specimens and impervious to irregular tissue surface geometries. In
contrast, optical scatter imaging has only surface layer sensitivity, which is a benefit for
providing spatially localized reflectance, but suffers from specular reflection and
demodulation artifacts that arise from irregular tissue surfaces. This limitation necessitates
the use of optically clear plates to create a flat, consistent tissue surface for wide-field
imaging. Future work could attempt to overcome this limitation of optical scatter imaging
by leveraging stereovision imaging to filter specular reflections and enable imaging of
irregular, 3D tissue surfaces [159]. Finally, while this initial comparison study highlights
the potential synergy of micro-CT combined with optical scatter imaging, future work
should quantitatively measure the improvement in BCS specimen margin assessment using
combined micro-CT and optical scatter imaging.
In this study, a total of 57 BCS tumor specimens exhibiting 13 pathology-confirmed
tissue subtypes were imaged using spatially co-registered micro-CT and optical scatter
imaging. The two main findings from this study were: first, optical scatter contrast was in
general similar to the radiological view of the tissue relative to DWL luminance; and
second, optical scatter revealed additional features associated with fibrous tissue structures
of similar radiodensity that may be relevant to diagnosis. Volumetric X-ray imaging has
clear value in its ability to rapidly scan the 3D morphology of BCS specimens. Micro-CT
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also has sensitivity to microcalcifications, which are not visible in the optical images (e.g.,
ILCa specimen in Figure 5.9), and are known to be related the histology of breast cancer
lesions [160]. The inability of micro-CT to clearly differentiate fibrous tissues on BCS
specimen margins may be addressed by coupling micro-CT with optical scatter imaging,
which senses reflectance from only the superficial layer of tissue with contrast arising
primarily from highly scattering, collagen-rich fibrous tissues. Future work could involve
evaluating micro-CT specimen scanning complemented by co-registered optical scatter
imaging to provide increased sensitivity to fibrous tissue subtypes and tumor structures and
boundaries that may appear along BCS specimen margins.

5.5 Conclusions
BCS re-excision rates are relatively high due to incomplete initial resection of cancerous
tissue. Improved intraoperative margin assessment could reduce the number of re-excision
procedures and associated health and financial costs. Projection radiography is standard of
care for intraoperative BCS specimen imaging, and volumetric X-ray scanning is emerging
as a powerful intraoperative tool for sensing the 3D morphology of BCS resections.
However, X-ray imaging alone lacks contrast between tumor-associated collagen and
healthy or otherwise benign collagen-rich tissues. The goal of this study was to investigate
the potential synergy between micro-CT and optical scatter imaging for analyzing BCS
tissues. Optical scatter contrast is similar to the radiological view of breast tissues in
general but provides additional contrast between healthy, abnormal benign, and malignant
fibrous tissues not readily differentiated by X-ray imaging (i.e., intra-tumoral structures
and boundaries between non-malignant fibrous tissues and tumor tissues) . Optical scatter
imaging with sensitivity to these fibrous tissue features has potential for improving
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intraoperative evaluation of margin adequacy during BCS procedures relative to X-raybased imaging alone.
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Chapter 6 Combined radiomic/optomic analysis of breast cancer tissues
This chapter is based on the following peer-reviewed article:
Streeter SS, Hunt B, Zuurbier RA, Wells WA, Paulsen KD, Pogue BW. Developing
diagnostic assessment of breast lumpectomy tissues using radiomic and optical signatures.
Scientific Reports. 2021 Nov 8;11(1):21832. DOI: 10.1038/s41598-021-01414-z.
Note that Table 6.2, Table 6.3, Figure 6.2, Figure 6.3, and Figure 6.7 and a limited
amount of background content presented in this chapter were drawn from the supplemental
materials associated with this publication. This chapter builds on the breast cancer optical
image textural analysis in Chapter 4 with several key advancements: first, the image feature
analysis is extended from a limited set of texture features to a large number of first-,
second-, and higher-order radiomic features; second, the image data in the analysis now
include multiple spatial frequency domain imaging (SFDI) optical wavelengths and spatial
frequencies of illumination as well as co-registered micro-computed tomography (microCT) image data; third, the image region of interest (ROI) sampling scheme is improved in
this study relative to the sliding-box algorithm implemented in Chapter 4, thereby
generating substantially more samples to train and validate the classification model; and
fourth, the increased sample sizes allowed for patient-level partitioning of cross-validation
(CV) folds to mitigate inter-patient bias. Finally, a significant contribution of this study is
the concept of “optomics,” which is the extension of standard radiomic image analysis to
high-dimensional optical image data.

6.1 Introduction
Breast cancer is the second-leading cause of cancer death among women in the United
States [2]. At the time of diagnosis, the disease is most frequently early-stage, localized
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cancer, which is predominately treated with surgical resection followed by radiation
therapy. The goal of the surgical procedure, termed a lumpectomy or breast-conserving
surgery (BCS), is to remove the malignancy with a surrounding layer or margin of noncancerous tissue. An ideal BCS procedure results in cancer-free tissue on the margins (i.e.,
negative margins), an outcome known to provide the best prognosis [3,7,12,13].
Determining the final margin status of a BCS resection takes a day or more to complete.
Depending on clinical context, one or more positive margins confirmed by histopathology
may necessitate a re-excision procedure to remove residual disease, given the known
association of positive margins with ipsilateral breast tumor recurrence [7–11]. Today,
approximately 20% of BCS procedures require a follow-up re-excision due to positive
margins [23,29–31]. Several studies report the negative health and financial impacts of
BCS re-excision procedures to the patient and healthcare system [14,34,35,37,161]. For
these reasons, improving intraoperative margin assessment in BCS is a pressing clinical
need. In this study, volumetric imaging by X-rays and surface imaging by optical light
were combined in a classification pipeline following conventions described in radiomics.
The purpose of the study reported in this chapter was to demonstrate how this approach
might improve intraoperative decisions during resection.
Standard-of-care margin assessment techniques include gross tissue inspection by
the surgeon [162,163], projection X-ray or radiographic specimen imaging [15], and at
some medical centers, frozen section pathology [16,164], imprint cytology [165,166], and
post-excision cavity shaving [15]. Gross tissue inspection is useful for detecting palpable
invasive cancers but is not as effective at detecting primary lesions intertwined with dense
fibroglandular tissue or ductal carcinoma in situ (DCIS), which frequently presents as a
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cluster of macrocalcifications without a localized mass [167,168]. Projection (i.e., twodimensional (2D)) X-ray imaging coupled with intraoperative reading by a radiologist is a
mainstay for analyzing margins, and X-rays offer excellent contrast between adipose and
fibrous tissue and sensitivity to microcalcifications [145]. Furthermore, recent advances in
volumetric X-ray imaging (i.e., CT and tomosynthesis) have demonstrated sensing of all
six anatomical margins of a specimen in a clinically relevant timeframe with high spatial
resolution [65,70,73]. For this reason, volumetric X-ray imaging is emerging as a powerful
ex vivo specimen scanning technology. However, a key limitation of X-ray imaging is its
inability to differentiate normal, abnormal benign, and malignant fibrous tissues that may
be relevant to diagnosis, thereby posing the risk of frequent false positives [65,145].
Intraoperative frozen section pathology and imprint cytology reduce positive margin rates,
but the approaches are not widely adopted, because they are resource-intensive (i.e.,
requiring pathology staff in the operating room (OR) or surgical suite during the procedure)
and suffer from slow turnaround times [18,58,164]. Post-excision cavity shaving is also
effective at reducing positive margin rates, requiring ≤ 10 minutes in the OR with minimal
impact to patient cosmesis [20,169]. However, positive margin rates after cavity shaving
are variable (6-24%) [20,170–175], suggesting alternative or complementary margin
assessment techniques are still needed.
Volumetric X-ray imaging coupled with a second imaging modality could be an
attractive solution for rapidly analyzing an entire BCS specimen with increased contrast to
fibrous tissues on the margin [57,58]. Pradipta et al. reviewed an array of margin
assessment techniques [58], ranging from intraoperative ultrasonography, bioimpedance
spectroscopy, and ex vivo magnetic resonance imaging to a host of optical techniques,
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including optical coherence tomography, ultraviolet-photoacoustic microscopy, and
fluorescence probes. Each technique offers advantages and disadvantages. DiCorpo et al.
reported that the average surface area of a BCS specimen is ~45 cm2 [70]. A limitation of
many proposed techniques is their relatively small field of view and/or long scan time, such
that analyzing the entire surface of a specimen would be too time-consuming for clinical
translation. Other limitations include: the need for exogenous contrast agents that must
preferentially accumulate in target tissues and be proven safe for human use; or lack of
evidence demonstrating efficacy when analyzing realistic BCS specimens, which can be
amorphous, variable in size, and heterogeneous with a combination of adipose,
fibroglandular, and potentially malignant tissues on the margin [57].
In this study, breast tumor tissues were imaged with spatially co-registered microCT scanning and multi-wavelength SFDI. SFDI is a wide-field, noncontact, structured light
imaging modality first introduced by Cuccia et al. [109] and further developed by the same
group into a quantitative imaging modality based on theoretical modeling of diffuse light
transport [117]. By imaging the reflectance from a range of one-dimensional sinusoidal
(i.e., discrete spatial frequency) illumination patterns, the tissue’s modulation transfer
function (MTF) can be measured discretely. The most common application of SFDI is
optical property quantification (e.g., absorption and reduced scattering coefficients)
[117,118]. Using nonlinear least squares fitting of the measured MTF to theoretical models
of light transport, tissue optical properties can be measured pixel-by-pixel. Recent studies
have demonstrated the potential of SFDI to differentiate breast tissues using optical
properties [110,123], particularly at high spatial frequencies of illumination, which yield
surface-weighted reflectance dominated by scatter-based contrast [119]. The interested
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reader is directed to a recent review of structured light in diffuse optical imaging for more
background about SFDI and related modalities [126].
Previous studies coupled machine learning models with SFDI data to classify or
predict different breast tissues. One study used SFDI-derived optical scattering properties
of breast tissue and an explicit mathematical model to predict the epithelial, stromal, and
adipose fractions of breast tumor samples [125]. Another study applied high spatial
frequency, monochromatic SFDI and a limited set of textural features to classify breast
tumor subtypes using a support vector machine classifier with accuracies ranging from
55% to 95%, depending on the tissue subtype [152]. Deep learning methods have also
determined optical properties from raw SFDI data [176–178]. The use of a limited set of
image features may not probe the image data sufficiently to extract the most useful
signatures for differentiating tissue types. On the other hand, the complexity of deep
learning methods hinders model interpretation and thus limits potential for clinical
translation. To address these issues, this study used a supervised machine learning pipeline
based on a large number of Image Biomarker Standardization Initiative (IBSI)-compliant
radiomic features [179]. The pipeline tested the ability of micro-CT alone, SFDI alone, and
the combination of micro-CT and SFDI data to classify malignant and non-malignant
image samples extracted from wide field-of-view images of breast tumors.
Radiomics involves the quantification of many image features, mining the features
to determine diagnostic signatures not readily discerned by visual inspection, and
subsequently using the features to build classification models to inform clinical decision
making [180,181]. The “radiomics approach” is frequently applied to conventional medical
imaging modalities (e.g., CT, magnetic resonance imaging, positron emission
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tomography). Applying it to optical imaging data is termed “optomics” here, extending the
“omic” concept to image features extracted from wide field-of-view optical images. The
goals of this study were to: first, determine whether combining X-ray micro-CT and optical
SFDI image data improves malignancy classification relative to micro-CT alone based on
an “omics” approach; and second, identify the most useful radiomic and optomic features
for classifying malignant breast tissues.
Portions of the data collected through this imaging protocol have been analyzed in
previous studies [75,123,152,178]. Specifically, SFDI data have demonstrated statistical
differences between normal, abnormal benign, and malignant tissue subtypes based on
color analysis and diffuse optical properties [123], and separately, using texture analysis of
monochromatic (i.e., 490 nm), high spatial frequency (1.37 mm-1) data (see Chapter 4)
[152]. SFDI data were also used in a deep learning framework, through which optical
properties were approximated directly from raw SFDI data [178]. Monochromatic, high
frequency SFDI and micro-CT data were also used in a comparative study to quantify
differences in the wide field-of-view optical and micro-CT images (see Chapter 5) [75].
The study found that optical imaging revealed intra-tumoral morphology and malignantfibrous tissue boundaries that were occult to micro-CT scanning. The present work extends
these prior contributions significantly with three key advances: first, by quantifying a large
number of IBSI-compliant image features; second, by incorporating multi-wavelength,
multi-spatial frequency SFDI and micro-CT data into the analysis; and third, by evaluating
the image data with a supervised machine learning pipeline with patient-level Monte Carlo
CV to quantify binary malignancy classification performance.
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6.2 Materials and methods
6.2.1 Imaging protocol
Note that the imaging protocol reported here is identical to that reported in Chapter 5
(Section 5.2.1). All methods were carried out in accordance with relevant guidelines and
regulations. Specimen imaging was performed at Dartmouth-Hitchcock Medical Center
(DHMC) in Lebanon, New Hampshire. The imaging protocol was approved by the
Committee for the Protection of Human Subjects, the Institutional Review Board at
Dartmouth College, and all aspects of the study followed the approved protocol. Tissue
specimens were procured from patients electing BCS at DHMC who participated in the
study under informed consent. Imaging was performed post-operatively during standardof-care pathological processing in the specimen grossing laboratory and did not impact
tissue processing or diagnostic reporting in any way. One representative, ~5-mm thick slice
from each BCS tumor was selected by an experienced Pathologists’ Assistant for imaging
and was de-identified and referenced only by a unique accessioning number. Each imaged
slice exhibited a clear cross section of the primary tumor and surrounding tissues, thereby
revealing clear regions of several normal, abnormal benign, and malignant breast tissue
subtypes. Each slice was firmly positioned between clear acrylic plates, creating a flat
tissue surface that mitigated specular reflection and demodulation artifacts in the SFDI
data. The top surface of each imaged slice underwent standard-of-care specimen
processing, sectioning, staining with hematoxylin and eosin, and microscopic analysis by
a board-certified breast pathologist (Wendy Wells, MD). Histologic slides corresponding
to the imaged tissue surface underwent whole slide, high-resolution digital imaging to
confirm tissue subtype ROIs. These microscopic ROIs were co-registered to the wide fieldof-view micro-CT and optical imagery.
96

6.2.2 Imaging system
Note that the imaging system and image acquisition settings reported here are identical to
those reported in Chapter 5 (Section 5.2.2). Imaging was performed with a customized In
Vivo Imaging System (IVIS) SpectrumCT system (PerkinElmer, Hopkinton, MA)
containing a cone-beam CT in a “pancake” geometry and retrofitted optical imaging
components [122]. Micro-CT scans were acquired with X-ray tube settings of 50 kVp and
1 mA with an exposure time of 100ms/projection for a total of 720 projections. The
reconstructed scan volume was 12 x 12 x 3 cm3 with 150 μm3 voxels, and the combined
acquisition and reconstruction time was ~4 min. These settings were the same as those used
in a previous micro-CT BCS specimen study [65]. The SFDI acquisition leveraged the
charged coupled device camera native to the IVIS SpectrumCT system (Andor iKon,
Andor Technologies Ltd, Belfast, UK) and a digital light projector (CEL5500 Fiber, Digital
Light Innovations Inc., Austin, TX) retrofitted in the light-tight, fully shielded imaging
cabinet for projecting the structured light patterns. The light source was a supercontinuum
laser (SuperK Blue, NKT Photonics, Denmark) with a tunable line filter (SuperK Varia,
NKT Photonics, Denmark). SFDI acquisition involved optical wavelengths of 490, 550,
600, and 700 nm, and illumination spatial frequencies of 0.00, 0.15, 0.61, and 1.37 mm-1.
Thus, 16 unique wavelength-spatial frequency reflectance images were collected per
specimen. SFDI acquisition and reconstruction time was ~8 min. Combined with the
micro-CT slice of the tissue surface, every specimen in the dataset had 17 channels of
image data (Figure 6.1a-b).
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6.2.3 Image data and pre-processing
A total of 70 specimens were imaged under the approved protocol. Sixteen cases failed to
meet data analysis eligibility criteria: five were excluded due to inconsistent micro-CT scan
settings, six were excluded due to ambiguous histology co-registrations, one was excluded
due to a small cross-sectional area (<2 cm2), and four were omitted, because they presented
tissue subtypes that were represented in fewer than three specimens in the dataset. Thus,
54 tumor specimens from 54 BCS patients were analyzed. From these specimens, 177 ROIs
were drawn, isolating regions of seven histologically confirmed breast tissue subtypes. Of
the 54 specimens, 14 contained only normal and/or abnormal benign tissues, three
contained only malignant tissue, and 37 contained both non-malignant and malignant
tissues. Table 6.1 summarizes the number of breast tumor specimens and the number of
ROIs categorized by tissue subtype. The number of sub-images extracted from each ROI
was proportional to the size of each ROI, providing an approximate baseline by which all
ROIs were equally sampled. Figure 6.1c illustrates the process of sub-image sampling
from the wide field-of-view tissue images. Table 6.2 lists totals of sub-image samples
categorized by subtype and by sub-image size.

Table 6.1 Breast tumor specimen and ROI totals by tissue subtype in this study. IDCa = invasive ductal
carcinoma.
Tissue Subtype
Healthy and abnormal benign
Adipose tissue
Normal connective tissue
Fibrocystic disease
Invasive cancer
Inv. ductal carcinoma low grade
Inv. ductal carcinoma intermediate grade
Inv. ductal carcinoma high grade
Inv. lobular carcinoma

Specimen
Count

98

ROI
Count

ROI Size
(average ± one std mm2)

49
13
14

93
20
22

43 ± 32
85 ± 66
112 ± 133

10
13
10
9

10
13
10
9

46 ± 33
59 ± 56
82 ± 58
99 ± 102

Table 6.2 Breast tumor sub-image sample totals by tissue subtype and sub-image size.
Tissue Subtype
Healthy and abnormal benign
Adipose tissue
Healthy connective tissue
Fibrocystic disease
Invasive cancer
Inv. ductal carcinoma low grade
Inv. ductal carcinoma intermediate grade
Inv. ductal carcinoma high grade
Inv. lobular carcinoma

2 mm x 2
mm

3 mm x 3
mm

4 mm x 4
mm

5 mm x 5
mm

4,472
1,951
3,061

1,992
890
1,415

1,015
505
779

508
307
471

514
898
911
1,095
12,902

237
419
420
507
5,880

118
231
243
282
3,173

64
132
150
170
1,802

Totals

Calibrated reflectance maps were generated at each of 16 wavelength-spatial frequency
settings using a previously described normalization process with a reflectance standard
[122]. Micro-CT scans were converted to linear attenuation coefficient values based on a
50 kVp X-ray energy. All image data were masked to remove regions with poor tissue
coupling to the top acrylic plate, thereby restricting the image analysis to flat, consistent
tissue surfaces. Micro-CT scanning and SFDI were completed sequentially, without
moving the tissue or acrylic plates between acquisitions, facilitating spatial co-registration
between modalities. Tissue subtype ROIs were sampled over a range of square sub-image
sizes (2 mm x 2 mm to 5 mm x 5 mm).
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Figure 6.1 Overview of tissue imaging and sampling protocol. (a) Diffuse color image of a representative
tissue specimen with 1-cm scalebar. (b) Optical imaging at four wavelengths and four spatial frequencies and
micro-CT scanning. (c) Sub-image sampling from histologically confirmed regions of distinct tissue
subtypes. (d) Samples grouped by subtype (colored borders), each with 17 channels (16 optical, one CT).
FCD = fibrocystic disease. IDCa IG = invasive ductal carcinoma of intermediate grade.

6.2.4 Radiomics package and classification pipeline
The classification pipeline performed binary stratification of samples as non-malignant or
malignant based on radiomic and/or optomic features. Fornacon-Wood et al. recently
reviewed several popular radiomic feature quantification software packages, identifying
strengths and weaknesses of each package [182]. Here, the pipeline was implemented in
the Python coding language (v3.7.9) using the PyRadiomics package (v3.0.1) for feature
quantification, given that it is IBSI-compliant for reproducibility, free of cost, and opensource [183]. The pipeline involved minimum redundancy maximum relevance (MRMR)
feature selection, a random forest classifier, and Monte Carlo cross-validation with n =
1000 splits partitioned on the patient-level.
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The classification pipeline (summarized in Figure 6.2) used Scikit-learn
(abbreviated “sklearn,” v0.24.1), an open-source Python library for machine learning
[184]. Because the distribution of tissue subtypes was variable across specimens, and
significant patient/specimen-level bias existed in the dataset, an appropriate CV scheme
was incorporated. Monte Carlo CV (using the GroupShuffleSplit sklearn function) was
performed (n = 1000 times), randomly partitioning specimens on a patient-level (equivalent
to specimen-level partitioning for this dataset) [185]. In each split, 20% of patients were
withheld from training. Patient-level bias was mitigated by reporting performance metrics
averaged over all splits. The random seed for selecting the training and testing set indices
was user-defined (by setting the “random_state” argument in GroupShuffleSplit sklearn
function), such that comparisons between different sets of parameter options were based
on an identical set of 1000 CV splits. Given that the dataset contained far more nonmalignant than malignant samples (Table 6.2), the non-malignant training samples were
randomly down-sampled to balance the training set in every split (using the
RandomUnderSampler function from the imblearn Python package [186], v0.8.0).
Radiomic and/or optomic features corresponding to training set samples were standardized
to z-scores (using the StandardScaler sklearn function), and the feature means and standard
deviations from the training set standardized the testing set features to minimize data
leakage. The number of radiomic/optomic features used in model training and testing, k,
was varied (all values k ∈ ℤ: k ∈ [1, 30]). MRMR feature selection identified the subset of

k features having the most correlation with the malignant class and the least correlation
between k features in the training set [187] (using the mrmr function from the pymrmre
Python package [188], v1.0.7). A random forest classifier with default settings
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(RandomForestClassifier sklearn function with default settings) was then trained and
tested on each split. The choices of MRMR feature selection and random forest classifier
were based on a thorough analysis by Parmar et al. that determined these selections
performed well for radiomics-based classification of CT segmentations of non-small cell
lung cancer [189]. Test set performance was recorded for each split in the form of
classification accuracy, sensitivity, specificity, and receiver operating characteristic (ROC)
area under the curve (AUC).
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combined
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Figure 6.2 The supervised machine learning classification pipeline with patient-level Monte Carlo crossvalidation. Key parameter options, Python packages, and Python functions are listed with green, purple, and
blue text, respectively. MRMR = minimum redundancy, maximum relevance.

6.2.5 Fixed bin widths for gray value discretization
Radiomic feature quantification first requires gray value discretization of the image data.
For this study, a fixed bin width of 0.005 for both calibrated reflectance (unitless) and 50
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kVp linear attenuation coefficient (cm-1) values was used. A fixed bin width rather than a
fixed bin count was used given that it provides improved reproducibility when inter-sample
dynamic range is variable [190]. Tixier et al. found that bin widths that resulted in 30-130
total bins yielded good reproducibility and performance [191]. All tissue pixel values
extracted from the micro-CT and SFDI images are shown in histogram form in Figure 6.3a
and Figure 6.3b, respectively. From these histograms, distribution percentiles and
appropriate bin width values were determined. This analysis found that a fixed bin width
of 0.005 fell within the 30 – 130 total bin range for both modalities based on the range
defined by the first and ninety-nineth percentile values for each modality.
The micro-CT tissue pixel distribution in Figure 6.3a was slightly bi-modal, which
is explained by the dominant X-ray contrast observed between fibroglandular tissue and
adipose tissue in breast tumors [65]. The SFDI tissue pixel distribution in Figure 6.3b was
highly skewed to low calibrated reflectance values due to the fact that the dataset included
non-zero spatial frequency reflectance, which is known to yield relatively low reflectance
from biological tissue, especially at sub-diffuse spatial frequencies (i.e., 0.61 and 1.37 mm1

) [110,119].
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Figure 6.3 Histograms of all tissue pixels extracted from (a) the micro-CT slice images (one channel) and
(b) the SFDI images (16 channels from every combination of four wavelengths and four spatial frequencies).
Horizontal axis limits in each subplot represent the 1st and 99th percentile tissue pixel values, while the three
vertical lines represent, from left to right, the 25th, 50th, and 75th percentile values.

6.2.6 List of quantified PyRadiomics features
Features were quantified from only micro-CT data (1 channel), only SFDI data (16
channels), and combined data (17 channels) (Figure 6.1d). A total of 92 PyRadiomic
features were extracted from each image channel. Thus, up to 1,564 features were
quantified from each sub-image sample (i.e., 17 channels x 92 features). Quantified
features included a range of first-, second-, and higher order pixel statistics: 18 first-order
(FO) histogram statistics, 23 gray level co-occurrence matrix (GLCM) features, 16 gray
level run length matrix (GLRLM) features, 16 gray level size zone matrix (GLSZM)
features, 14 gray level dependence matrix (GLDM) features, and five neighboring gray
tone difference matrix (NGTDM) features. Although the PyRadiomics package includes a
range of features quantifying two- and three-dimensional shapes from segmented ROIs, all
shape features were omitted given the consistent square sub-image sampling routine
implemented in this study. Furthermore, no filter-based features (e.g., Log of Gaussian,
Wavelet) were included in this study. Each feature name started with a prefix denoting the
modality from which it was derived: either “CT” for micro-CT or “###nm-#.##mm” for
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optical, where the first number depicted the optical wavelength (490, 550, 600, or 700 nm)
and the second number depicted the spatial frequency of illumination (0.00, 0.15, 0.61, and
1.37 mm-1). Quantified features are listed on the next page, categorized by feature class
with feature abbreviations in parentheses:
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First-order (FO) histogram statistics:
1.
10th Percentile (10Pe)
2.
90th Percentile (90Pe)
3.
Energy (Ener)
4.
Entropy (Entr)
5.
Interquartile Range (IR)
6.
Kurtosis (Kurt)
7.
Maximum (Maxi)
8.
Mean Absolute Deviation (MAD)
9.
Mean (Mea)
10.
Median (Medi)
11.
Minimum (Mini)
12.
Range (Rang)
13.
Robust Mean Absolute Deviation (RMAD)
14.
Root Mean Squared
15.
Skewness (Skew)
16.
Total Energy (TE)
17.
Uniformity (Unif)
18.
Variance (Vari)
Gray level co-occurrence matrix (GLCM) features:
1.
Autocorrelation (Auto)
2.
Cluster Prominence (CP)
3.
Cluster Shade (CS)
4.
Cluster Tendency (CT)
5.
Contrast (Cont)
6.
Correlation (Corr)
7.
Difference Average (DA)
8.
Difference Entropy (DE)
9.
Difference Variance (DV)
10.
Inverse Difference (Id)
11.
Inverse Difference Moment (Idm)
12.
Inverse Difference Moment Norm. (Idmn)
13.
Inverse Difference Normalized (Idn)
14.
Informational Measure of Corr. 1 (Imc1)
15.
Informational Measure of Corr. 2 (Imc2)
16.
Inverse Variance (IV)
17.
Joint Average (JA)
18.
Joint Energy (JEner)
19.
Joint Entropy (JEntr)
20.
Maximal Correlation Coefficient (MCC)
21.
Maximum Probability (MP)
22.
Sum Entropy (SE)
23.
Sum Squares (SS)

3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.

Gray Level Variance (GLV)
High Gray Level Zone Emphasis (HGLZE)
Large Area Emphasis (LAE)
Lrg. Area High Gray Lvl. Emph. (LAHGLE)
Lrg. Area Low Gray Lvl. Emph. (LALGLE)
Low Gray Level Zone Emphasis (LGLZE)
Size Zone Non-Uniformity (SZNU)
Size Zone Non-Uniformity Norm. (SZNUN)
Small Area Emphasis (SAE)
Small A. High Gray Lvl. Emph. (SAHGLE)
Small A. Low Gray Lvl. Emph. (SALGLE)
Zone Entropy (ZE)
Zone Percentage (ZP)
Zone Variance (ZV)

Gray level dependence matrix (GLDM) features:
1.
Dependence Entropy (DE)
2.
Dependence Non-Uniformity (DNU)
3.
Dependence Non-Uniformity Norm. (DNUN)
4.
Dependence Variance (DV)
5.
Gray Level Non-Uniformity (GLNU)
6.
Gray Level Variance (GLV)
7.
High Gray Level Emphasis (HGLE)
8.
Large Dependence Emphasis (LDE)
9.
Lrg. Dep. H. Gray Lvl. Emph. (LDHGLE)
10.
Lrg. Dep. L. Gray Level Emph. (LDLGLE)
11.
Low Gray Level Emphasis (LGLE)
12.
Small Dependence Emphasis (SDE)
13.
Small Dep. H. Gray Lvl. Emph. (SDHGLE)
14.
Small Dep. Low Gray Lvl. Emph. (SDLGLE)
Neighboring gray tone difference matrix (NGTDM)
features:
1.
Busyness (Busy)
2.
Coarseness (Coar)
3.
Complexity (Comp)
4.
Contrast (Cont)
5.
Strength (Stre)

Gray level run length matrix (GLRLM) features:
1.
Gray Level Non-Uniformity (GLNU)
2.
Gray Level Non-Uniform. Norm. (GLNUN)
3.
Gray Level Variance (GLV)
4.
High Gray Level Run Emphasis (HGLRE)
5.
Long Run Emphasis (LRE)
6.
Long Run High Gray Lvl. Emph. (LRHGLE)
7.
Long Run Low Gray Lvl. Emph. (LRLGLE)
8.
Low Gray Level Run Emphasis (LGLRE)
9.
Run Entropy (RE)
10.
Run Length Non-Uniformity (RLNU)
11.
Run Length Non-Uniform. Norm. (RLNUN)
12.
Run Percentage (RP)
13.
Run Variance (RV)
14.
Short Run Emphasis (SRE)
15.
Short Run High Gray Lvl. Emph. (SRHGLE)
16.
Short Run Low Gray Lvl. Emph. (SRLGLE)
Gray level size zone matrix (GLSZM) features:
1.
Gray Level Non-Uniformity (GLNU)
2.
Gray Level Non-Uniform. Norm. (GLNUN)
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6.2.7 Statistical analysis
For every combination of pipeline parameters, ROC curves (n = 1000) were generated
through Monte Carlo CV. Average ROC curves were derived by interpolating true positive
values to a constant range of false positives across all splits. DeLong’s test determined
whether differences between pairs of average ROC AUC values were statistically
significant [192,193]. A p-value ≤ 0.05 was considered significant.

6.2.8 Data availability
Image data in the form of comma-separated value files, classification pipeline source code,
and a PyRadiomics parameter file documenting all feature quantification settings are
available

with

this

publication

in

an

open-source

repository

(https://github.com/optmed/radiomics-optomics).

6.3 Results
6.3.1 Classification using radiomics and optomics
Adipose was the most frequent tissue type in the breast tumor dataset (Table 6.2). Relative
to fibroglandular and epithelial components, adipose tissue is straightforward to identify
by gross surgical inspection and is readily evident with micro-CT scanning [65,75]. To test
the hypothesis that including adipose samples improves performance, the classification
pipeline focused on two scenarios: one that included adipose tissue samples and one that
excluded them.
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Micro-CT Alone

(b)

Optical Alone

(c)

Combined

Adipose Included

(a)

(e)

(f)

Adipose Excluded

(d)

Figure 6.4 Mean classification accuracy derived from 5 mm x 5 mm sub-image samples as a function of the
number of optimal features selected by minimum redundancy, maximum relevance (MRMR) in n = 1000
Monte Caro cross-validation splits. Mean accuracies when adipose tissue was included (top row, a-c) and
excluded (bottom row, d-f). Dashed red vertical lines mark six features, the threshold at which the percent
change in mean accuracy dropped below 1% for combined classification in (c) and (f). Error bars represent
± one standard deviation.

Non-malignant versus malignant classification accuracy is shown for cases when
adipose tissue was included (Figure 6.4a-c) and excluded (Figure 6.4d-f). Accuracies are
plotted with respect to the number of optimal features selected by MRMR [187]. Subimage samples of tissue ranged in size from 2 mm x 2 mm to 5 mm x 5 mm and were
extracted from wide field-of-view ROIs defining distinct tissue subtypes in each specimen.
Only results from 5 mm x 5 mm sub-image samples are presented in Figure 6.4 (as well
as Figure 6.5 through Figure 6.8), because this sub-image size provided the best
classification performance overall (data from all other sub-image sample sizes are not
shown in this chapter). A 1% change in average accuracy determined an appropriate
minimum number of features to use in each case. Based on the combined radiomic/optomic
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classification accuracy (Figure 6.4c and Figure 6.4f), the 1% change in average accuracy
threshold required six features, when adipose tissue was both included and excluded.
Therefore, subsequent analysis focused on results derived from 5 mm x 5 mm sub-image
samples and with six radiomic/optomic features. Table 6.3 reports classification
performance (i.e., accuracy, sensitivity, specificity, ROC AUC) for 5 mm x 5 mm subimage samples and six total features. When adipose tissue was included and using six
features, mean accuracies achieved by micro-CT features alone, optical features alone, and
combined micro-CT and optical features were 82% (Figure 6.4a), 72% (Figure 6.4b), and
84% (Figure 6.4c), respectively. When adipose tissue was excluded, mean accuracies
decreased to 74% (Figure 6.4d), 70% (Figure 6.4e), and 80% (Figure 6.4f) for the same
respective feature sets.

Table 6.3 Classification performance metrics derived from 5 mm x 5 mm sub-image samples, six optimal
radiomic/optomic features per minimum redundancy, maximum relevance feature selection, and n = 1000
cross-validation splits (mean ± one standard deviation). AUC = area under the receiver operating
characteristic curve.
Micro CT Alone

Optical Alone

Combined

Accuracy

0.82 ± 0.06

0.72 ± 0.09

0.84 ± 0.07

Sensitivity

0.88 ± 0.08

0.79 ± 0.11

0.90 ± 0.08

Specificity

0.88 ± 0.08

0.78 ± 0.11

0.89 ± 0.08

AUC

0.88 ± 0.07

0.78 ± 0.10

0.90 ± 0.06

Accuracy

0.74 ± 0.09

0.70 ± 0.10

0.80 ± 0.08

Sensitivity

0.82 ± 0.12

0.75 ± 0.14

0.85 ± 0.10

Specificity

0.81 ± 0.12

0.75 ± 0.13

0.85 ± 0.10

AUC

0.78 ± 0.11

0.75 ± 0.12

0.85 ± 0.09

Adipose tissue included

Adipose tissue excluded
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Figure 6.5 ROC curve analysis based on six radiomic/optomic features derived from 5 mm x 5 mm subimage samples. Adipose tissue was included (top row) and excluded (bottom row). Each shaded region
depicts one standard deviation from the mean ROC curve (solid black). The 95% confidence band (CB)
contains 95% of the n = 1000 ROC curves that fell closest to the mean curve in each subplot (dashed black).

Figure 6.5 compares average ROC curves of optimized classifiers for micro-CT
alone, optical alone, and combined feature sets. Classification performance decreased when
adipose tissue samples were excluded (compare Figure 6.5a with Figure 6.5d, Figure
6.5b with Figure 6.5e, and Figure 6.5c with Figure 6.5f). Micro-CT data alone performed
better than optical data alone when adipose samples were included (AUC = 0.88 versus
0.78, p-value = 3.30e-13), but the two performed similarly when adipose samples were
excluded (AUC = 0.78 versus 0.75, p-value = 0.42). Classification performance using both
modalities was better than using either modality alone (e.g., when adipose tissue was
included: micro-CT versus combined, AUC = 0.88 versus 0.90, p-value = 3.65e-11; optical
versus combined, AUC = 0.75 versus 0.90, p-value = 3.60e-36). Improvement in combined
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feature performance relative to micro-CT alone was more pronounced when adipose
samples were excluded (micro-CT versus combined, AUC = 0.78 versus 0.85, p-value =
9.33e-14). ROC curves reflect relatively high variance depicted by one standard deviations
(shaded regions) and 95% confidence bands (dashed lines), providing a visual depiction of
how individual Monte Carlo CV splits performed.

6.3.2 Selected feature importance
The radiomic and optomic features selected by MRMR in each of n = 1000 splits were
tabulated. Figure 6.6 shows the distribution of these features for combined data
classification and highlights the fact that both micro-CT and SFDI features were selected
for inclusion in the optimal subset of features. This trend was true both when adipose tissue
samples were included (Figure 6.6a) and excluded (Figure 6.6b). (These features
correspond to the classification performances shown in Figure 6.5c and Figure 6.5f,
respectively.) Two trends can be inferred from Figure 6.6. First, the most important microCT radiomic features were first-order histogram statistics (noted by asterisks in the figure),
which contain intensity information alone (i.e., no spatial information). This trend was true
independent of whether adipose tissue was included. Second, important SFDI optomic
features were generally derived from high spatial frequency reflectance (illumination
frequencies of 0.61 and 1.37 mm-1; noted by dots in the figure), particularly when adipose
tissue was omitted from the classification task. Notably, all but two of the high spatial
frequency optomic features in Figure 6.6 were derived from second- and higher-order pixel
statistics, which depend on the spatial relationships between multiple pixels, and thus,
contain textural information.
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Figure 6.6 Most frequently selected features by MRMR derived from 5 mm x 5 mm sub-image samples
when adipose tissue samples were (a) included and (b) excluded. These subplots relate directly to
classification performances shown in Figure 6.5c and Figure 6.5f, respectively. Vertical axes signify the
fraction of all n = 1000 Monte Carlo CV splits that MRMR selected each feature. Asterisks (*) signify firstorder micro-CT features. Dots (•) signify high spatial frequency (0.61 or 1.37 mm-1) reflectance SFDIderived features. Twenty-five features are tabulated in each subplot, though additional features were selected
less frequently.

High-dimensional radiomic datasets are frequently visualized using hierarchically
clustered heatmaps [180,181,183]. Figure 6.7 shows a 2D hierarchically clustered heatmap
of the breast tumor 5 mm x 5 mm sub-image samples in similar fashion to other radiomics
visualizations (generated using the Python visualization library Seaborn v0.11.0 function
clustermap) [180,181,183]. Cluster 1 is characterized primarily by an adipose
radiomic/optomic signature. It contains all adipose tissue samples in the dataset, and only
15% of the samples are malignant. Cluster 2 is most closely designated as a malignant
signature; 43% of samples in this cluster represent various subtypes of malignancy. Cluster
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3 is mostly aligned with non-malignant fibrous tissue; only 22% of its samples are
malignant, while the remaining 78% are normal connective or benign fibrocystic disease
samples. The “Patient” column on the left side of the figure color-codes tumor samples on
the patient-level and indicates that individual patient data were dispersed between clusters.
Conventional radiomics does not typically relate hierarchical clustering to subsequent
classification results. Figure 6.7 establishes this connection visually; the probability of
malignancy associated with each sample is plotted vertically on the left side of the heatmap,
derived from all n = 1000 CV splits (i.e., using combined micro-CT and SFDI data, 5 mm
x 5 mm sub-image samples, and including adipose tissue samples; the data used to create
results in Figure 6.5c and Figure 6.6a in the main manuscript).

113

Figure 6.7 Hierarchical clustering with respect to samples (1,802 total; vertical axis) and features (1,564
total; horizontal axis) reveals natural groupings of breast tumor samples. Probability of malignancy is shown
along the left side (average ± one standard deviation depicted by black dots and red shading, respectively,
from all n = 1000 Monte Carlo CV splits). IDCa = invasive ductal carcinoma. ILCa = invasive lobular
carcinoma.

A t-distributed stochastic neighbor embedding plot, shown in Figure 6.8, reduces
the dataset to a 2D embedding of only six optimal radiomic/optomic features (using the six
most frequently selected features shown in Figure 6.6b). Each sub-image sample is colorcoded by tissue subtype, and representative samples are labeled with the associated microCT and optical image channels. Figure 6.8 suggests separability of normal (i.e., connective
tissue) and abnormal benign (i.e., fibrocystic disease) samples from malignant tissue
subtypes is possible when only six radiomic/optomic features are used. Adipose tissue is
also clustered effectively under these conditions.
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Figure 6.8 T-distributed stochastic neighbor embedding using six optimal minimum redundancy, maximum
relevance features (i.e., top features shown in Figure 6.6b). Dashed ellipses qualitatively delineate three
clusters of samples, which can be related to hierarchical clusters depicted in Figure 6.7. Image channel labels
show the micro-CT sub-image on the left (grayscale), followed by calibrated reflectance optical channels
with spatial frequency increasing from left to right (0.00, 0.15, 0.61, then 1.37 mm-1). Coloring of optical
channels illustrates the wavelength of light, increasing from left to right (490, 550, 600, then 700 nm) and
repeated for each spatial frequency. IDCa = invasive ductal carcinoma. ILCa = invasive lobular carcinoma.

Notably, the global structure shown in Figure 6.7 is maintained by Figure 6.8 using six
instead of 1,564 radiomic/optomic features. The image channel labels in Figure 6.8
exemplify representative tissue subtype image signatures: first, adipose tissue yields
relatively low linear attenuation coefficient values in the micro-CT sub-image relative to
all other subtypes [75]; second, adipose tissue and high grade invasive ductal carcinoma
are predominantly characterized by Mie scattering vacuoles and nuclei, respectively,
explaining the relatively low high spatial frequency optical reflectance for these samples;
and third, connective tissue and fibrocystic disease contain collagen fibril structures that
are strong Rayleigh-type scatterers, giving rise to an increased backscatter signal in these
optical sub-images [110].
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6.4 Discussion
Analyses indicate overall mean accuracy and AUC achieved were 84% and 0.90 (80% and
0.85 without adipose tissue), respectively, using only six optimal radiomic/optomic
features. These results appear to be the first application of radiomics to multi-wavelength,
multi-spatial SFDI data and represent a novel approach for validating and extending
radiomic feature analysis to optical imaging data. They provide a proof of principle for
how radiomic and optomic features can be combined to improve overall classification
accuracy. Other important contributions from this study include appropriate image data
normalization to linear attenuation coefficient and calibrated reflectance values and use of
IBSI-compliant image features in the classification pipeline, considerations that lend to
study rigor and reproducibility. Finally, use of defined image features within a supervised
machine learning pipeline provides increased model interpretability relative to deep
learning methods of tissue classification.
The radiomics approach is often deployed with other imaging modalities relevant
to the diagnosis and monitoring of breast cancer, mainly magnetic resonance imaging, CT,
positron emission tomography, and/or ultrasound. Most studies demonstrate radiomics
utility in identifying malignant lesions in the setting of pre-operative breast cancer
diagnosis, and recently published classification performance AUCs range from 0.57 to 0.98
for this task [194,195]. The work described here suggests that wide field-of-view optical
images of breast tumors likely contain useful image features, especially textural
information, relevant to diagnosis. The optomics approach provides an alternative to
optical property quantification, a process that requires tissue model assumptions and can
be computationally intensive to implement (e.g., ~1 hour for a 2.5 cm x 2.5 cm tissue
sample [110]). The study also demonstrates that the combined radiomics/optomics
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approach is synergistic for automated diagnostic assessment of breast tissues and may be
useful for intraoperative margin guidance in BCS.
Importantly, improvements in margin assessment were not directly demonstrated
in this study. Rather, freshly resected breast tumor slices were imaged to capture a range
of tumor pathologies. Only invasive cancers were analyzed due to a lack of pre-invasive
DCIS specimens in the dataset. This limitation is significant, given that relative to other
malignant tissue subtypes, DCIS is responsible for one of the largest shares of positive
margins leading to re-excision procedures [23]. Future studies should include DCIS
samples to demonstrate efficacy in classifying this important pre-invasive subtype. Finally,
future work should also involve radiomic/optomic analysis of intact BCS specimens, taking
advantage of the volumetric sensing of micro-CT in combination with surface-mapped
optical reflectance to improve sensing of cancer-positive tissues at the margin.

6.5 Conclusions
This study introduces an optomics paradigm for analyzing high dimensional optical
image data and represents a direct and quantitative assessment of the extent to which
coupling micro-CT scanning with optical imaging improves classification of malignant
breast tumor tissues. Volumetric X-ray imaging is complimentary to surface SFDI, which
provides additional sensing of tissue margins. These results warrant further research into
the combination of specimen X-ray imaging with wide field-of-view, noncontact optical
imaging, such as SFDI.
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Chapter 7 Active line scanning for increased dynamic range
This chapter is derived from the following peer-reviewed article:
Streeter SS, Maloney BW, Paulsen KD, Pogue BW. Active line scan with spatial gating
for sub-diffuse reflectance imaging of scatter microtexture. Opt Lett. OSA; 2020 Dec
1;45(23):6378–6381. DOI: 10.1364/OL.404415.
Note that Figure 7.2 and a limited amount of explanatory content were included in this
chapter for clarity but were not included in the peer-reviewed paper. The key takeaway
from this chapter is that sub-diffuse line scan imaging yields high spatial frequency
reflectance maps with increased dynamic range relative to sub-diffuse spatial frequency
domain imaging (sd-SFDI).
7.1 Introduction
Optical structured light imaging, which involves illuminating the target with spatially
modulated patterns of light, is used in a range of optical systems, geometries, and
applications. Structured illumination is used in microscopy, for example, to facilitate depth
sectioning [196], enable spatially localized fluorophore activation [197], and enhance
lateral resolution [198]. Structured light is also used in a wide-field geometry for mesoand macroscale imaging to extract three-dimensional (3D) surface profiles [159], quantify
bulk diffuse and sub-diffuse optical properties [110,118,123,199], perform tomography
[200], and extract surface layer features or textures from turbid samples [152].
A powerful wide-field structured light imaging approach for analyzing turbid media
is SFDI, through which a turbid target is modulated with one-dimensional (1D) sinusoidal
patterns of light at different spatial frequencies (fx) and with different optical wavelengths
(λ). At a single fx and λ, the phase of the sinusoidal pattern is shifted and imaged repeatedly
(often three phase shifts at Ф = 0°, 120°, and 240° are used). The three phase images
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provide three-point pixel-by-pixel amplitude demodulation that isolates reflectance from a
discrete fx and λ [109]. SFDI systems can be categorized as diffuse or sub-diffuse,
depending on the length scale and consequent light transport regime of the modulating
photon density waves (i.e., the fx of the 1D sinusoidal illumination). Sd-SFDI requires that
the length scale of modulation be finer than the length scale of diffuse photon propagation.
Through demodulation, the photons that undergo highly scattered paths are rejected, while
photons characterized by few scattering events and singular, large backscattering events
are detected. In biological tissues, for instance, fx values ~≥0.5 mm-1 yield sub-diffuse
reflectance [110]. Sd-SFDI senses microscopic surface layer features in turbid media
rapidly, without contact, and over a wide field of view. For these reasons, sd-SFDI and
wide-field, sub-diffuse imaging in general are of interest to the optics community,
particularly for biomedical imaging applications involving surface layer tissue
characterization.

7.2 The importance of modulation depth in spatial frequency domain imaging
Figure 7.1 illustrates the standard implementation of SFDI, comprised of a source, a spatial
light modulator (SLM), and a camera. The SLM technology often used in SFDI is a digital
micromirror device (DMD), given the ease of use for projecting arbitrary numbers of
sinusoidal frequency patterns. SFDI demodulation is achieved by imaging three phaseshifted sinusoidal patterns and combining the images using the equation shown in Figure
7.2a. Importantly, the demodulated amplitude (i.e., the dynamic range of the imaging
technique) is independent of the DC offset of the illumination pattern (Figure 7.2b) but is
proportional to the modulation depth of the illumination pattern (Figure 7.2c); an SFDI
system can utilize at most one-half of the illumination amplitude as useful demodulated
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signal.

Spatial Light
Modulator

Camera

Figure 7.1 Reflectance geometry SFDI, with images taken at three phases and demodulated to isolate
reflectance from a specific spatial frequency and wavelength of light.
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Figure 7.2 Investigating key relationships of the three-phase demodulation equation commonly employed
by SFDI systems. (a) The demodulation equation first proposed by Cuccia et al. [109] and adapted from
structured illumination in confocal microscopy [196]. In (b.i)-(b.iii), an increasing vertical axis (DC) offset
does not impact the amplitude (i.e., dynamic range) of the demodulated signal (red line). In (c.i)-(c.iii), an
increasing modulation depth results in a factor of one-half increase in demodulated dynamic range. Note that
this figure is not published in a peer-reviewed paper, but the basic trends that it illustrates are valuable for
understanding the motivation for investigating line scan imaging as an alternative to SFDI for wide field-ofview sub-diffuse reflectance imaging.

The central issue addressed in this chapter is that SFDI at high spatial frequencies
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of illumination is limited by low reflectance modulation depth and thus low demodulated
signal dynamic range. This phenomenon is first demonstrated by imaging projected
sinusoidal modulation patterns on a 99% reflectance, isotropic emission angle Spectralon
standard (Labsphere, Inc., North Sutton, NH) using a previously published SFDI system
[122]. Sinusoidal modulation patterns at six spatial frequencies were projected from the
DMD (CEL5500 Fiber, Digital Light Innovations Inc., Austin, TX) with maximized 8-bit
modulation depth (i.e., every input image contained a sinusoid that filled the 0-255
intensity range). The reflectance cross sections (Figure 7.3a) show the detected modulating
pattern at each fx. The approximated modulation depth (i.e., the difference between the
minimum and maximum intensity in each reflected sinusoidal pattern) at each fx is plotted
in Figure 7.3c as circles with a fitted curve (solid black). As the fx increases, the
modulation depth decreases markedly, which translates to a proportional reduction in
demodulated reflectance dynamic range according to the SFDI phase-shifting technique
first proposed by Cuccia et al. [109]. This limitation of SFDI is worsened by the low-pass
filtering (i.e., highly scattering, diffuse photon transport) effects of turbid media that
drastically lower the image modulation depth at higher spatial frequencies of illumination.
This compounding effect is demonstrated in Figure 7.3b, which shows the same
illumination patterns reflected from a silicone-TiO2 turbid or tissue-like phantom (reduced
scattering coefficient μs' = 1.4 – 0.8 mm−1, absorption coefficient μa < 0.01 mm−1 for λ ∈

471 – 851 nm, measured using a Reflect RS, Modulim Imaging, Irvine, CA). The depth of

modulation at the six fx values is plotted in Figure 7.3c as triangles with a fitted curve
(dashed black). The low-pass filtering effect of the turbid phantom demonstrates a
significant limitation of sd-SFDI. As in microscopy, other methods for achieving structured
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localization can be scanning points or lines [201], and in this study, the relative merits of
the latter are explored for wide-field imaging.

(a)

(b)

(c)

Figure 7.3 Measurements of SFDI modulation patterns at a single illumination phase, depth prior to
demodulation. (a) SFDI modulation patterns (λ = 600 nm) at six discrete spatial frequencies reflected from a
99% reflectance Spectralon standard. (b) The same SFDI modulation patterns reflected from a turbid
phantom. (c) Approximate modulation depth of each pattern from shown in (a) and (b) with fitted curves,
becoming unusable ~fx > 1.5 mm-1.

7.3 Sub-diffuse active line scan imaging
Active line scan imaging (LSI) involves orienting a focused line laser source perpendicular
to the direction of translation. As the line source (or the target) is translated, images are
captured at a rate such that the distance translated between images is less than the width of
the reflected laser line. The spatial gate width in the object plane (δ) defines the digital
mask that is applied to all light detector pixels such that only pixels proximal to where light
is incident on the target are detected. In effect, reflectance from primarily the shortest
source-detector separation distances is collected. Thus, line scanning with a narrow spatial
gate is most sensitive to sub-diffusely scattered photons. In this scenario, the technique
becomes sub-diffuse LSI (sd-LSI). Sd-LSI modulates the target with a focused line of light,
providing broadband spatial frequency modulation. After image acquisition, spatial gating
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effectively high-pass filters the modulation with the cutoff frequency (fc) corresponding to
the inverse of one-half the spatial gate width: fc = 2/δ. Sd-LSI is similar in concept to
spatially resolved reflectance measurements [202] or single-fiber reflectance spectroscopy
[203], except that a line source is used to capture high contrast, high dynamic range images
of sub-diffuse scatter microtexture over a wide-field, not necessarily to quantify optical
properties point-by-point.

Sub-diffuse

Camera

(b)
Line
Laser

f/8 Lens

15°
Diffuse

52 cm

(a)

Diffuse
δ

Figure 7.4 Illustration and schematic of line scan imaging in action. (a) A laser line projected on a turbid
medium with a spatial gate width of δ isolates reflectance from predominantly sub-diffusely scattered
photons. (b) Schematic of the line scanning system used in this study (red arrow indicates translation of the
laser).

Figure 7.4a illustrates reflectance from a line laser and the process of spatially gating the
reflected light (i.e., rejected reflectance in red). Figure 7.4b shows a schematic of the line
scan setup used in this study with a linearly translated laser line (red arrow). The laser and
camera were positioned ~52 cm above the object plane. The laser was angled ~15° off the
optical axis to mitigate specular reflections detected by the camera. The components used
in this study were a fast readout, 16-bit monochromatic complementary metal-oxidesemiconductor (CMOS) camera (Blackfly S BFS-U3-2353M, FLIR, Wilsonville, OR) with
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a 12-mm focal length lens with the iris fixed for f/8 (M1214-MP2, Computar, Cary, NC)
and a 410 nm line laser module (Streamline Laser, Osela, Inc., Lachine, QC, Canada)
mounted on a linear translation stage (DDSM100, Thorlabs, Newton, NJ). The laser
module was focusable externally without removing any optics and had a total optical output
power of ~70 mW. It had a fixed fan angle of 18°, and the intensity distribution along the
line varied by <10%. The line laser width (1/e2) at the working distance of 54 cm was ~260
μm and had a depth of focus of ~20.5 cm. The focused laser line reflectance width in the
object plane (full width half maximum) was 780 μm on the Spectralon and 870 μm on the
turbid phantom. A detector pixel corresponded to ~125 μm x 125 μm in the object plane.
Once a line scanning image stack was collected, wide-field reflectance
demodulation was accomplished using a custom MATLAB (v2020a, Mathworks, Inc.,
Natick, MA) script that performed the following steps on each sequential image (built-in
MATLAB functions listed in parentheses):
1. Intensity thresholding (imbinarize) created a binary map isolating each laser line.
2. Morphological skeletonization (bwskel) reduced each thresholded line to a onepixel thick line.
3. Morphological dilation (imdilate with a disk structural element) widened each onepixel thick line to the desired spatial gate width.
4. Rejected pixels (zero-valued elements) in the resulting binary mask were converted
to Not-a-Number (NaN) datatype elements, and the resulting mask was applied to
the image.
The final step in line scanning demodulation involved pixel-by-pixel averaging across all
acquired images while ignoring NaN elements (nanmean). Line scanning requires several
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images for wide-field demodulation, unlike the three phase images needed for SFDI
demodulation. However, a line laser can provide optical power densities that are orders of
magnitude greater than those projected by DMD-based systems, and a fast readout CMOS
camera enables imaging at frame rates that are 10s to >100 fps. With these components,
wide-field (i.e., 10 – 100s of cm2) sd-LSI scanning is feasible in 1 to 10s of seconds. For
all demodulated line scanning images presented in this study (Figure 7.5 and Figure 7.6),
the translation stage moved at a constant rate of 0.33 cm/s, triggering the camera every 250
μm, for a total distance of 10 cm. Thus, each scan involved a total of 400 images and took
~30 s. Exposure time was adjusted between 10 ms (for Spectralon in Figure 7.5, the paper
target in Figure 7.6) and 15 ms (for the turbid phantom in Figure 7.5).

(a)

(b)
ROI 1

(c)

(d)

ROI 2

Figure 7.5 (a) Black board (ROI 1) next to 99% reflectance Spectralon standard or turbid phantom (ROI 2,
Spectralon pictured) with a 5-mm scalebar. Relative dynamic range quantified using (b) SFDI images with
respect to discrete spatial frequencies of modulation (λ = 600 nm, shown with fitted curves) and (d) line
scanning with respect to spatial gate cutoff frequency (λ = 410 nm). In (c), reflectance cross sections from
the Spectralon (solid line) and the turbid phantom (dashed line) are shown with a noise floor threshold (red
line) defining the maximum gate width for imaging the Spectralon (blue lines, δ ≈ 18 mm) and turbid phantom
(green lines, δ ≈ 22 mm). Corresponding fc values are shown in (d) along left edge with the same coloring.

To quantitatively compare SFDI and line scanning, the relative dynamic range of
each approach was measured using the 99% reflectance Spectralon standard and the turbid
phantom. A piece of highly absorbing ~1 mm thick black board (Thorlabs, Newton, NJ)
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was set on top of the Spectralon standard and the turbid phantom to make two high-contrast
imaging targets. A region of interest (ROI) was defined on each side of each target (Figure
7.5a). Relative dynamic range was defined as ΔI/Io, where ΔI was the absolute difference
in intensity between the two ROIs at a given fx (or fc), and Io was – in the case of SFDI –
the average intensity from the bright region (ROI 2 in Figure 7.5a) under diffuse (i.e., fx =
0 mm-1) illumination or – in the case of the line scan – the peak line laser intensity reflected
from the bright region. SFDI relative dynamic range was measured with respect to discrete
spatial frequencies of modulation (Figure 7.5b). At the highest frequency (fx = 1.37 mm1

), sd-SFDI yielded a relative dynamic range of ~2% for both the Spectralon standard and

the turbid phantom. The relative dynamic range achieved by line scanning was measured
with respect to high-pass cutoff frequency (Figure 7.5d). As the spatial gate narrowed, the
relative dynamic range achieved by line scanning monotonically increased. At the limit,
which corresponded to a δ equal to the width of a single pixel, the relative dynamic range
of line scanning reached 91% for the black board/Spectralon standard and 72% for the
black board/turbid phantom. The relative dynamic range tended toward zero for the lowest
fc values, because the spatial gate was significantly wider than the blurred laser line
reflectance profile, and the line scanning demodulation was skewed by light detector noise.
This trend demonstrates the importance of defining a maximum practical δ
depending on the imaging setup and target medium, a process that is demonstrated in
Figure 7.5c. The maximum practical δ was defined by a threshold at three standard
deviations above the mean noise floor intensity of a representative image (15 ms exposure
time, red horizontal line in Figure 7.5c). These maximum practical δ values (and
corresponding fc values) are shown as blue vertical lines (for Spectralon) and green vertical

126

lines (for the turbid phantom) in Figure 7.5c-d. Importantly, the horizontal axes in Figure
7.5b and Figure 7.5d are not equivalent, given that fx depicts a discrete spatial frequency,
and fc represents a high-pass cutoff spatial frequency. The key point is that for high spatial
frequencies of modulation, the relative dynamic range achieved by sd-SFDI is low, while
that achieved by sd-LSI is quite high. The peak relative dynamic range that sd-LSI can
achieve depends on the light detector resolution in the imaging plane, the focus and λ of
the line laser, and the optical properties of the target. Notably, by adjusting the source light
intensity and/or camera gain in combination with moving the spatial gate away from the
incident laser line, line scanning with spatial gating can achieve high relative dynamic
range independent of δ.

(b)

(c)

(f)

(g)

(d)

(e)

(h)

(i)

(a)

Figure 7.6 A liquid paper target displaying the Dartmouth College Pine logo demonstrates SFDI and active
line scanning sensitivity to scattering microtexture. (a) The target as it appears to the naked eye with a 1-cm
scalebar, showing the construction paper (dark blue) and painted outline (light blue) regions. (b) SFDI
modulation at fx = 0.05 mm-1 and (c) corresponding demodulated reflectance image. (d) SFDI modulation at
fx = 0.61 mm-1 and (e) corresponding demodulated reflectance image. (f) Close-up of a laser line with δ = 5
mm (red lines) and a 1-mm scalebar and (g) corresponding demodulated reflectance image. (h) Close-up of
a laser line with δ=1 mm and (i) corresponding demodulated reflectance image. All images are shown without
histogram stretching and are windowed to the same intensity range.

To demonstrate the dynamic range of sd-SFDI and sd-LSI in the context of widefield feature detection, an 8 cm2 imaging target was composed of white construction paper

127

with a painted liquid paper outline of the Dartmouth College Pine logo. The target as it
appears to the naked eye (Figure 7.6a) exhibited low contrast. SFDI with modulation at fx
= 0.05 mm-1 (Figure 7.6b) and fx = 0.61 mm-1 (Figure 7.6d) yield demodulated images
with decreasing dynamic range, shown in Figure 7.6c and Figure 7.6e, respectively.
Subplots Figure 7.6f and Figure 7.6h show close-up (1 cm2) images of a single laser line
illustrating spatial gates (red lines) of δ = 5.0 mm and δ = 1.0 mm, respectively. The slight
asymmetry of the lines in Figure 7.6f and Figure 7.6h is due to the off-axis projection of
the line laser. The corresponding demodulated line scanning images are shown in Figure
7.6g and Figure 7.6i. All images in Figure 7.6 are shown without histogram stretching and
using the same intensity range. Line scanning with a narrow spatial gate more effectively
picks out scattering microtexture from the liquid paper while maintaining a relatively high
dynamic range (Figure 7.6i). Finally, to compare image quality between the SFDI and line
scanning reflectance images in Figure 7.6, the contrast-to-noise ratio (CNR) was
quantified between the brighter construction paper background (dark blue ROI in Figure
7.6a) and the lower intensity painted liquid paper (light blue ROI in Figure 7.6a). CNR
was defined as |Ipaper – Ipaint|/σpaper, where Ipaper was the average intensity in the paper ROI,
Ipaint was the average intensity in the liquid paper ROI, and σpaper was the standard deviation
of the paper ROI. The low fx (Figure 7.6c) and high fx (Figure 7.6e) SFDI images exhibited
CNR values of 0.6 and 0.2, respectively. The wide δ (Figure 7.6g) and narrow δ (Figure
7.6i) line scanning reconstructions exhibited CNR values of 2.6 and 3.7, respectively.
Sd-LSI can be used for wide-field, localized scatter imaging of the surface layer of
a turbid medium and requires just a few inexpensive components – a line laser source,
translation device, and a light detector. Results here indicate that sd-LSI provides superior
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relative dynamic range at high spatial frequencies of modulation, overcoming the low
dynamic range of sd-SFDI. sd-LSI also exhibits increased CNR at higher spatial
frequencies of modulation. In sd-LSI, a tradeoff exists between the gate width and the
resolution of the sd-LSI scanning. As the gate narrows, the translation distance between
sequential images in sd-LSI should be reduced, and the total number of images in the scan
should be increased to maintain demodulated image quality. High frequency noise along
the dimension of translation arises in sd-LSI when very narrow spatial gating is used. This
noise can be effectively filtered in the Fourier domain, where peaks in the two-dimensional
Fourier transform along the dimension of translation and far from the DC element can be
isolated and removed.
This study demonstrated the concept of sd-LSI using only flat imaging targets. This
simple geometry enabled consistent line laser modulation and avoided specular reflection
artifacts. In practice, however, the target of interest may have a complex surface profile
(e.g., a biological tissue sample). Recent SFDI studies used optically clear acrylic plates to
fix tissue samples, effectively providing a flat object plane to mitigate specular reflections
and demodulation artifacts [123,152]. Three-dimensional surface imaging is possible using
a wide range of optical structured light systems and illumination patterns [159], and optical
line scan or laser stripe systems dedicated for 3D surface profilometry are common for
industrial applications. In theory, the same principles could be implemented with sd-LSI
to correct for the surface profile of the target.

7.4 Conclusions
The goal of this study was to achieve high contrast, high dynamic range sub-diffuse
imaging over a wide field of view. Sd-LSI achieves this goal relative to sd-SFDI. While
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beyond the scope of this work, sd-LSI can in principle be used to extract quantitative
information from turbid media, including μs', μa, and a phase function parameter (e.g., γ
from Ref. [110], psb from Ref. [203]). Future work could involve sd-LSI optical property
quantification based on an approach similar to that used in single fiber reflectance
spectroscopy [203], leveraging multi-line laser technology to increase scanning speed, and
multispectral sd-LSI, enabling wide-field, sub-diffuse reflectance color imaging for rapid
detection of surface layer features in turbid media.
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Chapter 8 Intraoperative multimodal imaging of breast resection
margins
This chapter builds on the concept of improved margin assessment through multimodal
imaging, which was discussed in Chapter 2 (Section 2.3.2) and has been suggested recently
in the literature:
“… there is no reason why one couldn’t build a compound micro-[computed
tomography]/optical device, which would collect both X-ray data in the mass of the
specimen, and optical data on the surface of the specimen, so as to allow the surgeon and
pathologist to locate areas of concern with X-rays and go in for closer high-resolution
surface images optically.” – DiCorpo et al. 2020 [70].
This chapter is a manuscript in preparation that reports recent clinical trial results involving
intraoperative imaging of breast-conserving surgery (BCS) primary specimens
immediately after resection using both micro-computed tomography (micro-CT) and
spatial frequency domain imaging (SFDI) (ClinicalTrials.gov Identifier: NCT04257799).
The trial demonstrated the feasibility and workflow of intraoperative, multimodal imaging
for BCS margin assessment. The significance of the results reported in this chapter are
limited, primarily a result of relatively few pathologically positive margins in the trial
dataset. Nevertheless, micro-CT scanning coupled with radiological interpretation
outperformed standard margin assessment techniques for detecting positive margins. The
optical imaging was found to be of limited value given that it was not well suited for
analyzing irregular tissue surfaces, and the optical imagery could not be co-registered with
histopathology for ground truth validation (discussed further in Section 8.4).

8.1 Introduction
Breast cancer is currently the second-leading cause of cancer death among women in the
United States [2]. For early-stage cancers, BCS combined with radiation therapy is the
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most common course of treatment [5]. BCS involves local excision of breast cancer with a
surrounding margin of healthy tissue, while preserving the shape and appearance of the
breast. Achieving margins free of cancer is important, because a two-fold increase in
ipsilateral breast cancer recurrence is associated with positive margins [7–14]. The success
of BCS hinges on the ability of the surgical team to assess resection margins thoroughly
and rapidly during the initial procedure to avoid costly re-excision procedures that are
associated with increased patient distress, worse cosmetic outcomes [34,35], and increased
medical costs [36–41].
The overall re-excision rate due to positive margins is 17.2% based on a recent
analysis of Medicare claims, which found that a total of 185,227 initial BCS cases resulted
in 31,949 re-excisions between 2014 and 2017 [31], and a recent metanalysis of 30 peerreviewed clinical studies between 2014 and 2019 found a wide range of BCS re-excision
rates (1-23%) [32]. A very recent study tracked the BCS re-excision rates of 55 surgeons
between 2016 and 2020 at one integrated healthcare consortium; the overall re-excision
rate was 18.8% based on 9,054 total BCS procedures, and the individual surgeon reexcision rate varied from 7.8% to 36.8% [33]. A need exists for improving intraoperative
margin assessment, such that positive margin rates, and thus re-excision procedures,
become less frequent.
Current methods for intraoperative margin assessment in BCS include visual
inspection and palpation of the resected tissue, meticulous recording of resection
anatomical orientation using surgical ink and/or sutures, projection specimen radiography,
radiosensitive wire or surgical clip localization, and at some medical centers, routine
circumferential cavity shaving and intraoperative pathological processing [15]. Wire or
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surgical clip localization is used to identify the approximate center of nonpalpable cancers
but offers little information about the extent of disease. Although intraoperative
pathological processing provides high diagnostic accuracy (sensitivities of 73-91%) [16–
19], these methods are resource-intensive and time-consuming (~30 minutes per case)
[16,18]. Routine circumferential cavity shaving reduces re-excision rates substantially
(rates of 8-10% with vs. 21-24% without routine cavity shaving) [20–22]. However, the
technique necessitates the removal of increased volumes of tissue, raising cosmetic
concerns [18], and adds to procedural costs [21]. X-ray-based, projection specimen
radiography is a mainstay for intraoperative margin assessment. Importantly, overlapping
features and the margins normal to the imaging axis (typically the superficial and deep
margins) are occluded in the projection and cannot be assessed thoroughly. This limitation
may contribute to the fact that specimen radiography suffers from relatively low sensitivity
(pooled sensitivity of 53% from nine studies [18]) for assessing margin status. These
methods of intraoperative margin assessment provide value during BCS, but investigation
of additional margin assessment techniques is still warranted.
A multitude of novel technologies are under investigation for improved margin
assessment during BCS, including intraoperative ultrasonography, radiofrequency
spectroscopy, bioimpedance spectroscopy, micro-CT, optical coherence tomography, ex
vivo magnetic resonance imaging, photoacoustic microscopy, and fluorescence probes
[58]. These technologies are at various stages of preclinical and clinical evaluation, and
one or more of these techniques may be adopted in BCS for improved margin assessment.
Several studies have evaluated micro-CT for intraoperative margin assessment
during BCS, reporting a relatively wide range of performances for detecting positive
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margins: specimen-level sensitivities of 38-94% and specificities of 67-100% with sample
sizes ranging from 30 to 200 specimens (see Chapter 2) [65–67,70,73,204]. Micro-CT
provides rapid, volumetric scanning of an entire BCS resection with reconstruction
resolution ranging from 45-150 μm3 voxels [65,70]. The objective of this study was to
evaluate the performance of micro-CT as a tool for detecting positive margins during BCS
procedures performed at an outpatient surgery clinic where only intraoperative visual
inspection, margin palpation, and specimen radiography are used for margin assessment,
and only targeted cavity shaves are performed.

8.2 Materials and methods
8.2.1 Imaging system
The imaging system used in the trial was an upright In Vivo Imaging System SpectrumCT
(PerkinElmer, Hopkington, MA). Micro-CT settings reported previously [65] and known
to provide reasonable contrast, high-resolution, and rapid scanning were used (i.e., 50 kVp,
1 mA, 720 projections, 100 ms/exposure, 150 μm3 voxels, <4 min for acquisition and
reconstruction). Each specimen was placed in a specimen holder comprised of two
optically clear acrlyic plates with anatomical labels that were held together by four threedimensional (3D)-printed, flexible rubber clamps.

8.2.2 Study design
The study was a prospective, single-arm, observational study that enrolled 117 patients. It
was conducted at the Dartmouth Heath Outpatient Surgery Center in Lebanon, New
Hampshire, between February 2020 and January 2022 and was approved by the Dartmouth
Health Institutional Review Board. Each enrolled patient signed an informed consent form.
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Inclusion criteria were women 18 years of age or older, histologic diagnosis of invasive
breast cancer based on pre-surgical core biopsy, and the ability to give informed consent.
Exclusion criteria were patients with an expected BCS specimen size greater than the
specimen holder (i.e., >10 cm x 10 cm x 5 cm), prisoners, and cognitively impaired adults.
All patients were eligible for BCS and had no prior breast surgery or implants. The imaging
system was stationed in the surgical suite within 100 feet of the operating room (OR).
Each BCS involved a routine lumpectomy performed by a single surgical
oncologist with over 30 years of experience and proceeded according to Dartmouth Health
standard-of-care. Immediately upon completing tissue resection, the surgeon palpated the
six anatomical margins of the specimen (i.e., superficial, deep, cranial, caudal, medial, and
lateral), assessing each tissue edge for potential cancer involvement. The whole, un-inked
specimen was taken from the OR, placed on the specimen holder (Figure 8.1a-b), and
imaged in the surgical suite by a nonclinical member of the study team. One micro-CT
scan was performed, generating a volumetric map of X-ray attenuation (Figure 8.1c-d).
After imaging, the specimen was returned to the OR, the six margins of the specimen were
inked by the surgeon, and the specimen was imaged via projection specimen radiography.
The tissue was then transported to the Gross Pathology Laboratory for standard
histopathological processing (i.e., gross sectioning, paraffin embedding, hematoxylin and
eosin staining). Specimen transport to/from the OR and imaging for this study took <10
minutes per case. All clinical staff members were blinded to the micro-CT imagery, and
patient care was not impacted by the study.
Blinded, board-certified breast radiologists independently interpreted the standard
specimen radiograph (two readers) and the specimen micro-CT scan (three readers). Each
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radiological read was performed post-operatively and took ~5 minutes per case. Readers
were allowed to access patient history, preoperative images, and preoperative biopsy data.
However, they were not allowed to reference pathology information. For every margin in
the specimen radiograph and in the micro-CT scan, a status (i.e., negative or positive for
tumor on the margin) was recorded. Micro-CT radiological interpretation was performed
using 3D Slicer (v4.11) [205], a free and open-source medical image analysis software
program. Each radiologist was trained to use the software interface prior to the study. Each
scan was visualized with consistent contrast and with three orthogonal planes displayed
simultaneously (Figure 8.1e-g). Scans were analyzed based on the radiodensity (i.e., image
intensity) and macroscale morphology (i.e., structural features) in the micro-CT scan. Final
margin statuses, based on 1) margin palpation by the surgeon, 2) radiologists’ readings of
the specimen radiograph, and 3) radiologists’ readings of the specimen micro-CT, were
compared to those provided in the pathology report. Primary resection volume and surface
area were also calculated using the micro-CT scan and 3D Slicer Segmentation Editor tools
[206].
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Figure 8.1 Representative breast-conserving surgery specimen micro-CT scan. (a) Specimen holder
comprised of acrylic plates with laser-etched margin labels and 3D-printed rubber clamps, ready to receive
tissue. (b) Specimen in holder ready for scanning. (c)-(d) Volumetric rendering of micro-CT X-ray
attenuation; large margin labels and solid lines depict margins closest to the viewer, while small margin labels
and dashed lines depict margins farthest from the viewer. Radiological interpretation was performed using
three orthogonal planes displayed simultaneously in the 3D Slicer interface: (e) transverse plane, (f) coronal
plane, and (e) sagittal plane.

Analysis was only performed on primary lumpectomy specimens. Targeted cavity
shaves were guided only by standard-of-care surgeon visual inspection, surgical palpation,
and specimen radiography. If a specimen (plus any cavity shaves) yielded one or more
positive margins as determined by gold standard histopathology, the patient underwent a
BCS re-excision procedure according to standard-of-care at Dartmouth Health. Imaging of
cavity shaves and/or re-excision specimens was beyond the scope of this study.
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8.2.3 Statistical analysis
All statistical analyses were performed using MATLAB (v2021a, Mathworks,
Natick, MA). The primary study endpoint was the ability of a trained breast radiologist to
assess the presence of malignant tissue on the margins of primary BCS resections using
mico-CT, relative to gold standard histopathological examination. Performance metrics of
sensitivity, specificity, and accuracy with 95% Clopper-Pearson confidence intervals,
quantified on the margin-level (n=600) and on the specimen-level (n=100), were reported
for each margin assessment method (i.e., surgical palpation, standard specimen
radiography, specimen micro-CT). Fleiss’ kappa was used to evaluate inter-reader
agreement between the two sets of specimen radiography readings and three sets of microCT readings.
McNemar’s Chi-squared test was used to determine whether two diagnostic tests
(e.g., standard specimen radiography and specimen micro-CT reader 1) yielded statistically
equal marginal frequencies of negatives and positives. A p-value ≤ 0.05 was considered
statistically significant, indicating rejection of the null hypothesis of marginal homogeneity
(i.e., the two diagnostic tests in question were not statistically equivalent).
For specimen-level performance, the following results applied: first, a true negative
reading required that a technique correctly identified all margins as negative; second, a
false positive reading resulted if all margins were pathologically negative, but a technique
erroneously reported ≥1 positive margins; third, a true positive reading resulted if ≥1
margins were pathologically positive, and a technique correctly identified ≥1 involved
margins as positive; and fourth, a false negative reading resulted if ≥1 pathologically
positive margins were missed by a technique.
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8.3 Results
Analysis was performed on 100 primary BCS resections from 100 of 117 enrolled patients
(Figure 8.2). Eleven patients were not imaged due to scheduling conflicts (i.e., imaging
staff were unavailable, or the case could not be performed at the Outpatient Surgery
Center). Three more patients were not imaged, because consent was withdrawn prior to
surgery. One patient expired prior to surgery due to complications unrelated to their breast
cancer diagnosis. Two patients were imaged, but the image data were lost due to a technical
error. All six anatomical margins were analyzed on each specimen. In summary, 600
margin-level measurements and 100 specimen-level measurements were made.

Figure 8.2 Flowchart of enrolled patients in the study cohort.

The mean patient age was 62.9 years (38-91 years), and 93% of patients were of
white/non-Hispanic ethnicity. Patient demographics and preoperative information are
summarized in Table 8.1. Twenty-five patients (25%) had invasive ductal carcinoma
(IDC), 50 patients (50%) had IDC plus ductal carcinoma in situ (DCIS), one patient (1%)
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had pure DCIS, twenty-two patients (22%) had invasive lobular carcinoma (ILC), and two
patients (2%) had ILC plus pleomorphic lobular carcinoma in situ (LCIS). Tumor
pathology information is summarized in Table 8.2.

Table 8.1 Patient demographics and preoperative information.
Parameter
Age (yrs), n (%)
Mean (STD)
<40

Value (%)
62.9
1

(10.9)
(1)

40-50
50-60
60-70
>70
Race/ethnicity, n (%)
White/non-Hispanic

10
25
40
24

(10)
(25)
(40)
(24)

93

(93)

White/Hispanic or Latina
White/Unknown
American Indian or Alaska native
Unknown
Body mass index (kg/m2), n (%)
Mean (STD)

2
3
1
1

(2)
(3)
(1)
(1)

28.8

(6.3)

<18.5
18.5-25
25-30
>30
Tumor side, n (%)
Left

0
35
27
38

(0)
(35)
(27)
(38)

52

(52)

Right
Surgical guide wire present, n (%)
No
Yes
Surgical clip(s) present, n (%)
No

48

(48)

24
76

(24)
(76)

2

(2)

98

(98)

Yes
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Table 8.2 Tumor pathology information.
Parameter
Tumor type, n (%)
IDC

Value

IDC + DCIS
DCIS
ILC
ILC + Pleo LCIS
IDC subtype component*, n (%)
IDC low grade

25

(25)

50
1
22
2

(50)
(1)
(22)
(2)

27

(27)

IDC inter-grade
32
(32)
IDC high grade
15
(15)
Mucinous
2
(2)
*
One specimen presented with two foci of different grades (lowand inter-grade IDC), so a total of 76 IDC subtype components
are tallied from a total of 75 IDC specimens.

Primary resection volume, surface area, and weight data are reported in Table 8.3.
Resection volume was approximated using a ruler along the three anatomical axes of the
specimen according to standard-of-care pathological processing. Resection surface area
based on pathology report data was approximated assuming a cuboid geometry. Primary
resection volumes and surface areas were also calculated using the micro-CT scan and 3D
Slicer segmentation tools for comparison to standard-of-care pathology measurements.
Primary resection volumes and surface areas calculated from micro-CT scan data were
significantly lower than those reported in pathology reports (volume: paired t-test p-value
< 0.001; surface area: paired t-test p-value < 0.001).
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Table 8.3 Primary specimen size and weight data.
Parameter
Pathology report specimen volume (cm3)
Mean (STD)
Minimum
Maximum
Pathology report specimen surface area (cm2)
Mean (STD)
Minimum
Maximum
Pathology report specimen weight (g)
Mean (STD)
Minimum
Maximum
Micro-CT specimen volume (cm3)
Mean (STD)
Minimum
Maximum
Micro-CT specimen surface area (cm2)
Mean (STD)
Minimum
Maximum

Value
111.2

(65.2)

20.7
371.2
148.8
48.9
353.5

(56.0)

56.6
12.0
207.0

(30.9)

58.4

(30.5)

16.7
212.1
116.1
52.8
297.5

(42.0)

Of the 600 margins assessed, 3.5% (21/600) of margins were positive for cancer.
Positive margins were mainly due to high grade IDC (28.6%, 6/21) and ILC (23.8%, 5/21)
lesions. The anatomical margins responsible for the greatest share of positives were deep
and cranial, each being responsible for 23.8% (5/21) of positive margins recorded. Fourteen
(14%) primary resections contained at least one positive margin per histology. A total of
27 (27%) cases involved one or more targeted cavity shaves during the initial procedure,
effectively remedying three margin-positive cases. Consequently, eleven (11%) cases
necessitated re-excision procedures. Margin-level and specimen-level characteristics are
summarized in Table 8.4 and Table 8.5, respectively.
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Table 8.4 Margin status characteristics.
Parameter
Margin-level histologic assessment, n (%)
Negative margins
Positive margins
Pathology
IDC low grade
IDC inter-grade
IDC high grade
Mucinous
DCIS
ILC
Pleomorphic LCIS
Anatomical margin
Superficial
Deep
Cranial
Caudal
Medial
Lateral

Value
579

(96.5)

21

(3.5)

4
2
6
0

(19)
(9.5)
(28.6)
(0)

3
5
1

(14.3)
(23.8)
(4.8)

3
5

(14.3)
(23.8)

5
2
3
3

(23.8)
(9.5)
(14.3)
(14.3)

Table 8.5 Specimen status characteristics.
Parameter

Value

Specimen-level histologic assessment*, n (%)
Margin-negative specimens
Margin-positive specimens
Targeted shave(s) taken, n (%)
No
Yes

86
14

(86)
(14)

73
27

(73)
(27)

Re-excision procedure performed, n (%)
No
89
(89)
Yes
11
(11)
*
A “margin-positive specimen” is one that has ≥1 positive
margins.

Margin-level performance by surgical palpation yielded a sensitivity of 14.3%
(three true positive detections) and by specimen radiography yielded sensitivities of 4.814.3% (one and three true positive detections). Meanwhile, radiological interpretation of
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micro-CT yielded sensitivities ranging from 23.8-43.9% (based on 5-9 true positive
detections). Margin-level margin assessment performance is reported in Table 8.6. Interreader agreement evaluating specimen radiographs for margin involvement was “fair” on
a margin-level (two readers; Fleiss’ κ = 0.26; 95% confidence interval of 0.24-0.28). Interreader agreement evaluating micro-CT scans for margin involvement was also “fair” on a
margin-level (three readers; Fleiss’ κ = 0.36; 95% confidence interval of 0.34-0.37). Each
micro-CT reader exhibited statistically distinct marginal frequencies of negatives and
positives on a margin-level relative to surgical palpation (McNemar’s Chi-square ≥ 26.5,
p-value < 0.001) and specimen radiography (McNemar’s Chi-square ≥ 35.3, p-value <
0.001).

Table 8.6 Margin-level assessment performance with 95% Clopper-Pearson confidence intervals.
Parameter
Performance, n (95% CI)
Surgical palpation
Specimen radiography reader 1
Specimen radiography reader 2
Micro-CT reader 1
Micro-CT reader 2
Micro-CT reader 3

Sensitivity
14.3 (3.1-36.3)
14.3 (3.1-36.3)

Value
Specificity
97.2 (95.6-98.4)
97.9 (96.4-98.9)

Accuracy
94.3 (92.2-96.0)
95.0 (92.9-96.6)

4.8
28.6
23.8
43.9

97.8
88.8
89.8
87.7

94.5
86.7
87.5
86.2

(0.1-23.8)
(11.3-52.2)
(8.2-47.2)
(21.8-66.0)

(96.2-98.8)
(85.9-91.2)
(87.0-92.1)
(84.8-90.3)

(92.4-96.2)
(83.7-89.3)
(84.6-90.0)
(83.1-88.8)

On a specimen-level, surgical palpation correctly identified positive margins in
21.4% (3/14) of margin-positive specimens, and specimen radiography correctly identified
positive margins in 7.1-21.4% (1/14-3/14) of margin-positive specimens. Meanwhile,
micro-CT correctly identified positive margins in 35.7-50.0% (5/14-7/14) of marginpositive specimens. Specimen-level performance is reported in Table 8.7. Inter-reader
agreement evaluating specimen radiographs for margin involvement was “moderate” on a
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specimen-level (two readers; Fleiss’ κ = 0.41; 95% confidence interval of 0.35-0.46). Interreader agreement evaluating micro-CT scans for margin involvement was also “moderate”
on a specimen-level (three readers; Fleiss’ κ = 0.45; 95% confidence interval of 0.42-0.48).
Each micro-CT reader exhibited statistically distinct marginal frequencies of negatives and
positives on a specimen-level relative to surgical palpation (McNemar’s Chi-square ≥ 5.0,
p-value ≤ 0.026) and specimen radiography (McNemar’s Chi-square ≥ 12.0, p-value <
0.001).

Table 8.7 Specimen-level assessment performance with 95% Clopper-Pearson confidence intervals.
Parameter
Performance, n (95% CI)
Surgical palpation
Specimen radiography reader 1
Specimen radiography reader 2
Micro-CT reader 1
Micro-CT reader 2
Micro-CT reader 3

Sensitivity
21.4 (4.7-50.8)
21.4 (4.7-50.8)

Value
Specificity
82.6 (72.9-89.9)
88.4 (79.7-94.3)

Accuracy
74.0 (64.3-82.3)
79.0 (69.7-86.5)

7.1
42.9
35.7
50.0

88.4
62.8
68.6
55.8

77.0
60.0
64.0
55.0

(0.2-33.9)
(17.7-71.1)
(12.8-64.9)
(23.0-77.0)

(79.7-94.3)
(51.7-73.0)
(57.7-78.2)
(44.7-66.5)

(67.5-84.8)
(49.7-69.7)
(53.8-73.4)
(44.7-65.0)

8.4 Adjuvant optical imaging
The secondary objective of the clinical trial was to investigate the value of wide
field-of-view optical scatter imaging (i.e., sub-diffuse SFDI) [119] as an adjuvant
intraoperative imaging modality for detecting positive margins on intact, un-inked BCS
specimens immediately after resection. The optical imaging component of this trial built
on previous studies [75,152,207] (Chapter 4 through Chapter 6) that used optical scatter
imaging to analyze representative BCS tumor slices.
Wide field-of-view optical scatter imaging was performed at four wavelengths
(490, 550, 600, 700 nm) and a single spatial frequency of illumination (1.37 mm-1), settings
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used in previous studies of BCS tissues [75,207]. Optical image acquisition and
reconstruction took <2 additional minutes per side and took place immediately after microCT scanning. Optical imaging of the superficial margin was performed, and then the
specimen in its holder (Figure 8.1a) was flipped, and imaging of the deep margin wsa
performed (thus adding 3-4 minutes total to the imaging routine). The multimodal imaging
routine (combined micro-CT and optical scaning) took 10-12 minutes per case.
Results from the optical imaging were of limited value for the follow three key
reasons: first, the optical scatter imaging technique required flat tissue surfaces for accurate
measurements, thereby limiting the extent of optical scanning to only the superficial and
deep margins which were optically coupled with the specimen holder plates (peripheral
margins were not scanned); second, the imaging suffered from substantial specular
reflection artifacts and steam buildup on the acrlylic plates; and third, the optical imagery
was not co-reigistered to histopathological images for ground truth validation (only
positive/negative margin statuses were reported, but no specific features or tissue sections
were annotated as being tumor or normal tissue). (See Section 9.5 for more discussion
about the optical imaging in the clinical trial.) Despite these issues, individual margins did
exhibit optical scattering structures that appeared to coregister with suspicious, radiodense
features on the margin observed in corresponding micro-CT scans. Representative
pathologically positive margins are shown in Figure 8.3, both of which are deep margins
that were occluded in the standard specimen radiograph (Figure 8.3d and Figure 8.3h).
The figure highlights the key advantage of micro-CT to enable evaluation of the full
specimen volume over projection-based specimen radiography, which is standard-of-care
at most medical centers today.
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Figure 8.3 Two representative BCS resection margins (each row) confirmed positive for invasive cancer
based on post-operative pathological analysis. The first column shows diffuse color images (i.e., as the tissue
appears to the naked eye). The second column shows optical scatter images, generated by a previously
described method [75]. The third column shows coronal plane micro-CT slices with primary tumor
segmentations by the study radiologist (green regions), corroborating the study pathologist’s report of
positive margin status and exhibiting similarity with the optical scatter features on these margins; inset
transverse and sagittal plane micro-CT images are also shown. The fourth column shows the standard-ofcare intraoperative specimen radiographs, which cannot clearly resolve the superficial and deep margins
(which are normal to the imaging axis). The 2-cm scalebar shown in (a) applies to all images.

The multimodal imaging routine in this clinical trial demonstrated the feasibility of this
type of imaging in an intraoperative context. Finally, imaging complex, irregular tissue
surfaces is a longstanding problem in biomedical optics, and the optical imaging in this
trial identified key limitations of the technique that guide future developments to improve
the optical scanning (see Section 9.4).

8.5 Discussion
Intraoperative margin assessment in BCS is an ongoing clinical problem, as the overall reexcision rate due to positive margins is 17.2% based on recent Medicare data [31], 18.8%
based on very recent results from a large integrated healthcare consortium [33], and several
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studies report wide ranges of smaller study overall re-excision rates (1-23%) [32] and
individual surgeon re-excision rates (7.8-36.8%) [33]. Emerging technologies for improved
margin assessment are at various stages of development and evaluation.
Here we report on the results of micro-CT coupled with radiological interpretation
for detecting positive margins on primary BCS resections, demonstrating specimen-level
sensitivity, specificity, and accuracy ranges of 35.7-50.0%, 55.8-68.6%, and 55.0-64.0%,
respectively. These performances offer improvement for detecting positive margins over
standard methods of intraoperative margin assessment (i.e., surgical palpation and
specimen radiography) and are within the ranges of previously published micro-CT margin
assessment study results, which reported specimen-level sensitivities and specificities of
38-94% and 67-100%, respectively [65–67,70,73,204].
The wide range of performances reported by micro-CT for BCS margin assessment
are notable, and little if any discussion in previous studies has systematically addressed the
wide range of published performance metrics for micro-CT to evaluate margins. The total
number of positive margins and positive specimens in this study was relatively low (21/600
margins were positive from 14/100 specimens) compared to other studies, such as DiCorpo
et al., who reported micro-CT margin assessment results based on 114 margin-positive
specimens and only 59 margin-negative specimens (66% of specimens were marginpositive) [70], and Kulkarni et al., who reported micro-CT margin assessment results based
on 57 margin-positive specimens from a total of 200 (29% of specimens were marginpositive) [73]. It is reasonable to assume that the differences in positive margin prevalence
between these published studies are the result of differences in standard-of-care, e.g.,
differences in surgeon experience and the routine use of different margin assessment
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techniques, such as routine cavity shaving. Differences in micro-CT radiological
interpretation could similarly be the result of radiologist experience, level of training and
experience interacting with volumetric specimen scans, and how the volumetric data are
displayed and analyzed. Furthermore, the duration of radiological interpretation is
inconsistent between these studies, ranging from ≤5 minutes [66,67,73] to “many hours”
[70], a factor that very likely impacts reported margin assessment performances, while also
impacting the relevance of micro-CT scanning for use during BCS, as extended
radiological interpretation isn’t feasible in an intraoperative context.
Machine learning approaches, e.g., using radiomics (see Chapter 6) [180,183,182]
or deep learning [90,92], can achieve tumor prognostication and 3D segmentation tasks on
volumetric medical image data. However, these quantitative analyses benefit from data that
contain few if any artifacts. In this study, 76% of cases involved a surgical guide wire;
radiological assessments noted difficultly interpreting many scans due to the presence of
substantial beam hardening artifacts from the surgical guide wires (e.g., Figure 8.4).
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Figure 8.4 Representative specimens (each row) with beam hardening artifacts from the surgical guide wire
that impacted radiological interpretation of margins (yellow arrows). The columns from left to right (red,
green, then yellow) show intersecting transverse, coronal, and sagittal planes in each scan. Only the cranial
margin of the specimen in row (a), noted by the yellow arrow, was found to be pathologically positive, while
all margins of the specimens in rows (b) and (c) were found to be pathologically negative. Images shown
here are screenshots of the 3D Slicer interface [205].

The presence of these artifacts limited the potential value of computational analysis of our
micro-CT data. Future work could involve using deep learning techniques for CT metal
artifact reduction [87,88] as a means to enable computational, quantitative analysis. It is
also feasible to consider micro-CT specimen scanning after removal of the surgical guide
wire (after specimen radiography is performed) to avoid these artifacts. Radiological
assessments also noted that several cases were difficult to evaluate given the complexity
of intervening fibroglandular tissues, which presented structures of similar radiodensity to
tumor tissue (e.g., Figure 8.5).
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Figure 8.5 Representative specimens (each row) with complex tumor and fibroglandular tissue structures
making radiological interpretation reportedly difficult. The columns from left to right (red, green, then
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yellow) show intersecting transverse, coronal, and sagittal planes in each scan. The specimen in row (a) was
found to have four pathologically positive margins (red labels and arrows), while all other specimens in rows
(b)-(e) had only pathologically negative margins. Images shown here are screenshots of the 3D Slicer
interface [205].

This finding highlights a key limitation of micro-CT, as X-ray imaging is known to offer
poor soft tissue contrast, and suggests that micro-CT scanning could be complemented by
an adjuvant modality for improved margin assessment in these complex cases [57,70,204].
A compelling potential use of 3D radiomic analysis would be to quantify the
“fibroglandular complexity” of each whole BCS resection, thereby filtering specimens
requiring additional imaging or analysis for accurate margin assessment.
Primary resection volumes and surfaces areas calculated using segmentation
analysis of micro-CT scans were significantly lower than those reported in patient
pathology reports (resection volume: 58.4.6 ± 30.5 cm3 vs. 111.2 ± 65.2 cm3; p-value <
0.001; resection surface area: 116.1 ± 42.0 cm2 vs. 148.8 ± 56.0 cm2; p-value < 0.001).
Given the high-resolution, full 3D scanning of micro-CT, these results suggest that
standard-of-care processing involving resection measurements with a ruler may result in
overestimation of tissue removed from the surgical cavity. Micro-CT scanning may
provide rapid and more accurate macroscale measurement of resected BCS tissues.
Micro-CT scanning in this study identified approximately twice as many marginpositive cases (5-7 cases identified) relative to either surgical palpation (3 cases identified)
or specimen radiography (1-3 cases identified). Standard techniques combined detected 46 margin-positive cases (i.e., if surgical palpation and/or specimen radiography reading
identified a margin-positive case), but micro-CT identified some margin-positive cases that
were missed by standard techniques. As such, if micro-CT specimen imaging coupled with
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intraoperative radiological interpretation had been used in addition to standard techniques,
it is possible that an additional four margin-positive cases could have been identified during
initial BCS, hypothetically reducing the re-excision rate to 7% from 11%. However, the
relatively low number of positive margins in the study limits the generalizability of these
results.
Future studies are needed to better capture the effectiveness of micro-CT scanning
for intraoperative margin assessment during BCS. These studies should focus on reporting
institutional standard-of-care techniques for margin assessment, along with details related
to how and when radiological interpretation is performed, and the duration allowed for
image interpretation, so that differences between published BCS specimen datasets and
reported margin assessment performances can be better understood and characterized.

8.6 Conclusions
Our results suggest that intraoperative use of micro-CT scanning for margin assessment
can meaningfully reduce the number of margin-positive initial BCS cases relative to
standard techniques. This could in turn reduce the number of costly re-excision procedures
currently burdening breast cancer patients and the healthcare system. Importantly, microCT scanning is ineffective for margin assessment in complex cases when radiodense
fibroglandular tissue structures obscure the primary lesion. In these cases, adjuvant
methods of margin assessment used in combination with micro-CT may provide value.
Finally, differences in published performances for micro-CT evaluation of margins are
substantial and should be the focus of future studies as the technology is further evaluated
for intraoperative margin assessment during BCS.
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Chapter 9 Final remarks and future work
The purpose of this chapter is to briefly summarize the key findings from Chapter 2 through
Chapter 8 and to discuss future directions beyond the scope of this thesis. Note that all
figures in this chapter are unpublished but represent preliminary next steps or results based
on previous chapters.

9.1 Micro-CT for ex vivo specimen imaging
As discussed in Chapter 2, in the last five years, micro-computed tomography (micro-CT)
has emerged as a powerful technology for ex vivo tissue specimen analysis. Micro-CT
provides full three-dimensional (3D), high-resolution (45-150 μm3 [65,70]) scans of
macroscale tissue specimens within minutes (acquisition plus reconstruction in ≤10 min
[65,66,70,73]), and coupled with radiological interpretation, can act as a surgical decisionmaking tool [204]. Micro-CT scanning for breast-conserving surgery (BCS) margin
assessment has significant momentum toward translation with several clinical research
groups around the world actively publishing on its efficacy for detecting positive margins
in BCS [49,65–67,70,73]. A key limitation of micro-CT is limited soft tissue contrast,
which is important for differentiating fibroglandular and tumor tissues on the margin of
BCS specimens [49,65,66,70,75].

9.2 Optical scatter imaging for surface tissue characterization
As discussed in Chapter 3, optical imaging can be used to extract unique contrast from
biological tissues using measurements resolved in time, space, angle, wavelength,
polarization, and/or coherence (illustrated in Figure 3.1 and Figure 3.2) [208]. The optical
imaging method studied in this thesis is wide field-of-view optical structured light imaging,
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which leverages two-dimensional (2D) spatial patterns of light and involves coupled
source- and detector-encoding for modulating and demodulating the spatial patterns of
light.
As discussed in Chapter 4, the primary optical imaging modality studied in this
thesis is sub-diffuse spatial frequency domain imaging (sd-SFDI), which uses sharp
sinusoidal patterns of light for optical scatter mapping. This type of imaging benefits from
inherently high lateral resolution and low depth sensitivity [119], thereby restricting
measured reflectance to only superficial layers of tissue (e.g., margins) with textural
patterns that can be related to different breast tissue subtypes (e.g., Figure 4.6) [152]. The
key concept introduced in this chapter is that optical scatter maps of breast cancer tissues
contain textural information that can be leveraged for surface tissue differentiation and
even classification (i.e., Figure 4.10, Table 4.3) [152].
In Chapter 5, co-registered X-ray micro-CT and optical scatter images of BCS
tumor slices revealed the important finding that, on a macroscale, X-ray attenuation and
optical scatter images exhibited similar contrast (i.e., high intensity fibrous and tumoral
tissue structures embedded in backgrounds of low intensity adipose tissue), as seen in
Figure 5.6 and Figure 5.7. This X-ray attenuation and optical scatter contrast similarity
was quantified relative to diffuse white light luminance images of the same breast tumor
specimens: 89% (51/57) of specimens exhibited increased X-ray attenuation/optical scatter
mutual information versus X-ray atenuation/diffuse white light luminance mutual
information (Figure 5.8b; 0.48 ± 0.21 vs. 0.24 ± 0.12; p-value < 0.001) and 81% (46/57)
of specimens exhibited increased X-ray attenuation/optical scatter Dice coefficients versus
X-ray attenuation/diffuse white light luminance Dice coefficients (Figure 5.8d; 0.48 ± 0.21
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vs. 0.33 ± 0.18; p-value < 0.001) [75]. However, on meso- and microscales, optical scatter
revealed intra-tumoral structures (Figure 5.9) and tumor boundary structures (Figure 5.10)
that cannot be resolved by micro-CT scanning but could be valuable for intraoperative
margin assessment.

9.3 The synergy of micro-CT and optical scatter imaging for margin assessment
Chapter 6 detailed the development of a multimodal radiomic analysis pipeline using coregistered micro-CT and multiwavelength, multi-spatial frequency SFDI data of BCS
tumor specimens. The application of radiomics to high-dimensional SFDI data was termed
“optomics” in this work [207]. The key takeaway from this chapter was that combining
feature sets from both modalities improved the detection of malignant tissue samples
relative to using either modality alone (i.e., Figure 6.5, Table 6.3). Improvement in
malignant sample detection was more pronounced when adipose samples were excluded,
which is arguably the most important classification task (i.e., the detection of malignant
samples from radiodense, fibroglandular samples) (micro-CT versus combined, AUC =
0.78 versus 0.85, p-value < 0.001). Importantly, the final performance metrics reported in
this work should not be directly compared to other proposed techniques for BCS margin
assessment, because only 2D slices of the volumetric micro-CT scans were used. Rather,
the purpose of this analysis was purely to demonstrate that multimodal radiomic analysis
improves detection of malignant samples relative to using either modality alone.
A natural extension of this work involves 3D radiomic analysis of micro-CT and
optical scatter data. Optical scatter (i.e., calibrated sub-diffuse reflectance) values from the
tissue surface could be mapped to micro-CT volume voxels on the surface of the BCS
resection and then fed into a multimodal radiomics pipeline. Software resources for this
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type of analysis are readily available, e.g., PyRadiomics natively accommodates 3D image
data [183]. Although X-ray micro-CT suffers from poor soft tissue contrast, radiodense
structures that extend from the primary lesion to the resection surface could in principle be
detected using this type of analysis, and these extensions could be coupled with surface
tissue optical reflectance measurements for potential identification of involved margins.

9.4 Active line scan imaging and future work for 3D line scanning
In Chapter 7, an alternative form of optical structured light imaging using an active line
scan was introduced and compared directly to SFDI for generating wide-field optical
scatter maps. Active line scan imaging (LSI) provides the key advantage of substantially
increased dynamic range over sd-SFDI for creating sub-diffuse reflectance (i.e., optical
scatter) maps (SFDI provides ~2% signal preservation when measuring sub-diffuse
reflectance, while LSI maintains 72-91% signal preservation when measuring sub-diffuse
reflectance; Figure 7.5) [209]. Thus, sub-diffuse LSI (sd-LSI) provides superior
demodulated dynamic range relative to sd-SFDI. However, these optical imaging
techniques (both SFDI and LSI) can only scan flat target surfaces without suffering from
demodulation and specular reflection artifacts.
The requirement for relatively flat tissue surfaces for SFDI, LSI, and many other
wide-field optical imaging approaches is a substantial limitation that may inhibit clinical
translation of these techniques (e.g., in surgical guidance in open cavities or along margins
of irregularly shaped ex vivo specimens) and one that presents a significant technical
challenge. A common solution for wide-field imaging is to employ optically clear plates to
flatten tissue surfaces [110,123,152]. However, this causes tissue compression that alters
the natural position of the tissue and can cause X-ray scattering artifacts (e.g., see the
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superficial margin in Figure 8.1g) and optical artifacts due to steam build up on the
compression plate(s) (e.g., as discussed in Section 9.5 and illustrated in Figure 9.2).
Others, e.g., developed an elaborate mechanical system to raster scan macroscale, 3D tissue
surfaces for optical BCS margin assessment [51]. However, an ideal solution involves the
extension of 2D optical imaging to full 3D, non-contact surface tissue imaging. This would
overcome the need to use optically clear plates, thereby removing the need for tissue
compression or manipulation of any kind and would avoid artifacts associated with the
plates themselves (e.g., steam buildup from freshly resected tissues). Beyond BCS margin
assessment, the advancement of optical scanning to non-contact, 3D sensing has broad
implications for optical imaging of biological tissue surfaces that are often amorphous and
irregular in shape. The ability to map sub-diffuse reflectance to complex 3D surface tissues
has potential value for a range of ex vivo and in vivo clinical applications.
The field of 3D surface optical imaging is vast, particularly in industrial
applications [210] but also in medical applications [211,212]. Conventional optical depth
sensing leverages one or more of the following general techniques: structured illumination,
stereo vision, and/or time-of-flight. Different approaches use a range of optical detector
setups and/or unique illumination schemes [159]. In recent years, the advent of 3D printing
has spurred the widespread development of commercially available desktop 3D scanners
that employ optical illumination and 360° rotation to create detailed 3D models of targets.
This conceptual design seems appropriate for optical scanning of BCS resections, given
that the recent emergence of X-ray volumetric specimen imaging (see Chapter 2) already
necessitates 360° rotation of each specimen. An ideal multimodal (i.e., X-ray volumetric
specimen imaging and optical) solution could involve simultaneous X-ray and optical
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imaging as the specimen rotates, thereby providing multimodal acquisition rapidly [213].
Initial work on this objective involved the development of a stereo vision system
for 3D depth sensing coupled with structured illumination for optical imaging (Figure 9.1),
because these approaches are relatively low-cost and applicable for short working distances
(i.e., 10s of cm). System control was streamlined through a single Python script (v3.8.5)
and used two fast readout complementary metal-oxide-semiconductor (CMOS) cameras
(Blackfly S BFS-U3-04S2C, FLIR, Wilsonville, OR), a commercial pocket projector
(Luma 150 Ultra Mini Pocket Pico Projector, Kodak, Rochester, NY), and a high-precision,
computerized rotary table and controller (B4872 and VXM Stepper Motor Controller,
respectively, Velmex, Bloomfield, NY). The cameras were controlled via the Python
Spinnaker software development kit (v 2.3.0.77), which is FLIR’s application
programming interface for camera control. The projector was controlled via the Python
multimedia library Pyglet (v1.5.16) for displaying arbitrary illumination patterns via HighDefinition Multimedia Interface connection. The rotary table was controlled via a custom
Python function script that communicated with the rotary table’s Velmex VXM controller.
The stereo cameras were calibrated using the MATLAB Stereo Camera Calibrator
App (v2021a, Mathworks, Inc., Natick, MA) and a checkerboard pattern of known
dimensions. The rotary table axis of rotation was determined using a previously described
calibration procedure [214]. Briefly, the axis of rotation was determined via the following
steps: first, a planar target was positioned orthogonally to the surface of the rotary table;
second, stereo images were acquired of the planar target at discrete angles on the rotary
table, and a 3D point cloud of the planar target was generated at each angle; third, from
each point cloud, the vector normal to the planar target was estimated; fourth, the
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intersection point of all surface normals was approximated; fourth, the plane defining the
base of the rotary table was approximated using a stereo image-derived 3D point cloud of
the planar target lying flat on the base of the rotary table; and fifth, the vector normal to
the rotary table base and including the approximated intersection point was assumed to be
the axis of rotation. Once the system was calibrated and the axis of rotation was defined, a
3D target was placed on the rotary table, and stereo image pairs were collected at a set of
discrete angles around the target. Each stereo pair of images underwent horizontal
rectification, pixel disparity calculation, then 3D point cloud generation using MATLAB
built-in

functions

rectifyStereoImages,

disparitySGM

(or

disparityBM),

and

reconstructScene, respectively. Every stereo pair generated a 3D point cloud, which then
underwent affine transformations (i.e., translation and rotation) according to the axis of
rotation calibration and the relative angle of the rotary table. After a complete scan, the 3D
target surface of could be reconstructed by combining several individual point clouds (left
pane of Figure 9.1) and compared to the micro-CT scan surface (right pane of Figure 9.1).

Figure 9.1 Prototyped stereo vision and structured light imaging system. The left pane shows the stereo
vision setup with paired CMOS cameras, pocket projector, and computerized rotary table with a silicone
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breast tumor phantom based on an actual BCS resection. The left pane also shows stereo vision 3D
reconstructions under planar white illumination. The right pane shows the corresponding micro-CT volume
and surface segmentations for the actual BCS resection, created in 3D Slicer (v4.11) [205].

Optical depth sensing was implemented using only planar white illumination with
the prototype system. However, future work should focus on the implementation of a multiline illumination scheme, through which a set of equally spaced, focused lines of light are
projected onto and swept across the target. Such an illumination scheme should in theory
enable combined depth sensing and sub-diffuse reflectance imaging using the same
approach as that described in Chapter 7 (Section 7.3).
Since the development of the stereo vision system (Figure 9.1), a commercial
partner was identified in the winter of 2022 who will contribute to the development of an
sd-LSI system with depth sensing capabilities. Ajile Light Industries is a company based
in Ottawa, Ontario, Canada, with nearly a decade of experience developing scientific grade,
custom digital micromirror device and imaging technologies for a range of industrial and
biomedical applications. Specific to the technical challenge of mapping sub-diffuse
reflectance to 3D tissue surfaces, Ajile has a commercial DepthScan 3D imaging system,
which provides true color, <100 μm depth sensing resolution over a full field of view (~4
million data points) at a rate of 2 Hz and over working distances of 25 to >100 cm. The
DepthScan 3D system leverages structured illumination (i.e., highly focused lines of light)
to extract depth information, which offers potential synergy with the sd-LSI technique
discussed in Chapter 7. In short, the DepthScan 3D software could potentially be
customized to provide validated, high-resolution depth sensing with sub-diffuse optical
scanning for thoroughly analyzing complex tissue surfaces.
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9.5 Multimodal intraoperative imaging is feasible but requires additional study
Chapter 8 detailed results from an observational clinical trial through which BCS primary
resections were imaged using micro-CT and SFDI intraoperatively, immediately after
surgical removal from the patient (ClinicalTrials.gov Identifier: NCT04257799). The trial
demonstrated that this type of multimodal imaging and specimen handling is feasible and
does not hinder clinical workflow (<10 minutes per case; n = 100 cases). Importantly,
radiological interpretation of micro-CT scans demonstrated improved detection of positive
margins over standard-of-care techniques (specimen-level sensitivities of 35.7-50.0% for
micro-CT vs. 21.4% for standard-of-care surgical palpation vs. 21.4% for standard-of-care
specimen radiography). However, the optical imaging suffered from: first, the inability to
scan irregular tissue surfaces and peripheral margins (i.e., the cranial, caudal, medial, and
lateral margins); second, substantial specular reflection and steam artifacts (e.g., red and
cyan arrows in Figure 9.2); and third, a lack of direct correlation to histological ground
truth (e.g., suspected/possible yet unconfirmed positive margin features are noted by
yellow stars in Figure 9.2e-h). Figure 9.2 also highlights the fact that margins imaged in
the trial that are confirmed pathologically negative and positive do not exhibit obvious
differences in reflectance intensity or texture. In general, the pathologically positive
margins (Figure 9.2e-h) contain relatively subtle optical scatter signatures. Also, for
example, the deep margins of Case 4 and Case 58 (Figure 9.2a and Figure 9.2d,
respectively) contain healthy fibroglandular tissue, which exhibits relatively high intensity
optical scatter, but the deep margin of Case 116, which is pathologically positive, also
contains a feature with relatively high optical scatter intensity (leftmost yellow star in
Figure 9.2h). Without direct correlation to histological ground truth, it is not possible to
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determine which optical feature(s) in Figure 9.2h (or any of the pathologically positive
margins) are spatially correlated to cancer on the margin. Because of these limitations,
intraoperative, multimodal imaging of BCS margins using micro-CT and optical scatter
requires additional study beyond that reported in this thesis.

Figure 9.2 Representative BCS margins that are intact, uninked, and imaged immediately after surgical
resection. Margins shown in (a)-(d) are confirmed pathologically negative for cancer, while margins shown
in (e)-(h) are confirmed pathologically positive for cancer. The first column in each set shows a diffuse
reflectance color reconstruction (i.e., naked eye representation), and the second column shows a sub-diffuse
(i.e., optical scatter) color reconstruction. Reconstructions were created using a previously described process
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[122]. Scalebar in (a) applies to all images. Red arrows = specular reflection artifacts. Cyan arrows = steam
artifacts. Yellow stars = suspected/possible yet unconfirmed positive margin features.

Findings from the trial motivate the proposed advancement of optical scatter
imaging such that measured reflectance is mapped to 3D tissue surfaces and the tissue need
not be compressed or manipulated in any way for imaging (discussed in Section 9.4). This
advancement would enable thorough optical scanning of intact, freshly resected BCS
specimen margins. Finally, future margin assessment imaging studies involving intact,
whole BCS resections must involve meticulous co-registration to microscopic
histopathological information (like that performed for BCS tumor slices as illustrated in
Figure 4.2) such that specific 3D image features and morphologies (in both micro-CT and
optical imagery) can be directly related to confirmed tissue (sub)types.
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